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SUMMARY OF Ms. Irene Gómez Luque’s DOCTORAL THESIS 
1. Introduction/Aims of the Thesis 
Liver cancer is the fifth most common and the second most frequent cause of cancer-related death globally. 
Hepatocellular carcinoma (HCC) represents about 90% of primary liver cancers and constitutes a major global 
health problem.  
According to the World Health Organization (WHO) the incidence rate of HCC has increased in the last three 
decades and will maintain this trend in 2030. In accordance with the last published world record, 854.000 new 
cases and 810.000 deaths are diagnosed every year, representing 7% of all cancer’s deaths.  
The prognosis of the response to treatment is different depending on the type of HCC and its status at the 
time of diagnosis. For this reason, HCC classification and choice of the most suitable treatment is relevant for a 
successful response. Surgical approach is the first treatment option in patients with very early-stage and 
preserved liver function with a 5-years OS rate around 60-80%.  
Under the EASL guidelines surgical resection is recommended as the treatment of choice in patients with HCC 
arising on a non-cirrhotic liver. Indications for resection of HCC in cirrhosis should be based on a multi-
parametric composite assessment of liver function, portal hypertension, extent of hepatectomy, expected volume 
of the future liver remnant, performance status and patients’ comorbidities. In patients with chronic liver disease 
or cirrhosis, the choice of surgical resection should be more debated and, in certain cases, discarded.  
Liver Transplant (LT) is recommended as the first-line option for HCC within Milan criteria but unsuitable for 
resection. Laparoscopic liver approach is now a standard of practice for several procedures and has overpassed 
the tip point from pioneers to being currently widely adopted by several groups. Because of cirrhotic-associated 
complexity, laparoscopic liver resection for HCC may be more complex due to different factors: liver failure, 
coagulopathy, collateral circulation, and parenchymal stifness.  
The current situation is a trend towards the expansion of laparoscopic surgery in both simple resection and 
complex hepatectomies. The early diffusion of this approach made the current Guidelines Meeting in Laparoscopic 
Liver Surgery another landmark in the field. 
2. Contents of the research 
The alternative hypothesis proposed for our study was if laparoscopic hepatic surgery offers advantages 
compared to open surgery in the management of Hepatocellular carcinoma.  
The aim of this study was to perform a systematic review and meta-analysis comparing the short- and long-
term outcomes of laparoscopic and open liver resections for hepatocellular carcinoma. To evaluate if considering 
severe morbidity, including liver-specific posthepatectomy liver failure and 90-days mortality, laparoscopic 
approach offers benefits against the open. To evaluate if laparoscopic approach has an impact on long-term 
outcomes considering overall survival and disease-free survival. To demonstrate whether laparoscopic approach 
for the treatment of hepatocellular carcinoma may be considered as the first option and in which cases it could be 
considered as standard of practice. 
To identify all the comparative manuscripts reporting on laparoscopic and open liver resection for HCC, all 
published English-language studies with more than 10 cases were screened. In addition to the primary meta-
analysis, four specific subgroup analyses were performed on patients with Child–Pugh A cirrhosis, resections for 
solitary tumors, and those undergoing minor and major resections.  
 
VIII 
The manuscripts included in the meta-analysis are subjected to a double-check quality analysis. That 
assessment was performed first under the Scottish Intercollegiate Guidelines Network (SIGN) methodology 
criteria and then in accordance with the Newcastle-Ottawa Quality Assessment Scale (NOS) for cohort and case-
control studies (Ottawa Hospital Research Institute). This double assessment of each manuscript included is 
performed to reduce the risk of biases and thus enhance the quality of their results.  
Once the first step is completed, the evidence level on the topic is produced based on the quality of the 
available literature assessed at the previous step. The next step, once the evidence tables of each manuscript have 
been made, is to produce recommendations according to the evidence found in each one of them for the 
elaboration of guidelines of liver laparoscopic surgery.  
From the initial 361 manuscripts, 28 were included in the meta-analysis. Five of these 28 manuscripts were 
specific to patients with Child–Pugh A cirrhosis (321 cases), 11 focused on solitary tumors (1003 cases), 16 
focused on minor resections (1286 cases), and 3 focused on major resections (164 cases). Three manuscripts 
compared 1079 cases but could not be assigned to any of the above subanalyses. In general terms, short-term 
outcomes were favorable when using a laparoscopic approach, especially in minor resections. The only advantage 
seen with an open approach was reduced operative time during major liver resections. No differences in long-
term outcomes were observed between the approaches. 
3. Conclusions 
 Our exhaustive literature review, and assessment of current evidence by SIGN methodology has been the 
basis for the development of the European Guidelines Meeting on Laparoscopic Liver Surgery and for the 
eachievement of consistent, reliable and evidence-based statements in the application of minimally invasive 
approaches for the treatment of hepatocellular carcinoma.  
 According to the results of our updated meta-analysis, a minimally invasive approach might be more 
beneficial compared to an open approach as it may offer a lower rate of complications, blood loss, 
transfusion rate and postoperative hospital stay for patients with Child-Pugh A cirrhosis, solitary tumors 
and those undergoing minor resections. 
 Considering severe morbidity including liver-specific posthepatectomy liver failure and 90-days mortality, 
laparoscopic approach was not different compared to open approach.  
 Laparoscopic approach does not have an impact on short-, mid- and long-term outcomes considering overall 
survival. A trend towards better disease-free survival when laparoscopic approach is used was observed but 
no robust conclusions may be obtained.  Its impact on re-do hepatectomies or on feasibility of rescue or 
salvage transplantation procedures remains unresolved. 
 Considering the optimal results obtained from laparoscopic approach, its use for the treatment of 
hepatocellular carcinoma should be considered as first option and standard of practice in selected patients 
from high-volume centers in which a multimodal strategy can be offered to these complex patients.  
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1.1.  Overview of Hepatocellular 
Carcinoma 
1.1.1.  Historical Introduction 
Liver cancer is the fifth most common and the 
second most frequent cause of cancer-related death 
globally. Hepatocellular carcinoma (HCC) 
represents about 90% of primary liver cancers and 
constitutes a major global health problem (1). 
According to the World Health Organization (WHO) 
the incidence rate of HCC has increased in the last 
three decades and will maintain this trend in 2030 
(2). In accordance with the last published world 
record, 854.000 new cases and 810.000 deaths are 
diagnosed every year, representing 7% of all 
cancer’s deaths (3). 
HCC incidence has increased according to the 
ageing of the population. The decade of the 70’s is 
the most common age for diagnosis. However, the 
distribution of age at diagnosis varies according to 
demographic characteristics of the population. In 
countries such as China or Africa, the age of 
diagnosis is lower. The incidence of HCC is more 
frequent in male than in female with a ratio of 2-
2.5:1 (4). Geographical distribution of HCC does not 
show a clear pattern. A high incidence can be 
observed in East of Asia and South of Africa with 
another hot zone in the South of Europe. At the 
moment, an HCC’s pattern of distribution has not 
been described yet despite the increase of its 
incidence in recent years (Figure 1). 
 
 
Figure 1.  Incidence rates of primary liver cancer according to geographical distribution in Europe. Total 
numbers per country and age-adjusted incidence rates per 100.000 of liver cancer in Europe in 2012.  
Source: GLOBOCAN 2012. IARC 
 
Several risk factors have been reported in the 
physiopathology of the HCC. Chronic hepatitis B 
virus infection (HBV), Chronic hepatitis C virus 
infection (HCV), Non-alcoholic fatty liver disease 
(NAFLD), Non-alcoholic steatohepatitis (NASH), 
alcoholic liver disease (ALD), hereditary 
hemochromatosis and other etiologies have been 
associated with the development of HCC. 
1.1.2.  Hepatocellular Carcinoma 
Classification 
Hepatocellular carcinoma is an heterogeneous 
tumor with different onsets. It can be diagnosed as a 
single nodule on a healthy or cirrhotic liver, as a 
large lesion along more than half of the liver with or 
Impact of minimally invasive approach surgery in hepatocellular carcinoma 
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without lymph node involvement or distant 
metastases or as a multinodular tumor. 
The prognosis of the response to treatment is 
different depending on the type of HCC and its 
status at the time of diagnosis. For this reason, HCC 
classification and choice of the most suitable 
treatment is relevant for a successful response. 
Liver cirrhosis is an important prognostic factor for 
the response to treatment as well as for the 
recurrence rate in the follow-up. 
Table 1. Tumor-Node-Metastases Staging 
Stage Tumor Node Metastasis 
Stage I T1: solitary tumor without vascular invasión N0: No regional node 
metastasis 
M0: No distal metastasis 
Stage II T2: Solitary tumor with vascular invasion or 
multiple tumors <5 cm 
  
Stage IIIA T3: Multiple tumors>5 cm or tumor involving 
major branch of the portal vein 
  
Stage IIIB T4: Tumor that invades adjacent organs other 
tan gallbladder or perforates visceral 
peritoneum 
  
Stage IIIC Any T N1: Regional lymph node 
metastasis 
 
Stage IV Any T Any N M1: distant metastasis 




Figure 2.  Variables used in various HCC 
classification and staging methods.  
Incorporated serum biomarkers, such as alpha-fetoprotein. Benyam 
D et al. Classification and Staging of Hepatocellular carcinoma. An 
Aid to clinical decision-making. Clin Liver Dis 19 (2015) 277-294. 
Different classifications and staging systems 
(Figure 2) have been developed in the last decades.  
Several factors have been included. Some of 
them are common shared among them, such as size, 
numbers of nodules, location, liver dysfunction and 
performance status. Some others are not common 
and are intrinsic to each system (5).  
TNM Classification 
This system is based on the standardized solid 
tumor classification system that was reported in 
1968 by the french surgeon Pierre Denoix. The TNM 
classification (Table 1) consists of three variables, 
tumor size, the presence and extension of lymphatic 
involvement and the presence of distant metastases.  
Its limitation is that it does not take into 
account or evaluate the existing liver function. 
However, it has been proven that the TNM 
classification has greater prognostic capabilities 
than the Okuda classification or CLIP score (6). 
Okuda Classification 
The Okuda classification (Table 2) was published in 
1985 (7). This staging system was the first score in 
which the liver function is included based on the 
presence of bilirubin, ascites and albumin.  
Tumor size is another of the items included 
(greater or lesser than 50% of the liver). The way in 
which it classifies the tumoral size could be the 
main drawback of this classification since the tumor 
Tesis Doctoral  Irene Gómez Luque 
5 
size is currently an important prognostic factor for 
the choice of treatment.  
Table 2. Okuda Classification 
 0 point 1 point 
Tumor size <50% of liver >50% of liver 
Ascites No Yes 
Albumin >3 g/dL <3 g/dL 
Total bilirubin <3 mg/dL >3 mg/dL 
Stage I (0 points); Stage II (1-2 points); Stage III (3-4 points) 
Cancer of the Liver Italian Program 
This staging system is based on tumor morphology 
(nodular or multinodular), presence of portal 
thrombosis and liver function. The CLIP (Table 3) 
system was reported in 1998 (8). This classification 
has shown to be a good indicator of long-term 
results after therapies with curative intention.  
 
 
Table 3. Cancer of the liver Italian Program (CLIP) 
 0 Points 1 Points 2 Points 
Child-Turcotte-Pugh class A B C 
Tumor morphology Single tumor and <50% of liver Multiple tumors and <50% of liver >50% of liver 
Alpha-fetoprotein <400 ng/mL >400 ng/mL  
Portal vein thrombosis No Yes  
Early stage (0 points); Intermediate stage (1-3 points); Advanced stage (4-6 points) 
 
Table 4. Japanese Integrated Staging Score 
 0 Point 1 Point 2 Points 3 Points 
TNM I II III IV 
Child-Turcotte-Pugh class A  B C  
JIS Score: Sum of points 
 
Japan Integrated Staging 
The Japan Integrated Staging (JIS) is a score based 
on the combination of the TNM system and the liver 
function evaluated by the Child-Pugh classification 
(Table 4). These variables are grouped into intervals 
with a score of 0 to 5 points. The JIS system was 
updated in 2008 (9) adding serological markers to 
the variables evaluated. 
Barcelona Clinic Liver Cancer Staging (BCLC) 
In 1999, the Barcelona Clinic Liver Cancer Staging 
(BCLC) classification was described (10) and 
proposed as a classification and staging system. 
BCLC classification is based on tumor’s variables 
(size and extension, macrovascular invasion and 
extrahepatic dissemination), liver function (Child-
Pugh classification), performance status of the 
patient and the presence of any constitutional 
symptoms related with the tumor.  
The BCLC system is considered one of the best 
and more used scores for HCC classification. For this 
reason, BCLC has been chosen by the European 
Association for the Study of the Liver Clinical 
Practice Guidelines and American Association for 
the Study of Liver Disease as the main pathway to 
the clinical management of HCC. It has been 
extensively validated (11).  
This system links the tumor stage with the 
treatment strategy in a dynamic way, which is its 
greatest advantage. This characteristic allows the 
incorporation of novel advances in understanding 
the prognosis and the management of HCC (1).   
A prognostic classification that includes all the 
involved variables is difficult to obtain. The BCLC 
classification (Figure 3) allows for a clear definition 
of the prognosis for each patient as well as for the 
treatment to be applied in a more objective way. 
Impact of minimally invasive approach surgery in hepatocellular carcinoma 
6 
According to the progresses in several fields as 
oncology, radiotherapy, interventional radiology 
and especially laparoscopic liver surgery, certain 
limitations have been observed in the BCLC 
classification. Within the BCLC-B and BCLC-C stage, 
a large number of patients with very heterogeneous 
characteristics are grouped. These patients should 
be evaluated in a more individual way because some 
patients could currently benefit from more 
aggressive therapies with curative intention-to-
treat, offering  lower rate of complications.  
 
Figure 3.  The BCLC system establishes a prognosis in accordance with the five stages that are linked to first-line 
treatment recommendation. If the recommended option is not feasible because of an individual 
patient’s condition, the treatment approach for the next evolutionary disease stage should be 
considered. 
(Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012 Mar 31;379(9822):1245–55) 
 
Thanks to high resolution radiological imaging, 
HCC can be diagnosed in earlier stages. This 
improvement in diagnosis has turned in the 
definition of a new stage in the HCC classification 
(Stage 0) (12). Therefor, different modifications 
have been established with new chemotherapeutic 
schemes being added. One of the latest updates is 
the incorporation of radiofrequency for the 
treatment of HCC< 2 cm (13).  
Hong Kong Liver Cancer Prognostic Staging 
Scheme 
Hong Kong Liver Cancer Prognostic Staging Scheme 
(HKLC) is the most recent published score (14). 
HKLC (Figure 4) is similar to the BCLC classification. 
However, this score shows more aggressive 
attitudes towards patients with tumors in advanced 
stages, which leads to a better prognosis than other 
scores. HKLC is based on a chronic liver disease 
population with HBV as the leading etiology and 
may not be generalizable to regions with a high 
prevalence of hepatitis C virus or alcoholic liver 
disease-induced HCCs (5). 
1.2. Therapeutic strategies of 
Hepatocellular Carcinoma 
There is a wide range of therapeutic possibilities in 
the treatment of HCC. Techniques with curative 
intention are ablative therapies, surgical resection 
or liver transplantation (LT). Systemic 
chemotherapy treatment and support for and 
adequate treatment with palliative measures are 
strategies applied to advanced stages of the disease.  
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The different scores, referred in the previous 
section, act as a tool to identify the most suitable 
treatment for each patient with the highest survival 
rate. Due to the heterogeneity in the HCC’s 
presentation and the specificity of the current 
treatments, the decision of each treatment must be 
taken by a specialized committee including 
hepatologists, interventional radiologists, 
oncologists, liver surgeons and intensivists. 
 
Figure 4. Hong Kong Liver Cancer Stanging (5,14) 
 
1.2.1. Ablative Therapies 
Radiofrequency (RFA) and chemoembolization 
(TACE) might be considered the most used ablative 
techniques.  
RFA can be defined as the necrosis or 
destruction of tumor’s tissue using a thermal 
mechanism generated by radiofrequency (15). The 
damage caused by RFA is due to the heat friction 
produced by the ionic agitation of the particles close 
to the tissue as a consequence of the application of 
an alternate current.  
On the other hand, TACE is performed by the 
injection of a combination of chemotherapeutic 
agents with polyvinyl alcohol particles with the 
objective of embolizing the branch of the hepatic 
artery that perfuses the tumor and achieving a 
sustained release of the chemotherapeutic agent 
(generally doxorubicin, cisplatin and/or mitomycin 
C) to induce ischemia or necrosis of the tumor (5). 
RFA is a safe and effective treatment of small 
HCC in cirrhotics awaiting OLT as a bridge 
treatment or as a downstaging technique, although 
tumor size >3 cm and time from treatment >1 year 
predict a high risk of tumor persistence in the 
targeted nodule (16).  
The survival rate provided by RFA is 95.5%, 
59.7% and 32.3% at 1-, 5- and 10 years respectively 
(17). Although it could be considered a more 
innocuous treatment than surgical resection or liver 
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transplantation, RFA is not free of complications. An 
overall complication rate of 4.1% and a mortality 
rate of 0.15% have been reported in the literature 
(18). In addition, a series of absolute and relative 
contraindications have been reported since not all 
HCCs are subsidiary of ablative treatment (Table 5). 




Altered mental status 
Active infection 




More than 4 lesions 
Severe pulmonary o cardiac disease 
Refractory coagulopathy 
Courtesy of World J Gastrointest Pharmacol Ther 2016 November. 
Local ablative treatments for hepatocellular carcinoma: An updated 
review. 
Surgical resection might be considered the 
treatment of choice for HCCs. Hepatectomy and 
percutaneous RFA are the two best treatment 
options for small HCC. Current studies have been 
designed to compare the efficacy of RFA with 
surgery in early stages of HCC. Four randomized 
studies have been published comparing the results 
of both techniques, in those studies, the superiority 
of the surgical approach over the RFA in terms of 
survival and recurrence was found (19) (20) (21) 
(22).  
In these studies, no differences in survival rates 
for both methods have been found for tumors < 
2cm. However, relevant selection biases were 
observed in those studies. Patients in the RFA group 
have a poorer liver function and are older, leading 
to a worse prognosis (23) (24). By performing 
subgroup analyses, it was observed that for very 
early-stage HCC and in the presence of two or three 
nodules <3cm, RFA is more cost-effective and 
provided similar survival and recurrence rates than 
surgical resection (25). 
According to the BCLC classification, 
transarterial chemoembolization (TACE) is the first 
line of treatment for intermediate stages, which 
includes asymptomatic patients with unresectable 
or multinodular lesions, without vascular invasion 
or extrahepatic disease who have a preserved liver 
function (26).  
In the latest published reviews, the BCLC 
system accepts TACE as a treatment for patients 
with early-stage HCC in which the other therapeutic 
strategies can not be used or have failed. There are 
two options, conventional TACE-Lipidol and TACE 
with drug-eluting beads (DEB-TACE). A current 
meta-analysis has shown that there are no 
differences between both techniques in terms of 
tumor response and survival rate (27).  
Therefore, TACE could be considered an 
intention-to-treat technique that provides an 
increase in survival rate in intermediate BCLC stage 
patients. Besides, according to the current EASL 
guidelines, this technique is recommended as 
neoadjuvant therapy prior to LT, as a bridge 
treatment on the waiting list or as a downstaging 
technique to satisfy LT criteria. 
Actually, several studies have been carried out 
to evaluate the combined use of both ablative 
therapies (RFA and TACE).  
In a recent meta-analysis in which 8 RCTs were 
analyzed including 598 patients, the combination of 
both techniques offered a significantly higher 3 year 
OS rate [odds ratio (OR): 2.65, 95% CI: 1.81-3.86, P 
< 0.001] and 3-year RFS rate (OR: 3.00, 95% CI: 
1.75-5.13, P < 0.001) than the treatment with RFA 
alone, with equivalent complications rate (28).  
In the subgroup analysis, the survival rate was 
significantly higher in patients with intermediate-
stage and larger size HCC who were treated with 
this strategy than with other therapies but did not 
improve the survival rate in patients with smaller 
HCC.  
Therefore, these results concluded that the 
combination of RFA and TACE were beneficial to in 
terms of survival and recurrence rate in those HCC 
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cases classified as intermediate-stage with larger 
size. 
1.2.2. Surgical Approach 
Surgical approach is the first treatment option in 
patients with very early-stage and preserved liver 
function (29) with a 5-years OS rate around 60-
80%. Under the EASL guidelines (1) surgical 
resection is recommended as the treatment of 
choice in patients with HCC arising on a non-
cirrhotic liver.  
Indications for resection of HCC in cirrhosis 
should be based on a multi-parametric composite 
assessment of liver function, portal hypertension, 
extent of hepatectomy, expected volume of the 
future liver remnant, performance status and 
patients’ comorbidities. In patients with chronic 
liver disease or cirrhosis, the choice of surgical 
resection should be more debated and, in certain 
cases, discarded.  
The ideal patient diagnosed with HCC on a 
cirrhotic liver candidate to surgical resection was 
reported on the 2012 EASL guidelines and should 
meet several criteria: solitary tumor with preserved 
liver function, systemic-portal gradient <10 mm Hg 
or platelet count >100.000/mL. The fulfilment of all 
these requirements is very complex and unusual in 
clinical practice. These patients are much more 
complex, with greater comorbidities and a higher 
rate of postoperative complications. The choice of 
surgical treatment is based on a complex decision, 
that depends on the characteristics of each patient.  
Different advances in surgical techniques, such 
as the development of laparoscopic liver surgery 
and perioperative management have improved 
surgical outcomes in cirrhotic patients. These 
changes have led to an expansion in the inclusion 
criteria for the choice of surgical resection as the 
first therapeutic option. In this way, a greater 
proportion of patients might benefit from this 
treatment. 
EASL has established as a prognostic or risk 
factors for the surgical indication in cirrhotic 
patients the presence of portal hypertension, the 
extension of hepatectomy and liver function (Figure 
5). 
 
Figure 5.  Multiparametric assessment of the risk of liver decompensation after LR for HCC in cirrhosis.   
EASL Guidelines (2018) 
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Once the previous criteria have been met, the 
indication of the surgical approach for an HCC has to 
take into account other important factors such as 
size and location of the tumor, as well as the 
number of tumors (nodular or multifocal tumour). 
For HCCs ≤2 cm located in the peripheral 
parenchyma, liver resection by minimal-invasive 
approach is the treatment of choice. But when the 
HCCs are located deeply or centrally, RFA has to be 
considered because it offers better cost-effective 
results with the same survival rates (1).  
The size of the tumor is a very important 
prognosis factor. Studies have confirmed that post-
resection outcome decreases as the tumor size 
increases. For this reason, the threshold of 5 cm is 
considered as the limit for intermediate-stage HCC 
in Hong Kong Liver cancer Prognostic Staging. 
Certain studies propose the extension of surgical 
approach for patients in BCLC stage B and C, as long 
as the extension of the resection and the liver 
function are taken into account (30).  
Others important published factors that have 
been evaluated and must be fulfilled to obtain a 
successful resection are: MELD≤9, Child-Pugh A and 
PS<2 (31). In multifocal HCCs, the choice of 
treatment is still under debate. The published 
studies may be biased due to their retrospective 
nature and meta-analyses based on non-
randomized studies with a low grade of evidence. If 
patient performance status and co-morbidities 
allow for surgical resection, and if liver function and 
remnant liver volume-preserving principles are 
met, HCCs presenting multiple nodules are not a 
contraindication per se for surgical approach (1). 
1.2.3. Liver Transplant 
Liver Transplant (LT) is recommended as the first-
line option for HCC within Milan criteria but 
unsuitable for resection (1). 
Milan Criteria (MC) are used in HCC patients 
who are candidates to LT. The expected five-year 
survival rates after LT for HCC meeting MC are 65-
80%. Mazzaferro published the Milan Criteria in 
1996 (32). This study was performed over 48 
patients who were candidates for LT. The 
conclusions were that MC was an accurate predictor 
of good survival rates after liver transplantation 
(Table 6) 
The Milan Criteria have been used for more 
than 20 years due to the high survival rate and low 
recurrence rate in the patients who met its 
requisites. The MC were included in the BCLC 
staging system, the American Association for the 
Study of Liver Diseases (AASLD) and the European 
Association for the Study of the Liver-European 
Organisation for Research and Treatment of Cancer 
(EASL-EORTC) practice guidelines.  
Table 6. Milan Criteria  
Criteria 
 Single tumor ≤ 5 cm or 
 2-3 tumors not exceeding 3 cm, and 
 No vascular invasion and/or extrahepatic 
spread 
Milan Criteria (Mazzaferro et al. 1996) 
Mazzaferro suggests that the tumour size and 
number used as criteria for transplantation should 
be defined at a regional level depending on the 
dynamics of the waiting list, the proportion of 
patients with and without HCC on the waiting list, 
the harm to the patients remaining on the waiting 
list and the donor availability.  
However, with the increase in the donors’ pool 
and the advances in diagnosis and treatment, some 
restrictions and limitations have been observed in 
MC. Several groups have proposed different 
expanded criteria with acceptable results.  
Yao et al. proposed that patients with HCC 
meeting the following criteria: solitary tumor ≤ 6.5 
cm, or ≤ 3 nodules with the largest lesion ≤ 4.5 cm 
and total tumor diameter ≤ 8 cm, had survival rates 
of 90% and 75.2%, at 1 and 5 years, respectively, 
after LT versus 50% at 1-year survival for patients 
with tumors exceeding these limits (p = 0.0005) 
(33).  
In 2002, Roayaie et al. created a multimodal 
protocol where patients free of extrahepatic disease 
and unresectable HCC measuring 5 cm or larger 
were included. Patients underwent pretransplant 
arterial chemoembolization and systemic 
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chemotherapy for a total of six cycles. A tumor size 
larger than 7 cm and the presence of vascular 
invasion significantly correlated with HCC 
recurrence (55% vs 34%).  
Authors concluded that patients with HCC 
measuring 5 cm or larger may achieve adequate 
long-term survival rates after LT in the context of 
adjuvant therapy (34). Subsequently, Duffy et al. 
published a study comparing 467 patients, 126 of 
them fulfilled the Milan criteria, 208 fulfilled the 
UCSF criteria (single tumor <6.5 cm, maximum of 3 
total tumors with none >4.5 cm, and cumulative 
tumor size <8 cm) and 133 exceeded the UCSF 
criteria.  
Overall survival and recurrence rates were 
compared for each group. Overall survival rates for 
the entire group at 1, 3, and 5 years after 
transplantation was 82%, 65%, and 52% 
respectively.  
Authors reported that post-transplant survival 
rates for patients with tumors within UCSF criteria 
(either by pretransplant imaging or pathologic 
examination) was similar to the survival rate of 
tumors within the Milan criteria. They found poorer 
survival rates for patients with tumors beyond the 
UCSF criteria, with 3 and 5-year survival rates 
below 50% (35). Even the BCLC group published an 
expanded criteria that include one tumor <7 cm, 3 
tumors <5 cm, 5 tumors <3 cm, or down-staging to 
conventional Milan criteria with pretransplant 
adjuvant therapies (1). With this approach, they 
showed a better survival rate compared to support 
palliative treatment alone (50% vs 20%) at 5-years 
post-LT.  
At present, European Liver and Intestine 
Transplant Association (ELITA) and International 
Liver Transplantation Society (ILTS) have 
developed an interesting project, which offers a 
prognosis calculator to obtain the survival rate of 
each patient candidate for a transplant which is 
related to HCC. The Metroticket is based on pre-
transplant tumor determinants at radiology 
staging (e.g. maximum size of the vital HCC and 
number of vital HCC nodules) combined with the 
serum alpha-fetoprotein (AFP) level (www.hcc-olt-
metroticket.org). 
Current literature seems to support that the 
modest expansions of LT criteria for HCC beyond 
MC offer comparable results to the ones of the Milan 
criteria.  
The indication for LT in HCC is a complex 
decision. Currently, many factors influence it. There 
is a general concern about how the expansion 
criteria for LT related HCC could have an impact on 
the waiting list.  
The Michigan group studied such possible 
influence by performing a Markov theoretical model 
comparing the survival benefit of transplanting a 
patient with HCC beyond the MC and the harm 
caused to the other patients on the waiting list. They 
showed that the expansion criteria could induce an 
increase in the risk of death on the waiting list (36).  
These conclusions should be taken with 
caution. The waiting list is influenced by a multitude 
of factors, including demographic factors. In the last 
few years, there has been a change in the pattern of 
patients on the waiting list. On one hand, the 
introduction of new antiviral therapies has led to a 
decrease in LT related HCV, which has a direct 
impact on the increase of the waiting list. On the 
other hand, the donor’s pool is changing, which 
could decrease the waiting list.  
The use of expanded criteria donors, aged 
donors, donor after circulatory determination of 
death (DCDD), living-related donor and the use of 
perfusion machines may lead to an increase in the 
number of donors. The decision on whether to 
expand the HCC transplantation criteria or not 
should probably be done at a regional level after 
analysing the impact of all variables previously 
described (37). 
1.3. Development of minimally invasive 
liver surgery 
1.3.1. Historical Evolution 
There are several manuscripts in which procedures 
similar to a laparoscopy began to be performed 
around 1901 (38). This technique had a widespread 
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in Europe, where laparoscopy was performed 
mostly for diagnosis.  
In 1991, Reich et al. published the first 
laparoscopic liver resection for a benign tumor (39). 
In 1996, Azagra and Kaneko reported the first series 
of anatomical resections performed by laparoscopic 
approach (40, 41). However, the evolution of LLS 
has been slower than other surgical specialities, 
probably due to the complexity of hepatobiliary 
surgery.  
The first resections consisted of lesions located 
on the anterior or inferior segments, pedunculated 
or small size lesions with a benign nature. Due to 
the parallel advance of the surgical devices 
(harmonic scalpel for liver transection and others) 
and the development of the laparoscopic surgeon's 
learning curve, the evolution of LLS has grown 
exponentially.  
The progression of laparoscopic liver resections 
in recent years has been exponential and now, 
complex liver resections, major hepatectomies, 
sequential procedures and even living donation are 
performed laparoscopically. 
In the development of surgeons’ learning 
curves, liver resections became increasingly 
complex. In an effort to easily estimate the difficulty 
of the LLS before surgery, a novel difficulty scoring 
system was created to define the range of difficulty 
of liver resection (42). The Iwate Score (IwS) was 
developed due to the complexity of LLS procedures.  
The IwS (Figure 6) is the most universally 
extended score. This score is based in a range from 
0 to 12 points, that defines the complexity of the 
surgical procedure. The location of the lesion 
(segments), its size, proximity to vessels, type of 
resection (segmentectomy, partial resection), liver 
function and the use of hybrid techniques are the 
items of IwS. Recently, IwS has been validated in a 
multicenter study by Tanaka et al. over 2.199 
patients from 74 Japanese centres (43).  
 
Figure 6.  IWATE criteria proposed at the ICCLLR as an up-versioned difficulty scoring system. ICCLLR, 
International Consensus Conference on Laparoscopic Liver Resection.  
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In this study, they concluded that the difficulty 
encountered by surgeons is based mainly on the 
characteristics of the tumor (localization-
anterior/inferior- size and proximity to hilum) and 
the presence of liver dysfunction. These factors 
were in correlation with the conversion rate, 
intraoperative bleeding, operative time and 
mortality.  
IwS could be a valuable tool for assessing the 
difficulty of LLR and predicting intra- and 
postoperative complications after LLS. To date, 
several different scores have been published based 
on different items in order to achieve a greater 
predictive value (44) (45). The purpose of these 
scores is to achieve a possible prediction of the 
difficulty of the liver resection. These scores may 
also be useful from an academic point of view and in 
order to settle an adequate learning curve.  
Since the introduction of laparoscopic surgery 
in 1990, the evolution of this approach has been 
exponential; from partial resection, left lateral 
sectionectomy, hemihepatectomy, sectionectomy, 
segmentectomy, resection of posteriosuperior 
segments until parenchymal preserving limited and 
modified anatomical resection.  
1.3.2. Current situation 
Laparoscopic liver approach is now a standard of 
practice for several procedures and has overpassed 
the tip point from pioneers to being currently 
widely adopted by several groups.   
Because of cirrhotic-associated complexity, 
laparoscopic liver resection for HCC may be more 
complex due to different factors: liver failure, 
coagulopathy, collateral circulation, and 
parenchymal stifness.  
A concern on oncological safety may also arise 
in the setting of laparoscopic liver surgery for 
malignancies. May it offer any benefit compared to 
open approach? Is it possible to perform this 
approach in complex liver resections? Several 
comparative studies have been published to find the 
answers to these questions.  
In the early 2000s, a large series of laparoscopic 
cases of HCCs was published (46) (47), reporting 
the extension  of this approach and its use for 
complex resection on cirrhotic livers. During the last 
Consensus Conference that was held in Morioka in 
2014, a systematic review and meta-analysis of 
more than 9.000 cases collected from the available 
literature was carried out (48). The current 
situation of the laparoscopic approach in liver 
surgery is reflected in this systematic review and 
meta-analysis published by Ciria et al (Figure 7). 
 
Figure 7.  Laparoscopic liver resection reported 
series. Number of yearly reported 
manuscripts of laparoscopic liver 
resections including comparative 
laparoscopic vs open procedures and 
case series  
(Courtesy of Ciria et al. Annals of Surgery 2016) 
The main objective of this review was to offer a 
global perspective of the worldwide status of the 
laparoscopic approach and secondly, to perform a 
meta-analysis regarding short-term outcomes of 
laparoscopic vs open approach. Their findings show 
that the laparoscopic approach might be considered 
a feasible alternative to the open approach in minor 
and major resections without vascular or biliary 
reconstructions.  
This meta-analysis also shows that laparoscopic 
approach is associated with fewer complications, 
less blood loss, fewer transfusions, and shorter 
hospital stay, with equivalent operative time and 
equivalent resections margins, especially in minor 
liver resections (Level of Evidence 2+, grade of 
recommendation B). After Morioka Consensus, 
nonanatomic wedge and left lateral resection were 
considered as the standard practice in several 
centres.  
Impact of minimally invasive approach surgery in hepatocellular carcinoma 
14 
The recent publication of the first randomized 
trial (The OSLO-COMET Randomized Controlled 
Trial) comparing laparoscopic vs open approach in 
colorectal liver metastases (49) can be considered 
as a true landmark in minimally invasive liver 
surgery. Two hundred and eighty patients with liver 
metastases were randomly assigned to laparoscopic 
(n=133) or open (n=147) resection.  
The main objective of this study was to 
compare postoperative complications in the first 30 
days after surgery, the difference in terms of quality 
of life, blood loss, hospital stay, operative time and 
differences in oncological terms. The study shows 
that laparoscopic approach reduced postoperative 
complications, offered the same oncological safety 
(equality resection margins) and was more cost 
effective, with similar costs but higher QALYs than 
open resection.  
Their conclusions are that laparoscopic surgery 
is a safe approach that presents a lower rate of 
postoperative complications and does not present 
any difference in oncological terms. They emphasize 
that these conclusions should be taken with caution 
since these results might only be applied in high-
volume centres and performed by surgeons with a 
wide learning curve in LLS.  
The current situation is a trend towards the 
expansion of laparoscopic surgery in both simple 
resection and complex hepatectomies. The early 
diffusion of this approach made the current 
Guidelines Meeting in Laparoscopic Liver Surgery 
another landmark in the field.  
1.3.3. Consensus meetings and European 
Guidelines 
The spread of LLS and the increasing number of 
series published have made Consensus and 
Guidelines Meeting a feasible tool in order to make 
an objective analysis of literature. Two consensus 
meetings have been held to date. The first one in 
2008 and the second in 2014. Recently, in 2017, the 
first European Guidelines Meeting on Laparoscopic 
Liver Surgery was held in Southampton.  
The objective of these Consensuses was to 
analyze the evidence published to date with regards 
to laparoscopic liver surgery.  
In the Louisville Conference (50), 45 recognized 
experts met to define the status of LLS and its future 
challenges. The sections of this meeting were: 
indications for surgery, patient selection, surgical 
techniques, complications, patient safety and 
surgeon training. 
The conclusions of the Louisville consensus 
settled a basis for the incoming years. First, the 
indications for laparoscopic liver resections were 
defined: solitary lesions of 5 cm or less and/or 
located in anteroinferior segments (2-6).  
Based on the experts’ opinion, major 
laparoscopic hepatectomies were considered to be 
carried out only in specialized centres and by expert 
surgeons. The role of hand-assisted and hybrid 
approaches was also defined for complex cases. 
Regarding living donation, experience with pure 
laparoscopic approach for pediatric and hybrid for 
adult was also stated. Nevertheless, both 
approaches were considered procedures with few 
evidence and to be performed in the context of a 
worldwide registry in order to avoid donor 
complications and/or death.  
Concerns on oncological results have increased 
in parallel. In this consensus, great importance was 
given to the achievement of safety margins and the 
detection of hidden lesions. In the published cases, 
no differences were observed in terms of survival or 
oncological margins between the two approaches.  
The conclusions were that the laparoscopic 
approach could obtain similar results in oncological 
terms than the open approach and that the 
existence of an adequate preoperative image study 
is of great importance.  
In summary, the experts concluded that the 
laparoscopic approach is safe and effective for the 
treatments of liver lesions. This approach should be 
carried out in specialized centres and by expert 
surgeons. The creation of global societies, meetings 
and international registries is of great importance 
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for the establishment of clinical guidelines and 
universal indications.  
The consensus meeting held in Louisville (50) 
reviewed the feasibility of LLS and settled the first 
indications and recommendations from very early 
adopters in this field. Six years later, the second 
consensus of laparoscopic liver surgery was held in 
Morioka.  
The Morioka Consensus (51) focused on a 
comparison with open resections and added an 
extensive literature search using GRADE method, 
showing the widespread of LLS and its role in the 
modern era of liver surgery (52).  
This consensus was carried out with a more 
scientific basis, in terms of current literature 
evidence and analysis. The organizing committee 
invited 43 respected surgeons, that is, an expert 
panel with 34 members with demonstrated 
experience in LLR, plus 9 jury members, to provide 
evidence and draw recommendations (51). 
Seventeen questions were posed, the first seven 
focused on the risks and benefits of this approach 
and the other ten on its technical aspects.  
Due to an exhaustive review of literature, the 
gathered answers to these questions generated 
statements and recommendations that were 
expected to be accepted worldwide and to be used 
as an uniform guideline in all liver surgical centres.  
For minor resections, laparoscopic approach 
was defined as the standard practice due to the 
lower complication rate and shorter hospital stay 
compared to the open approach. Similar results 
were observed in major resections, although the 
number of available series was lower.  
In regards to technical questions, the caudal 
approach was presented as a novel concept to 
optimize hilar dissection and liver parenchymal 
transection. The lateral approach for the dorsal 
view was also reported as a feasible technical 
approach for the resection of lesions located in 
posterior segments.  
In 2017, the last meeting of experts was held in 
Southampton for the creation of the Clinical 
Guidelines for Laparoscopic Liver Surgery. The aim 
of these Guidelines was to provide to both 
experienced and training surgeons opinions to 
reduce variations in practice and to facilitate the 
safe expansion of LLS with the goal of improving 
patient care (52). 
Table 7.  Methodology used in the European 
Guidelines for laparoscopic liver surgery 
SIGN methodology To asses the evidence and develop 
guideline statements 
Delphi method To establish experts consensus 
AGREE II-GRS To assess the methodological 
quality and validate the final 
statements 
The methodology for the analysis of the 
literature was a meticulous process using three 
validated methods: the SIGN methodology (Scottish 
Intercollegiate Guidelines Network), the Delphi 
method and the AGREE II-GRS (Global Rating Scale) 
instrument (Table 7). 
Table 8.  Sections of EGMLLS (European 
Guidelines Meeting for Laparoscopic 
Liver Surgery) 
Section 1: Indications 
Topic 1: Colorectal Liver Metastases (CRLM) 
Topic 2: Bening and rare non-colorectal Metastases 
Topic 3: Hepatocellular Carcinoma (HCC) 
Topic 4: Living donor 
Section 2: Patients and Complex Diseases 
Topic 5: High-risk Patients 
Topic 6: Redo Liver Resections 
Topic 7: Technically Complex Settings 
Section 3: Procedures 
Topic 8: Major Hepatectomies 
Topic 9: Minor Resections, resections on difficult 
segments, parenchyma sparing/anatomical 
segmentectomies 
Section 4: Technique 
Topic 10: Minimally invasive approaches, surgical 
devices, intraoperative staging and planning 
Topic 11: Anatomic Major resection (Formal Right/left 
Hemi-hepatectomies) 
Topic 12: Bleeding control/conversion 
Section 5: Implementation 
Topic 13: Surgeon/Center/Learning curves 
Topic 14: Training/Registries 
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The consensus Guidelines was divided into 
several sections, each one divided into different 
topics (Table 8). In this consensus, the topics to be 
debated were broadened; expanding the field in 
terms of purely surgical techniques, indications, 
learning curves and patients’ profile. An attempt 
was made in order to define the concepts of “high-
risk patient” and expert surgeons. 
A new concept of major hepatectomy was 
introduced; resection of posterior segments or 
complex resections were also considered major 
hepatectomies. Great importance was given to the 
development of courses and fellowship, which are 
considered of relevance for the training of young 
surgeons and for the safe expansion of the 
laparoscopic approach, taking place in high volume 
centres.  
In these guidelines, it is defined that for lesions 
in the anterior and left lateral segments, the 
laparoscopic approach is considered to be the 
standard practice. Besides, complex resections and 
lesions in posterior segments should also be 
performed by laparoscopic approach.  
These Clinical Guidelines provided statements 
and recommendations based on strong scientific 
evidence and were endorsed by both an expert 
committee and external validation committee.  
1.4. Laparoscopic Liver Surgery in 
Hepatocellular Carcinoma 
Liver resections for Hepatocellular carcinoma have 
been universally considered complex resections. 
The reason is that HCC is normally developed in 
cirrhotic patients with several adversities, such as 
thrombocytopenia, portal hypertension, ascites and 
greater probabilities of liver failure after resection.  
The laparoscopic approach for HCC is especially 
difficult due to the difficult bleeding control in 
cirrhotic liver and the other reasons mentioned 
above. The laparoscopic approach began to be used 
in HCC resections with the intention of reducing 
postoperative complications and providing the 
benefits of this approach. Cirrhotic livers require a 
deeper knowledge of liver and laparoscopic surgery.  
1.4.1. Literature review 
The first reports are observed around the year 
2000. These manuscripts consisted of a series of 
cases with a small number of patients. The inclusion 
criteria in the first reports were more strict: lesions 
in anteroinferior segments with a size smaller than 
4-5 cm, and in which the tumor should not be 
located adjacent to any large vessels. Another 
requirement was the presence of a compensated 
liver function (Child A) (46).  
The conclusions were that the laparoscopic 
approach could be considered a good option for the 
treatment of small or subcapsular HCC on well-
compensated liver functions (53). This approach 
offers an acceptable alternative to the open 
resection with equivalent results regarding 
oncological-terms.  
Furthermore, these series of cases, each time 
with a larger sample, showed how the laparoscopic 
approach improved the postoperative course of 
cirrhotic patients (54). Even considering surgery as 
a bridge therapy to liver transplantation, the 
laparoscopic approach could improve the surgical 
time (shorter operative time, less blood loss, shorter 
cold ischemia time).  
With the widespread of laparoscopic approach, 
the number of published cases increased. The 
studies showed greater statistical power since 
comparative studies of both groups were also 
reported (open vs laparoscopic approach).  
The first comparative reports consisted of 
small-sized series (less than 100) with a short 
follow-up period (55) (47) (56) (57). The results 
showed were homogeneous, where the laparoscopic 
approach offered clear benefits for HCC resections 
in cirrhotic livers vs the open approach. In 2014, 
some comparative studies with propensity score 
matching (PSM) analysis were published (58).  
The PSM is a statistical matching technique that 
attempts to estimate the effect of a treatment or 
intervention by accounting for the covariates that 
predict receiving the treatment. PSM attempts to 
reduce the bias due to confounding variables that 
could be found in an estimate of the treatment effect 
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obtained from simply comparing outcomes among 
the ones that received the treatment versus those 
that did not. PSM homogenizes two groups based on 
similar variables in the studies: age, sex, number 
and size of lesions and degree of liver failure. In this 
way, this statistical tool avoids the confusion factors 
that could influence the results and homogenizes 
both groups to obtain more robust results (59).  
Under these well-balanced comparative groups, 
the results were similar to the ones published in 
previous studies. LLR showed shorter hospital stay, 
less postoperative ascites (58), lower postoperative 
morbidity (60) (61), less median blood loss (62). 
Median overall survival rate and median disease-
free survival rates were similar for both groups in 
the comparative studies.  
A more complex level in comparative studies is 
the meta-analysis. Twaij in 2014 (63) analyzed 
several comparative studies in patients with proven 
cirrhosis. Operative time, blood loss, need of 
transfusions and histological tumor margins were 
evaluated. Postoperative measures included 
morbidity and mortality rates, length of stay in 
hospital, long-term survival rates and diseases free 
survival rate. This meta-analysis included 4 
comparative cohort studies (64) (65) (66) (67) with 
a total of 420 patients (LLR=150, OR=270).  
Authors reported that patients undergoing 
laparoscopic procedures had less blood loss, 
reduced risk of transfusion, better tumor resection 
margins, shorter length of stays in hospital and less 
postoperative morbidity. No statistically significant 
difference was reported across all studies with 
regards to both long-term survival and disease-free 
survival rates in the laparoscopic cohort vs OR.  
A year later, Chen (68) published a systematic 
review and meta-analysis based on 7 retrospective 
trials (64) (65) (66) (67) (69) (70) (71) showing 
similar results. Patients undergoing LLR had wider 
tumor margin, less blood loss, less blood 
transfusion, less postoperative morbidity and less 
hospital stay while overall survival and disease-free 
survival rates were similar.  
Leong published in the same year another 
interesting meta-analysis with a higher number of 
comparative studies, including a total of 17 
retrospective cohorts studies. Authors showed that 
postoperative complications were significantly 
lower in laparoscopic groups.  
Morise performed in 2015 (72) a systematic 
review of the current literature. The conclusions 
showed that the laparoscopic approach offered 
reduced blood loss, reduced postoperative 
complication rate and similar surgical margins. 
Regarding oncological terms, no significant 
difference was observed between the two 
approaches in overall survival or recurrence-free 
survival rates. The same author would report a 
meta-analysis of postoperative ascites (9 
comparative studies) and postoperative liver failure 
(6 comparative studies) in cirrhotic patients 
undergoing laparoscopic vs open approach. In the 
analyses, the laparoscopic approach seemed to be 
associated with a reduced incidence of 
postoperative ascites (OR 0.26; 95% CI, 0.14-0.49; 
p<0.0001) and liver failure (OR 0.24; 95% CI, 0.14-
0.49; p=0.001).  
Over the past years, publications reporting 
patients undergoing laparoscopic resections for 
HCC have increased. Although there is no full 
statistical quality in the published studies, due to its 
retrospective nature, the literature currently 
available suggests a great benefit of the 
laparoscopic approach in these patients. With the 
current results, the laparoscopic approach for 
resections in cirrhotic patients should be 
considered as a feasible alternative.  
1.4.2. Anatomical Laparoscopic resection  
Surgical resection and liver transplantation 
represent the main therapeutic options with an 
intention-to-treat perspective for HCC. Liver 
resection is an alternative option and is now widely 
accepted as a potentially curative treatment for 
patients with HCC.  
As mentioned above, the initial criteria for HCC 
liver resection were stricter: solitary tumors and 
very well-preserved liver functions, hepatic vein to 
portal system gradient ≤10 mm Hg or platelet 
≥100.000/mL.  
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The complete resection of the entire tumor 
lesion, preserving enough liver remnant to avoid 
postoperative liver failure is the oncological 
principle for hepatic resection for HCC in cirrhotic 
livers (73). The importance of an anatomical 
resection results in obtaining a correct oncological 
margin, thus, reducing the risk of post-resection 
recurrence.  
The first surgeon who described the area that 
should be resected for HCC as the subsidiary 
territory to the portal venous system in which the 
tumor is drained was Makuuchi (74). It was later 
described by Takasaki (75) through the Glissonian 
pedicle. This type of resection is considered as an 
anatomical resection (AR).  
In contrast, there is the concept of non-
anatomical resection (NAR). NAR is defined as the 
resection of a lesion regardless of the anatomical 
segment or section of the lobar anatomy and 
includes limited resection or enucleation (76).  
There is a debate about the potential benefit of 
AR in HCC patients. It is considered that in AR, the 
territory removed includes a wider parenchymal 
area and possible satellite nodules. Most of the HCC 
develop on cirrhotic livers that have limited liver 
functions. The AR requires a greater resected 
parenchyma and a higher risk of developing liver 
failure.  
Several studies have been conducted to 
compare the real benefits of AR and whether it 
provides better survival rate. There is another novel 
anatomical concept for defining the territory of the 
liver disease that must be resected in the HCC. This 
territory is called "cone unit" and was described by 
Takasaki (75).  
This anatomical territory consists of portal 
tertiary branches that are tributary to the area 
where the HCC is located. For Takasaki, each 
segment consists of six to eight cone units. 
Following this concept, the liver as a whole is 
encompassed between 18 and 24 subsegments 
(which are designated as cone units) (77). The cone 
unit concept is universally considered as an 
anatomical resection.  
This territory may be smaller than one 
Couinaud’s segments (sub-segmentectomy) or 
involve more than one segment. This type of 
resection is considered precise from the anatomical 
and vascular point of view and seems to be related 
to a lower risk of complications such as ischemic 
areas in resection edges and bile leak (78). Both 
types of resections can be carried out by 
laparoscopic approach. In properly trained centres, 
LR should be considered via laparoscopic (1). 
1.4.3. Theoretical benefits of laparoscopic 
approach for patients with 
Hepatocellular Carcinoma 
Laparoscopic left lateral sectionectomy and minor 
laparoscopic liver resection are now considered 
standard approaches, especially for tumors located 
in the anterolateral segments of the liver (1).  
Recent studies question whether there are 
benefits of using laparoscopy in complex resections 
such as posterosuperior segments. Xiao et al. (79) 
reported, through a case-control study, that LR for 
patients with HCC in these segments might offer the 
same oncologic outcomes as conventional 
procedures, being associated with advantages such 
as lower blood loss, fewer complications and 
shorter hospital stay.  
Improved laparoscopic techniques, better 
visualization of the operative field using a flexible 
laparoscope, and routine use of a laparoscopic 
ultrasonic surgical aspiration devices for 
transecting the deeper portion of the liver 
parenchyma have allowed laparoscopic resection to 
be performed in more complex cases.  
Regarding short-term results, operative time 
seems to be similar between both approaches (due 
to the improvement with the progression of the 
learning curve). Blood loss and need of transfusions 
is reduced in patients undergoing LLR compared to 
OLR. Postoperative morbidity is significantly lower 
in LLR group (80) (less ascites, less infection, less 
chest complication, less pleural effusion and less 
abdominal wall complications).  
In general, patients undergoing OLR had 
significantly longer hospital stay than LLR patients 
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(81). Postoperative mortality is similar in both 
groups. Regarding long-term and oncological 
results, tumor margins were similar in both groups. 
In some studies it was significantly wider in LLR 
than in OLR (60); this could be explained by two 
factors: tumor size in OLR group tends to be greater 
and usually closer to vessels and hepatic pedicle. 
Overall survival and disease-free survival rates 
are similar in both groups. In different studies, 
disease-free survival seems is better in LLR group 
than in OLR (82). This might be because patients in 
LLR groups tend to have smaller tumour size and 
microscopic vascular invasion was more frequent in 
the OLR group.  
Therefore, selection bias might be present in 
these studies. According to the previous results. In 
general, short-term outcomes are favourable to 
laparoscopic approach (80) (83) (fewer 
complications), whenever it is performed in expert 
centres.  
Long-term outcomes and survival and disease-
free survival rates are similar in both groups. The 
last meta-analysis reported by Twaij et al. (63) 
suggests that LLR for HCC in cirrhotic livers is safe 
and might offer improved patient outcomes. LLR 
seems to be associated with better short-term 
outcomes compared to OLR in HCC liver resection. 
Long-term oncological outcomes could be 
comparable in both groups. 
These results should be handled with care, as 
they are all based on selected patients, in the setting 
of non-randomized comparative retrospective 
studies with selection biases mainly due to tumour 
characteristics. However, nowadays there have 
been many meta-analyses, retrospective studies and 
case-matched studies with propensity score 
matching comparing the open and laparoscopic 























Null Hypothesis:  Laparoscopic surgery is not inferior to open surgery in the management of 
Hepatocellular carcinoma.  
Alternative Hypothesis:  Laparoscopic hepatic surgery offers advantages compared to open surgery in the 
























1. To amalgamate, weigh and summarize the current evidence literature by SIGN methodology for the 
development of the European Guidelines Meeting on Laparoscopic Liver Surgery and to elaborate 
consistent and evidence-based statements in the application of minimally invasive approach for the 
management of hepatocellular carcinoma.  
2. To assess the distribution of available studies with regards to disease stage and resection type and 
perform secondary subgroup meta-analyses by grouping like studies in order to increase the level of 
evidence for specific disease stages and resection types (Solitary tumor, Child-Pugh A resections, minor-
only liver resections, Major-only liver resections and Combined resections). 
3. To expose the current evidence regarding the short-term outcomes as rate of complications, blood loss, 
transfusion rate and postoperative hospital stay for each group of study  
4. To evaluate if considering severe morbidity, including liver-specific posthepatectomy liver failure and 
90-days mortality, laparoscopic approach offers benefits against the open. To evaluate if laparoscopic 
approach have an impact on long-term outcomes considering overall survival and disease-free survival. 
5. To demonstrate whether laparoscopic approach for the treatment of hepatocellular carcinoma may be 
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4.1. Study design and search strategy 
In the context of the European Guidelines Meeting 
on Laparoscopic Liver Surgery (EGMLLS) held in 
Southampton, UK, from 9 to 11 February 2017, an 
updated meta-analysis was prepared in which five 
submeta-analyses were performed after assessing 
the patterns of all available studies comparing the 
laparoscopic and open approaches in the 
management of HCC (84). 
The systematic review was conducted in 
accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines (85). PRISMA is an evidence-minimum 
set of items for reporting in systematic reviews and 
meta-analyses (Appendix 1) www.prisma-
statement.org.  
PRISMA focuses on the reporting of reviews 
evaluating randomized trials, but can also be used 
as a basis for reporting systematic reviews of other 
types of researchs, particularly evaluations of 
interventions. A systematic review using Ovid 
Medline and Pubmed was undertaken in July 2016 
and repeated in January 2017 to review all the 
existing literature.  
The Pubmed, Embase, Cochrane Library, and 
Web of Science electronic databases were searched 
using the following search strategy: ((hepatocellular 
[Title] OR HCC) AND (laparoscopic [Title] OR 
laparoscopy [Title] OR minimally [Title] OR hybrid 
[Title])) and their associated combinations of 
controlled vocabulary (Medical Subject Heading 
[MeSH]) terms. 
4.2. Study selection and inclusion 
criteria 
The inclusion criteria were studies conducted in 
humans published in English language. All the 
included studies were comparative studies between 
groups under open versus laparoscopic approach 
published in the last 15 years (Table 9). Reviews, 
case reports and other observational studies were 
excluded. In addition studies comparing 
radiofrequency, chemoembolization, robotic or 
hybrid surgery were also excluded.  
A huge emphasis was made in the identification 
of duplicate cases. This process was performed by 
matching both author names and publication 
centres. Once the full-text version was obtained, two 
reviewers performed the screening stages 
independently. Disagreements were resolved after 
consultation with a third reviewer. These reviewers 
reviewed the final included articles to confirm they 
met the inclusion criteria.  
Table 9.  Exclusion and inclusion criteria.  
Inclusion criteria Exclusion criteria 
Human studies Animal / Experimental 
studies 
Comparative studies Review / Editorial / Case 
report / Letter 
English language Radiofrequency / TACE 
Only laparoscopic versus 
open 
Liver transplant involved 
Only the last 15 years Robotics / Hybrid cases 
Duplicated data, most 
recent included 
Adenomas or non-confirmed 
HCC 
All manuscripts were screened to find out if 
subgroup analyses could be obtained. A secondary 
screening was performed to find out if a reasonable 
number of series could be achieved for a meta-
analysis in the subsequent groups: major and minor 
resections, solitary tumors and Child-Pugh A 
tumors.  
4.3. Definitions 
Once the literature search has been carried out, the 
next step was to establish the concepts that are 
going to be taken into account in order to have these 
concepts understood in a universal way. 
Considering the aims of our study, the following 
definitions and patterns were considered: 
 The type of resection was defined according to 
the criteria established in the First Consensus 
that was held in Louisville (50). For this, the 
structure described by Couinaud is followed. 
Minor resections involve two or fewer 
Couinaud segments and major resections 
involve three or more continuous Couinaud 
segments.  
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 Each manuscript was assessed to establish if 
results reported could be applicable to more 
than one of the subgroups. If so, the results 
were separated and individually analysed 
within their subgroups.  
 There is a group of resections in which a 
specific type is not performed. Therefore, for 
our study we consider them as combined 
resections. These cases might not be grouped 
in any of the defined subgroups and will be 
excluded for the subgroup analysis. 
4.4. Variables and End-Points 
The variables analysed in each manuscript as well 
as the endpoint variables are universally 
established according to the reviewed manuscripts 
in order to lose the minimum number of cases in the 
literature.  
 Short-term outcomes (intraoperative 
parameters): operative time (minutes), 
operative blood loss (mL) and the number of 
patients requiring blood transfusion (%). 
 Short-term outcomes (postoperative 
parameters): total number of early (<30 days), 
complications (%), duration of postoperative 
hospital stay (days), mean resection margin 
(mm), post-hepatectomy liver failure (PHLF) 
and perioperative (30-day, 90-day, or 
undefined) mortality. 
 Long-term outcomes. 1-, 3- and 5-year overall 
survival (OS) rate; 1-,3-, and 5-year disease-
free recurrence rate.  
4.5. Quality analysis of the studies  
The manuscripts included in the meta-analysis are 
subjected to a double-check quality analysis. That 
assessment was performed first under the Scottish 
Intercollegiate Guidelines Network (SIGN) 
methodology criteria and then in accordance with 
the Newcastle-Ottawa Quality Assessment Scale 
(NOS) for cohort and case-control studies (Ottawa 
Hospital Research Institute).  
This double assessment of each manuscript 
included is performed to reduce the risk of biases 
and thus enhance the quality of their results.  
4.5.1. SIGN Methodology 
The Scottish Intercollegiate Guidelines Network 
(SIGN) was described by Harbor in 1993 (86). The 
SIGN methodology has been the basis of the first 
national programs for the elaboration of Clinical 
Practice Guidelines (CPG).  
Table 10.  Key to evidence statements and forms of 
recommendations. Methodology 
procedure for Developing 
Recommendations By SIGN Guidelines. 
Levels of evidence 
1++ High-quality meta-analyses, systematic 
reviews of RCTs, or RCTs with a very low risk 
of bias 
1+ Well-conducted meta-analyses, systematic 
reviews, or RCTs with a low risk of bias 
1- Meta-analyses, systematic reviews, or RCTs 
with a high risk of bias 
2++ High-quality systematic reviews of case-
control or cohort studies 
High-quality or cohort studies with a very low 
risk of confounding or bias and a high 
probability that the relationship is causal 
2+ Well-conducted case-control or cohort studies 
with a low risk of confounding or bias and a 
moderate probability that the relationship is 
causal 
2- Case-control or cohort studies with a high risk 
of confounding or bias and a significant risk 
that the relationship is not causal 
3 Non-analytic studies, eg case reports, case 
series 
4 Expert opinion 
The SIGN methodology consists of a 
manuscripts evaluation process that guarantees 
high quality in the selection process. These 
checklists are available for systematic reviews and 
meta-analyses, randomized controlled trials, cohort 
studies, case-control studies, diagnostic studies, and 
economic studies. The evaluation of the quality of 
manuscripts gives rise to the qualification of the 
study as: ++High quality, +Acceptable and –low 
quality (Table 10). 
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Once the first step is completed, the evidence 
level on the topic is produced based on the quality 
of the available literature assessed at the previous 
step. The next step, once the evidence tables of each 
manuscript have been made, is to produce 
recommendations according to the evidence found 
in each one of them.  
 
Figure 8. Summary of Findings (SoF) example.  
 
The structure of this table is perfectly designed. 
In the first part, the main topic of the clinical 
guideline and the clinical question under study 
should be explained. Later on, the bibliographic 
information of the article is described: Authors, 
journal and year of publication. Within the 
evaluation of the paper, the type of comparative 
study must be described (case-control, cohort, 
meta-analysis).  
There are two sections in which the 
characteristics and number of cases and controls 
must be shown (PSM study, describe the variables 
on which this analysis is based). Another section is 
for the notes where the aspects of the design of the 
study must be described (follow up time, bias found 
or other data that could be important for its 
evaluation).  
The larger section is dedicated to performing a 
brief summary, results, limitations and conclusions 
of the study. And finally, the SIGN classification 
score of each of them (Figure 8). 
According to the SIGN methodology, 
recommendations are formulated in order to 
produce appropriate conclusions (Table 11). 
Balancing all the issues described is complex 
and presents a challenge to any guideline group. 
The outcome of the decision-making process is to 
produce a recommendation that is rated as either 
“strong” or “conditional”.  
High quality evidence from well conducted 
studies should lead to a strong recommendation, 
but relating the trial populations to the target 
population of a guideline and taking into account 
issues of cost and patient acceptability might lead to 
a recommendation that is much weaker than first 
thought.  
Equally, there will be circumstances where the 
evidence is flawed but there are few or no 
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downsides to the treatment and the clinical 
importance of the topic is such that a strong 
recommendation is justifiable.  
Table 11.  Forms of recommendation by SIGN 
Methodology 















desirable and undesirable 
consequences is closely 
balanced or uncertain 
Recommendation for 
research and possibility 
conditional 
recommendation for use 
restricted to trials 
Desirable consequences 










Good Practice points 
Recommended best practice based on the clinical 
experience of the guideline development group 
4.5.2. Newcastle-Ottawa Methodology 
The Newcastle-Ottawa Scale (NOS) was developed 
to evaluate the quality of non-randomized studies 
seeking to incorporate quality assessments in meta-
analysis interpretation of the results obtained. The 
NOS evaluates the quality from the content, design 
and ease of use in the interpretation of the meta-
analysis. It is composed of eight items, divided into 
three dimensions (comparability, selection, type of 
study) of the transversal study or case-control.  
The apparent validity and content was 
established based on a critical review of the items 
by specialists in the area. Stars awarded for each 
quality item serve as a quick visual assessment. 
Stars are awarded so the studies with the highest 
quality are awarded up to nine stars (Table 12 y 
13). The method was developed as a collaboration 
between the University of Newcastle, Australia, and 
the University of Ottawa, Canada using a Delphi 
process to define variables for data extraction. The 
scale was then tested on systematic reviews and 
furtherly refined (87).  
The criteria for “representativeness of cases” 
was the consideration of consecutive, or 
representative series of cases without potential 
selection bias. Specifically, no star was given if the 
cases included were not matched by the year of 
inclusion (due to potential selection bias) and/or 
different surgeons and/or an inclusion period >10 
years (due to potential technical bias).  
Similarly, an equal distribution of type and 
severity of underlying liver disease was an 
exclusion criterion that was given a star. For the 
“control for impact factor” rating, two stars were 
given if laparoscopic and open cases were matched 
by age, sex, American Society of Anesthesiologists 
(ASA) score, body mass index, type of resection, 
Child-Pugh score, and number and size of the 
lesions. If any of these factors were not specifically 
mentioned or were not correctly matched, only one 
star was given. If two or more of these factors were 
not correctly matched or were not mentioned, no 
stars were given.  
4.6. Statistical Methodology 
4.6.1. Methodology for the estimation of 
the mean and deviation 
To perform meta-analyses, means and standard 
deviations (SDs) were needed, and estimations of 
means and SDs were performed to avoid discarding 
important studies. According to a recent publication 
from Wan et. al (94), in the event that a manuscript 
reported data in different measures other than 
mean and SD, different scenarios were considered.  
A number of studies reported the study using 
the median, the minimum and maximum values, 
and/or the first and third quartiles. Four 
possibilities are available in all paper (Figure 9). 
The perfect situation is the articles in which the 
variables are expressed in mean and SD.   
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Table 12.  Newcastle-Ottawa Scale for Cohorts 
Studies 
Newcastle-Ottawa Quality Assessment Scale:  
COHORT STUDIES 
Selection (★★★★) Comparability (★★) Outcome (★★★) 
Selection 
1. Representativeness of the exposed cohort 
a. Truly representative of the average 
________(describe) in the community (★) 
b. Somewhat representative of the average ________ in 
the community (★) 
c. Selected group of users eg nurses, volunteers 
d. No description of the derivation of the cohort  
2. Selection of the non exposed cohort 
a. Drawn from the same community as the exposed 
cohort (★) 
b. Drawn from a different source 
c. No description of the derivation of the non 
exposed cohort 
3. Ascertainment of exposure to implants 
a. Secure record (eg surgical records) (★) 
b. Structured interview (★) 
c. Written self-report 
d. No description 
4. Demonstration that any outcome of interest was not 
present at the start of the study 
a. Yes (★) 
b. No 
Comparability 
1. Comparability of cohorts on the basis of the design or 
analysis 
a. Study controls for _______ (select the most 
important factor) (★) 
b. Study controls for any additional factor (This 
criterion could be modified to indicate specific 
control for a second important factor) (★) 
Outcome 
1. Assessment of outcome 
a. Independent blind assessment (★) 
b. Record linkage (★) 
c. Self-report 
d. No description 
2. Was follow up long enough for outcomes to occur 
a. Yes (select an adequate follow-up period for the 
outcome of interest) (★) 
b. No 
3. Adequacy of follow up of cohorts 
a. Complete follow up-all subjects accounted for (★) 
b. Subjects lost to follow up unlikely to introduce 
bias-small number lost >___% (select an adequate 
%) follow up, or description of those lost (★) 
c. Follow up rate <___% (select an adequate 
%) and no description of those lost 
d. No statement 
 
 
Table 13.  Newcastle-Ottawa Scale for case-control 
Studies 
Newcastle-Ottawa Quality Assessment Scale:  
CASE-CONTROL STUDIES 
Selection (★★★★) Comparability (★★) Exposure (★★★) 
Selection 
1. Is the case definition adequate? 
a. Yes, with independent validation (★) 
b. Yes, eg record linkage or on self-reports 
c. No description 
2. Representativeness of the cases 
a. Consecutive or obviously representative 
series of cases (★) 
b. Potential for selection biases or not stated 
3. Selection of controls 
a. Community controls (★) 
b. Hospital controls 
c. No description 
4. Definition of controls 
a. No history of disease (endpoint) (★) 
b. No description of source 
Comparability 
1. Comparability of cases and controls on the basis 
of the design or analysis 
a. Study controls for ________(select the most 
important factor) (★) 
b. Study controls for any additional factor 
(this criterion could be modified to 
indicate specific control for a second 
important factor) (★) 
Exposure 
1. Ascertainment of exposure 
a. Secure record (eg surgical records) (★) 
b. Structured interview, blind to case/control 
status (★) 
c. Interview not blinded to case/control 
status 
d. Written self-report or medical record only 
e. No description 
2. Same method of ascertainment for cases and 
controls 
a. Yes (★) 
b. No 
3. Non-response rate 
a. Same rate for both groups (★) 
b. Non-respondents described 
c. Rate different and no designation 
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In this case, there is no need to perform any 
calculation to perform the meta-analysis. The 
scenario 2 is the situation in where the variables are 
expressed by mean and 95% CI. In this case mean 
and CI must be converted to median and range 
(Scenario 3) in order to apply the formula of Wan to 
obtain the mean and SD. And the last possibility 
(Scenario 4) is when the variables are expressed in 
Median and interquartile range (IQR). In this case 
applying again the expressed formula mean and SD 
are obtained.  
For the meta-analysis, we decided to perform 
calculations only if at least three series could be 
identified for each variable, avoiding results derived 
from analyses of two reports.  
 
Figure 9. Different Scenarios to obtain mean and standard desviation for meta-analysis.  
 
4.6.2. Determination of the heterogeneity 
of the samples 
Heterogeneity I2 test 
An important point in the methodology is to 
quantify the heterogeneity between the studies 
included for the meta-analysis, its magnitude 
derives not only the method used to combine the 
individual results but also the validity of the global 
conclusions.  
One of the aspects of heterogeneity, the one 
related to clinical or biological differences between 
studies and the differences in procedures, is first of 
all a methodological problem, since it will be 
necessary to decide whether the differences 
between the studies, which always exist, allow or 
not to combine them, independently of the results 
that have been obtained in them.  
Therefore, the identification of the 
heterogeneity is prior to the execution of the meta-
analysis. The statistical heterogeneity tries to 
quantify the variability of the result measured in the 
different studies with respect to the average global 
result, and determine whether that variability is 
higher than what would be expected by pure 
chance.  
The standard heterogeneity test used was the I-
square statistic. Based on the method reported by 
Der Simonian and Laird (88), substantial 
significance was set when the p-value was <0.10 
and a random-effects model was used (89). 
The I2 parameter indicates the proportion of the 
variation among studies with respect to the total 
variation, so, the proportion of the total variation 
that is attributable to the heterogeneity, as follows: 
 
   
  
     
 
 
An I-square value of <25% was defined to 
represent low heterogeneity, between 25 and 50% 
was defined as moderate heterogeneity, and >50% 
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was defined as high heterogeneity. If I2 <25%, 
studies are regarded as homogeneous and the fixed 
effect model of meta-analysis can generally be used. 
If I2>75% then, the heterogeneity is very high, and 
one should use a random effect model for meta-
analysis.  
A random-effects model takes into account that 
there might be other unpublished studies, 
overlooked in the systematic literature search, or to 
be undertaken in the future which were not 
included in the meta-analysis at hand (90). 
Funnel plots 
Meta-analysis results are commonly displayed 
graphically as “forest plots”. Publication bias was 
also assessed visually using a funnel plot for 
standard error by effect size. Each calculation for 
every group has a specific funnel plot. In the funnel 
plot, the X-axis represents the mean result (that 
might be an odds or risk ratio, or a percentual 
difference) and the Y-axis shows the sample size or 
an index of precision.  
The symmetry of the plot might vary depending 
on whether the sample size or inverse standard 
error is used as an index of precision. The points 
that represent each mean value are widely spread at 
the base and narrow as they move to the top, thus 
resembling an inverted funnel or a fir tree.  
The basis of assessing bias is that if all the 
studies are given random assessments of the same 
unbiased mean value, the plot should be 
symmetrical. If the studies are biased, for example, 
by having too few small studies with positive results 
and large effect sizes, then the funnel plot becomes 
asymmetrical with a deficit near the bottom (91). 
4.6.3. Selection of the statistical test 
according to heterogeneity 
Data that was not significantly heterogeneous 
(p>0.1) was calculated using a fixed-effects model 
using the Mantel-Haenszel method (92). OpenMEE 
software, based on Open MetaAnalyst Sotware, was 
used for statistical analyses (93).  
Analyses were performed using log odds ratios 
(OR) with 95% confidence intervals (CIs) for 
dichotomous variables, and weighted mean 
differences (WMD) with 95% CIs for continuous 
variables.  
For those dichotomous variables in which any 
observed value was 0, the calculation of the OR was 
not possible, so rate differences were used (94).  
In cases where a high heterogeneity (I2) was 
obtained, the test used will be a random-effects 
model to obtain a lower degree of bias and greater 
statistical significance. For variables with low 
heterogeneity (I2<25), we assume that the sample is 
distributed homogeneously and therefore, the fixed-
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5.1. Flow chart and choice of studies 
A search through PubMed, EMBASE and Google 
Scholar databases was performed to identify all 
studies, case series and comparative studies 
analysing LLR compared with open resection for 
HCC patients. Keywords were “Hepatocellular” and 
“HCC”, “laparoscopic” or “laparoscopy” or 
“minimally” or “hybrid” (hepatocellular[Title] OR 
HCC[Title]) AND (laparoscopic[Title] OR 
laparoscopy[Title] OR minimally[Title] OR 
hybrid[Title]). Our search was restricted to human 
studies published during the last fifteen years.  
Only comparative studies were included, 
therefore, case series, case reports and other kinds 
of studies were excluded. Robotic manuscripts and 
radiofrequency treatments were also excluded. For 
meta-analysis, we included only manuscripts with 
endpoints short-term, long-term and oncological 
comparative outcomes between LLR and OLR.  
 
 
Figure 10. Flow chart and choice of study 
 
From the initial 361 manuscripts identified in 
the initial search, 34 comparative studies remained 
after the inclusion and exclusion criteria were 
applied (Figure 10). Six manuscripts (95) (79) (96) 
(97) (55) (98) did not reach a mínimum 
requirement of acceptable quality (measured by 
SIGN scoring) or 6 points (measured by NOS) and 
were subsequently discarded (Table 14). Resulting 
in 28 manuscripts being finally considered for the 
systematic review and meta-analysis. 
Five of these 28 manuscripts were specific to 
patients with Child-Pugh A cirrhosis [321 cases] 
(81) (59) (58) (66) (99), 16 focused on minor 
resections [1286 cases] (47) (61) (58) (64) (65) 
(66) (69) (71) (99) (100) (101) (102) (103) (104) 
(105) (106), three focused on major resections [164 
cases] (80) (81) (83) and 10 focused on solitary 
tumors [1003 cases] (47) (56) (57) (59) (99) (101) 
(107) (108) (109) (110). The remaining three 
manuscripts (comparing 1079 cases) could not be 
individually classified as they did not divide among 
specific HCC subgroups and, hence independent 
results could not be obtained (60) (62) (82); these 
were analyzed as “combined” resections. 
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5.2. Quality analysis of literature 
Thirty-four manuscripts were obtained after 
verifying the inclusion and exclusion criteria. The 
next step was to perform an evaluation according to 
the SIGN Methodology for developing 
recommendations and Newcastle-Ottawa 
assessment. Six manuscripts (95) (79) (96) (97) 
(55) (98) did not reach a mínimum requirement of 
acceptable quality (measured by SIGN scoring) or 6 
points (measured by NOS) and were subsequently 
discarded (Table 14), resulting in 28 manuscripts 
being finally considered for the systematic review 
and meta-analysis. All baseline results are depicted 
in Table 15. 
5.2.1. Quality results based on SIGN 
Methodology (Appendixes 2 and 3) 
According to the criteria established by SIGN 
Methodology (Appendixes 2 and 3), the manuscript 
published by Hu (96) does not meet the mínimum 
items obtaining a “Low” Classification, being 
discarded. This paper describes a retrospective 
evaluation of a cohort of patients who underwent 
laparoscopic hepatectomy at a single centre.  
The aim was to investigate the effects of 
laparoscopic hepatectomy for the treatment of HCC. 
The limitations of this article were the small sample 
size, only performed one control per case. The 
recurrence and survival rate were low (although 
there were no significant differences) and did not 
show how much percentage of patients completed 
follow up at 5 years. The checklist evaluation for the 
cohort studies has a low score.  
There are several questions that are not 
resolved with the manuscript of Hu. For example, in 
the section for the selection of subjects, for the ítem 
related to whether the study indicates how many 
people asked to take part on the study, actually did 
so, for each of the groups being studied the answer 
is always not.  
Besides, for the ítem related to the likelihood 
that some eligible subjects might have the outcome 
at the time of enrolment is assessed and taken into 
account in the analysis the answer is not. An 
important objective that does not comply with this 
study is the control of possible confounding factors, 
which results in low power of evidence study and 
with a high level of biases that could alter the 
results. Additionally, confidence limits are not 
provided in this paper. Confidence limits are the 
preferred method for indicating the precision of 
statistical results and can be used to differentiate 
between an inconclusive study and a study that 
shows no effect. In this case, a single value is 
reported with no assessment of precision, so it 
should be treated with extreme caution. Therefore, 
this study is considered unacceptable and is 
discarded for the meta-analysis.  
5.2.2. Quality results based on Newcastle 
Ottawa Scoring system 
According to the Newcastle Ottawa scale, the 
manuscripts published by Lee (95), Xiao (79), Ker 
(97), Aldrighetti (55) and Endo (98) do not meet the 
mínimum items for obtaining a score higher or 
equal than 7 stars. As observed in Table 14 and is 
explained in the methodology section, there is a 
mínimum of items that each article must meet to 
pass the NOS evaluation.  
Most of these articles have a deficiency within 
the case and control selection (there are not enough 
representative samples or the way to select them is 
biased). In the case of Ker (97), Aldrighetti (55) and 
Endo (98) a deficiency can also be observed in the 
comparability section: a statement that is not 
fulfilled in these articles is that either exposed and 
non-exposed individuals must be matched in the 
design and/or confounders must be adjusted for the 
analysis. Statements of no differences between 
groups or that differences were not statistically 
significant are not sufficient for establishing 
comparability.  
5.3. Summary of findings (Appendix 4) 
After analyzing every manuscript and performing 
individual checklists, all of them are summarized 
into a “Summary of findings proforma” (SoF). 
(APPENDIX 4). By doing so, the experts obtained a 
brief summary of them and a quick visualization to 
evaluate the reason why some of them are 
discarded.  
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Table 14.  Overall quality analysis from all comparative studies including Newcastle-Ottawa and SIGN scores. Red marked studies were the discarded ones 
because of NOS <7 stars or Low scoring in the SIGN analysis. 
Author 
Country Year Nlap Nopen Etiology Conversion 
Quality assessment by Newcastle-Ottawa Scale 
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Table 14. (Cont) Overall quality analysis from all comparative studies including Newcastle-Ottawa and SIGN scores. Red marked studies were the discarded 
ones because of NOS <7 stars or Low scoring in the SIGN analysis. 
Author 
Country Year Nlap Nopen Etiology Conversion 
Quality assessment by Newcastle-Ottawa Scale 



























2015 53 53 HCC 
Were 
excluded 



















2015 41 86 HCC 
3 
(7.32%) 




























2013 28 28 HCC 
5/23 hybrid 
(21,73%) 






2013 32 64 HCC 
6 hand-assist 
(18,8%) 
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Table 14. (Cont) Overall quality analysis from all comparative studies including Newcastle-Ottawa and SIGN scores. Red marked studies were the discarded 
ones because of NOS <7 stars or Low scoring in the SIGN analysis. 
Author 
Country Year Nlap Nopen Etiology Conversion 
Quality assessment by Newcastle-Ottawa Scale 



































































2015 24 19 HCC 
3 
(12.5%) 
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Table 14. (Cont.) Overall quality analysis from all comparative studies including Newcastle-Ottawa and SIGN scores. Red marked studies were the discarded 
ones because of NOS <7 stars or Low scoring in the SIGN analysis. 
Author 
Country Year Nlap Nopen Etiology Conversion 
Quality assessment by Newcastle-Ottawa Scale 









2015 53 53 HCC 
Were 
excluded 





2015 41 86 HCC 
3 
(7.32%) 


















2014 70 76 HCC 
6 
(8.57%) 

















2011 26 29 HCC 
3 
(10.3%) 
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Table 14. (Cont.) Overall quality analysis from all comparative studies including Newcastle-Ottawa and SIGN scores. Red marked studies were the discarded 
ones because of NOS <7 stars or Low scoring in the SIGN analysis. 
Author 
Country Year Nlap Nopen Etiology Conversion 
Quality assessment by Newcastle-Ottawa Scale 
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51 3 350±432 3 211±131 8,2±4,6 17±17   41   35 




29 4 483 ±820 1 210±82 7,7±2,9 11,1±6,7 29 29 27 24 18 16 




36 9 452±442 1 193±104 6,5±2,7 9,5±2,8   25   13 




13 4 620±130 1 267±79 15,3±8,6 9±2,5  12   6  
14 13 720±240 4 182±57 17,3±18,9 8,8±1,3  8   6  
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43 8    10,5±6,86 8,25±4,34  32,2 16,3  17,6 10,75 




31  118±36  117±38 4,5±1,3 21±12     5  




53 16 265±57  222±51 13±4       21 




52 4 923±735 2 350,5±88,1 18,5±8,9   41,2 33  16,7 8,37 




24 4 178±126 0 220±103 5,8±2,3  24 21 17 23 17 12 




63 6 456±742 4 299,5±128 10,3±4,4 7,4±8,7     43 21 




45 9 475±340,6 0 171,3±72 20,8±15,7 17,5±11 40  27 36  9 




29 4 484±820 1 210,5±82 7,7±2,9 11,1±6,8 29 29 27 24 18 16 
29 11 261±301 0 203,5±51,1 13,4±7,3 10±7,5 28 27 25 23 18 12 
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28 3 269±223,7 0 260±111 12,8±4,8 7±4,5       




32 2 465±329 0 246±91,9 6,5±3,4 12,3±7,3 31 28 25 28 23 17 




24 0 350±303 0 206,5±91,4 11,3±2,3  24 24  22 12  




36 9 452,2±442 1 193,4±104 6,5±2,7 9,5±2,8   25   13 




23 5 260±127 0 148±29,7 8,2±2,6  22 15  18 12  




30 3 350±210  182±38 14,9±7,1    18   9 




13 4 620±130 1 267±79 15,3±8,6 9±2,5  12   6  




17 1 546±696,8 1 323±175 12±5 8±7       
38 4 808±482 2 271±79,4 22±8 7±6       
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20 0 180±20,5 0 143±35,6 7±1 21,25±3,8 20   20   




38 12 280±205,9 2 377,5±98,1 17,3±11,2   28   19  




24 2   567,4±212 10,6±4,8 30±58   19   10 





53 16 265±57,4  222,5±50,7 13±4        




51 3 350±432,5 3 210,7±131 8,2±4,6 17±17   40,9   34,6 




70 5  17 215,5±122 12±23 10±13,7  46 42  41 36 




97 9 460±426 4 245±105 8,2±3,6 15,3±5,9 91 83  90 64  
178 53 454±365 5 225±112 13,5±3,8 13,6±6,2 169 157  164 119  
  
Impact of minimally invasive approach surgery in hepatocellular carcinoma 
52 











26 1  5 210±115 11,1±5     22   




17 6 101  235 4,1 11,2 14 12  12 11  




42 5 364±435 4 233±92,7 6,7±5,9 10,4±8 39 31 25 34 26 19 
42 12 723±559 7 222±46,3 9,6±3,4 10,6±9 34 30 20 30 23 16 
Lai 
Chai Wan-Hong Kong 
2009 
25 4   146,3±34 7,3±1,8   15   13  




30 3 350±210  182±38 14,9±7,1    18   9 




13 4 620±130 1 267±79 15,3±8,6 9±2,5  11,6   5,7  




17 1 546±697 1 323±174,6 12±5 8±7       
38 4 808±481,5 2 271±79,4 22±8 7±6       
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387 26 219,3±297 28 294±158 13,3±6,7  370 334 297 324 226 158 




88 11 3675±2784 18 370±163 14±6,5 22,5±13,7 81 77 67 61 46 39 




43 10 1775±1487  241±103 16±11 21,75±13,5       
86 34 1225±715,8  207±3±60 24±15 26±15,5       
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5.4. Export of results to the EGMLLS 
The evaluation of a body of evidence should be 
completed before deciding guidelines 
recommendations. The quality of available evidence 
is the cornerstone over which conclusions are held.  
The Southampton Guidelines derived from the 
above mentioned methodology and thus, are based 
on published evidence and expert opinions (52). 
After carrying out the literature search described 
above and evaluating the manuscripts to obtain the 
highest level of evidence, a complex process for the 
development of a former guidelines document 
starts. In this case a guideline for the surgical 
approach in liver resection (HCC).  
In the first stage for this development, after the 
selection of experts, the steering committee 
identifies relevant topics to be addressed according 
to the purpose of the guidelines. In the last 
Southampton consensus two clinical questions were 
proposed for HCC: 
 CQ1: Are LLR indicated for the management of 
HCC? Short-term outcomes/Oncologic and 
Long-term outcomes 
 CQ2: What is the role of LLR in cirrhotic 
patients? Short term outcomes/Oncologic 
outcomes/Special advantages/difficulties for 
cirrhotic patients/Technical aspects for liver 
resections in cirrhotics. 
The second stage consists of formulating 
recommendations and developing an agreement. 
The expert panel formulated recommendations in 
response to the CQs by the SIGN Methodology. The 
process starts with a critical appraisal of the 
literature, including the assessment of the study 
quality and the evidence levels available for each 
topic. After this, recommendations are produced.  
For an adequate appraisal of the quality of 
evidence to the clinical question it is mandatory to 
perform several questions: How reliable are the 
studies in the body of evidence?/ Are the studies 
consistent in their findings?/Are the studies 
relevant to our target population?/ How sure are we 
that estimates of the size of effect are reliable?/ Are 
we sure of all the relevant evidence?. These 
questions must be answered, therefore exposing the 
level of evidence available.  
5.4.1. Quality of evidence CQ1 
For the clinical question number 1: Are LLR 
indicated for the management of HCC? Short-term 
outcomes/Oncologic and Long-term outcomes?, 
the quality of evidence obtained based on SIGN 
methodology is: 
To the question: How reliable are the studies 
in the body of evidence? 
There are three meta-analyses (17 studies/7 
studies/4 studies), 53 comparative studies and 24 
series studies (non-comparatives) that compared 
laparoscopic vs open approach in HCC patients. 
These studies follow the SIGN minimum rules for 
evidence-based analysis. The statistics methodology 
and bias assessment were good in general; however, 
the common problem of all of these studies is that 
all collected manuscripts collected are 
observational,  retrospective and non-randomized.  
The number of patients and the sample size of 
each study were not very high (from 20 to 200). 
Eight (61) (111) (62) (60) (102) (59) (58) (107) of 
the 53 comparative studies used Propensity score 
matching methods to improve the level of evidence 
and avoid biases that might occur during the sample 
selection process. Evidence level 1+. 
Laparoscopic LLS and minor LLR for HCC 
patients are now considered standard approaches 
(61) (103), especially for tumors located in the 
anterolateral segments. These patients show lower 
transfusion rate, lower risk of bleeding, shorter 
hospital stay and fewer complications. Evidence 
level 1++. 
Recent studies question whether there are 
benefits of using laparoscopy in complex resections 
such as posterosuperior segments (high Iwate 
score). Xiao (79) with a case-control study with over 
127 patients without PSM concluded that LR for 
HCC patients in these segments might offer the 
same oncologic outcomes as an open approach. LR 
is associated with several advantages as lower 
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blood loss, fewer complications and shorter hospital 
stay. Evidence level 2+. 
Regarding major hepatectomy for HCC patients, 
there are several comparative studies. Komatsu 
(80) does a comparative study to identify the 
benefits of the laparoscopic approach in major 
resections. The sample size is very small. This was 
an intention-to-treat analysis; for this reason, the 12 
converted cases in the laparoscopic group were 
analysed as laparoscopic cases, resulting in not very 
reliable conclusions.  
Ai et al. (108) did an interesting study about 
patients who underwent major resection for HCC 
greater than 5 cm. The majority of the patients 
underwent major hepatectomy or with high Iwate 
score. Over 275 resection, they concluded that there 
were no significant differences in the mean 
operative time (p=0.469), mean estimated 
intraoperative blood loss (p=0.913), or blood 
transfusion (p=0.480) between the laparoscopic and 
open group. There was a lower rate of postoperative 
complications in these patients, being the hospital 
stay shorter than in the open group (p=0.028).  
The principal selection bias in this study was 
that patients with previous surgery were excluded 
from the laparoscopic group and they did not do a 
subgroup analysis over major/minor resection. 
Most of the studies showed that the short-term 
outcomes were superior compared to the open 
approach (fewer complications) and that technical 
feasibility has been proved in expert centres. 
Evidence level 2-. 
Regarding complex resections with high Iwate 
score (as posterosuperior segments), there are a 
few numbers of manuscripts. The most recent is 
from Xiang et al. (112) where over more than fifty 
patients had been diagnosed with HCC in 
posterosuperior segments, and a comparative study 
versus anterolateral segments resections was 
performed.  
Authors concluded that the operation time is 
longer in these patients (217.5 ± 63.7 vs 176.8 ± 
48.4 min, p = 0.000), because of the process 
required the full mobilization of the liver and more 
time to expose the lesion.  
The number and duration of Pringle’s cycles are 
higher and thus, enzyme peak is higher in these 
patients.   
Xiao et al (79) did another interesting study in 
the same year, comparing open versus laparoscopic 
approach in posterosuperior segments. They 
concluded that intraoperative blood loss was 
significantly lower and postoperative hospital stay 
significantly shorter in the LLR.  
The overall complication rate was significantly 
lower in the laparoscopic group (p=0.021). Liver 
resection in HCC patients in the posterosuperior 
segments might offer the same oncologic outcomes 
as with conventional procedures while being 
associated with such advantages as lower blood 
loss, fewer postoperative complications and shorter 
hospital stay. Evidence level 2-. 
Regarding short-term results, there are several 
comparative studies (some of these with PSM) and 
three meta-analyses. Leong (113) and Chen (68) 
concluded that operative time seems to be similar 
between both groups (p=0.2) (due to the 
improvement with the progression of the learning 
curve). Blood loss (p=0.03) and need of transfusions 
(p=0.004) are lower in patients undergoing LLR 
than OLR.  
Postoperative morbidity is significantly lower 
(p<0.0001) in LLR group (fewer ascites, less 
infection, less chest complication, less pleural 
effusion and less abdominal wall complications), 
similar postoperative mortality (p=0.48) and 
shorter hospital stay (p=0.0002). Evidence level 1+. 
Regarding long-term and oncological results, 
tumor margin was not different in comparative 
studies. Twaij et al. (63) showed wider resections 
margins in laparoscopic approach; this might be 
explained because the tumor size in the open group 
is usually bigger and closer to vessels and hepatic 
pedicles. Overall survival and disease-free survival 
rates are similar in both groups in comparative and 
review studies.  
In different studies, the disease-free survival 
rate seems to be better in LLR group than in OLR. 
This might be because patients in LLR group may 
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undergo a selection bias and have smaller tumor 
size. Evidence level 2+. 
To the question: Are the studies consistent in 
their conclusions? 
It is possible to conclude that there are no 
inconsistent studies in the laparoscopic approach 
for the treatment of HCC patients. All studies 
published at the moment concluded the same 
results.: the fair benefits of this approach in these 
patients. The lowest evidence could be found on the 
disease-free survival rate of these patients.  
This is because in most of the studies, the 
follow-up period remains short. Furthermore, the 
main limitation is that all comparative studies 
included are non-randomized controlled studies 
with a retrospective matching. Selection of patients 
in both groups tends to be heterogeneous. However, 
it is unknown whether patients in the open group 
tend to have greater size tumour and closer to main 
vessels. Matching and PSM analysis try to avoid 
these selection biases. 
To the question: Are the studies relevant to 
our target population? 
It is possible to conclude that most of the 
results from our studies might be exportable to 
other populations. There are two main comparing 
groups (open and laparoscopic) with equivalent 
characteristics as tumor size, ASA score and number 
of segments resected. Most of the studies have 
similar aims (short and long-term 
outcomes/oncologic outcomes and survival and 
disease-free survival rates).  
Results are depicted using same measurement 
units (blood loss, transfusion rate, operative time, 
tumor size, Pringle’s cycle) and use a recognized 
definition of the complications, including most 
commonly used scales (Dindo Clavien). A high 
number of studies use several methods to avoid 
selection bias as matchings and propensity score 
matching and an adequate technical description of 
each technique is performed in most of the studies. 
To the question: Are there concerns about 
publication bias? 
Publication bias is a type of bias that occurs in 
published academic research. It happens when the 
outcome of an experiment or a research study 
influences the decision of whether to publish or 
otherwise distribute it. Multiple factors contribute 
to this publication bias and may be difficult to be 
controlled. In this case, a strict literature search 
without language restrictions on MEDLINE, 
EMBASE, and the Cochrane Library has been 
performed.  
Eligible studies were identified using the 
following index words: hepatocellular carcinoma or 
HCC or hepatic tumour; open surgery or open 
hepatectomy or open liver resection; laparoscopic 
surgery or laparoscopic hepatectomy or 
laparoscopic liver resection. The studies included 
should compare the two types of approach, should 
report data on short-/longterm outcomes and 
intraoperative outcomes. In this literature review, 
publication bias has not been reported. 
5.4.2. Quality of evidence CQ2 
For the clinical question number 2: What is the 
role of LLR in cirrhotic patients? Short term 
outcomes / Oncologic outcomes / Special 
advantages / difficulties for cirrhotic patients / 
Technical aspects for liver resections in 
cirrhotics, the quality of evidence obtained based 
on SIGN methodology is: 
To the question: How reliable are the studies 
in the body of evidence? 
There are two systematic reviews and eight 
comparative studies on patients diagnosed with 
HCC undergoing laparoscopic surgery compared 
with open surgery. Liver resection in cirrhotic 
patients was reported to have higher morbidity 
rates compared to non-cirrhotic patients. With the 
advancement of laparoscopic surgery, this approach 
could be beneficial in cirrhotic patients and prevent 
existing complications after open surgery. 
Regarding short-term outcomes, most of the 
studies show a superiority of the laparoscopic 
approach versus open in HCC in cirrhotic patients. 
In general, for cirrhotic HCC patients, more 
postoperative adverse events might happen, 
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including infections, pleural effusion, or liver failure. 
In the meta-analyses by Chen (68) tumor margin is 
significantly wider in the laparoscopic group than in 
the open group (p=0.002). However, operative time 
seems to be similar in both groups. In laparoscopic 
groups,less transfusion are need (p=0.004) and less 
blood loss is reported (p=0.03).  
Postoperative complications are significantly 
lower in the laparoscopic group (P<0.0001). The 
kind of approach does not seem to have an impact 
on postoperative mortality (p=0.48) (68). Evidence 
level 1+. 
Regarding long-term and oncological outcomes, 
no significant survival rate benefit was shown 
between both groups. Belli et al (67) showed a trend 
towards better survival benefit in laparoscopic 
approach in HCC patients with liver cirrhosis.  
The authors reported a wider resection margin 
(p<0.0001) and a theoretical better visualization of 
micro-invasive satellite vascular areas. Evidence 
level 2++. 
In recent studies, Shehta (114) and Han (60), 
also reported interesting results. In laparoscopic 
resection performed Child-Pugh-C patients. 
Although all patients underwent minor resections, 
recovery after surgery without significant 
morbidities was reported. Evidence level 2+. 
Regarding technical concerns, one of the major 
drawbacks of LLR in cirrhotic patients is the risk of 
massive bleeding. Cirrhotic patients are at high risk 
of bleeding mainly due to primary hemostasis 
dysfunction. The reason for conversion in most 
manuscripts is bleeding from parenchymal 
transection.  
Twaij et al. (63) reported significantly lower 
blood loss in the laparoscopic group compared to 
the open groups (p<0.001). This finding was 
explained thanks to high-definition laparoscopic 
devices which allow magnification, enabling 
surgeons to obtain a decent view for performing 
proper haemostasis.  
A secondary point is the better access and 
exposure during a salvage transplant after a 
primary resection for an HCC. In this sense, 
laparoscopic approach versus open may reduce 
adhesions and bleeding in a further transplant.  
Some manuscripts have reported improved 
results in the hepatectomy phase of the transplant 
and a smaller cold ischemia time in these patients 
(114). Evidence level 2++. 
To the question: Are the studies consistent in 
their conclusions? 
There are no inconsistent studies in the 
minimally invasive approach for HCC in liver 
cirrhotic patients. The lowest evidence was 
obtained due to the impossibility to reach an 
accurate conclusion regarding the benefits and risks 
of laparoscopic resection in the absence of RCTs. 
To the question: Are the studies relevant to 
our target population? 
Most of the results from our studies might be 
exportable to other populations. However, some 
difficulties may be considered. Few papers have 
evaluated laparoscopic resection for HCC in 
cirrhotic patients.  
The patients in the open group have bigger 
tumour size and underwent more complex 
resections compared to laparoscopic approach 
group (important selection bias of these studies). 
To the question: Are there concerns about 
publication bias? 
Eligible studies were identified using the 
following index words: cirrhosis or cirrhotic; 
hepatocellular carcinoma or HCC or hepatic tumour; 
open surgery or open hepatectomy or open liver 
resection; laparoscopic surgery or laparoscopic 
hepatectomy or laparoscopic liver resection.  
The studies included should compare the two 
types of approach, should report data on 
short/long-term outcomes and intraoperative 
outcomes.  
In this literature review, publication bias has 
not been reported and do not appear from the 
studies considered. 
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5.4.3. Evidence to recommendations and 
making recommendations 
One of the factors that seem to influence a 
practitioner’s decision to implement a 
recommendation is the degree of confidence that 
they have in it; that is, how certain they are that 
following the recommendation will produce the 
expected improvement in the outcome for their 
patients.  
Not only does this certainty relate to the degree 
of confidence in the size of the effect of an 
intervention in relation to specific important 
outcomes, but it also encompasses other issues such 
as patient preferences and the availability of 
resources to support the introduction of a new 
intervention.  
For this reason, the guideline development 
group has to consider both the overall quality of the 
supporting evidence and the other factors that 
might influence the strength of the 
recommendation.  
The guideline development group should focus 
on outcome, impact, number of studies and 
quality/certainty of the body of evidence. 
Fundamental to making any recommendation is the 
need to have a clear understanding of how 
substantial the expected benefits of an intervention 
are likely to be in practice.  
The guideline development group also needs to 
consider how substantial the downsides are. 
Balancing all the issues described is complex and 
presents a challenge to any guideline group. The 
outcome of the decision-making process is to 
produce a recommendation that is rated as either 
strong or conditional.  
High-quality evidence from well-conducted 
studies should lead to a strong recommendation but 
relating the trial populations to the target 
population of a guideline and taking into account 
issues of cost and patient acceptability might lead to 
a recommendation that is much weaker than first 
thought. Likewise, there will be circumstances 
where the evidence is flawed but there are few or 
no downsides to treatment and the clinical 
importance of the topic is such that a strong 
recommendation is justifiable. 
5.4.4. Statements and recommendations 
to CQ1 (Appendix 5) 
Laparoscopic liver resection for HCC offers better 
postoperative outcomes in selected patients when 
compared with open resections in terms of a decreased 
morbidity and hospital stay without compromising 
oncologic outcomes. Evidence level 1-, Form of 
recommendation: Strong.  
To the question whether LLR is indicated for 
the management of HCC, several meta-analysis and 
large propensity score-matched studies of open 
versus laparoscopic liver resection for HCC have 
strongly suggested that LLR for HCC is associated 
with reduced blood loss, transfusión rate, 
postoperative ascites, and liver failure and hospital 
stay with comparable operation time, disease-free 
margin, and recurrence rates (115) (62). This has 
been confirmed for major resections in a recent 
series (116).  
For minor resections, a laparoscopic approach 
was found to be the only independent factor to 
reduce the complication rate in resections for HCC 
(61). 
Leong (113) performed a comparative study 
over 152 patients (LLR vs OLR) and concluded that 
the duration of operation in the LLR group was 
significantly shorter. Similarly, intraoperative blood 
loss, need for transfusions and hospital stay were 
also lower. There was no difference in the overall 
complications rate or specific complications. 
Laparoscopic approach was equal in terms of tumor 
recurrence and did not impact the oncologic 
outcomes (overall survival and disease-free survival 
rates).  
Moreover, a significant increase in disease-free 
survival rates in the LLR group [52.5% DFS at 5 
years for LLR group Vs 38.2% for OLR p=0.035] 
(maybe due to the higher incidence of 
microvascular invasion found in the open group) 
was reported. The authors performed a parallel 
meta-analysis of 17 studies with favourable results 
to minimally invasive approach in terms of hospital 
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stay and postoperative complications. No significant 
differences were observed between LLR and OLR in 
regards to post-operative mortality (P=0.07). 
Chen (68) performed a systematic review and 
meta-analysis on 7 comparative studies. They 
concluded that the tumor margin was significantly 
wider in LLR than in OLR (p=0.002); however, 
curative resection in LLR was not significantly 
better than in OLR patients (p=0.26).  
Operative time was similar between both 
groups. Blood loss (p=0.03) and need of 
transfusions (p=0.004) were lower in patients 
undergoing LLR compared to OLR.  
Postoperative hospital stay and morbidity were 
significantly lower (fewer ascites, less infection, less 
chest complication, less pleural effusion and less 
abdominal wall complications).  
Regarding oncological outcomes, patients in the 
LLR group have higher 5 years survival rate than 
OLR (p=0.04); however, the disease-free survival 
rate is similar in both groups.  
Sposito et al. (61) recently reported a 
propensity score matching analysis of two 
comparable groups of 43 LLR and OLR patients. 
Complications rate and hospital stay were 
significantly lower in the LLR group.  
They performed a multivariable logistic 
regression analysis in which the only independent 
factor that reduced the risk of postoperative 
complications was the use of laparoscopy (odds 
ratio 0,12 [0.03-0.55] CI 95). Long-term outcomes 
were not different between groups.  
The laparoscopic approach seems to be 
superior to the open approach in terms of hospital 
stay, transfusion rate, operative time, blood loss and 
postoperative complications without compromising 
oncologic outcomes.  
However, it should be kept in mind that they 
are usually based on studies in which patients might 
have had some kind of selection bias (size and 
location of the tumour, superficial or peripheral 
locations). 
For HCC, indications and type of resection should 
not differ between laparoscopic and open approaches. 
For HCC located in the postero-superior part of the liver 
(i.e. segments 1, 4a, 7 and 8) laparoscopic resection is 
technically demanding, not well standardized yet and 
should only be performed in experienced centres. 
Evidence level: 2-. Form of recommendation: 
Conditional. 
Procedures on posterosuperior (PS) segments 
of the liver are more challenging than those on 
anterolateral (AL) areas and should be reserved for 
experienced surgeons at major laparoscopic 
centres. Advances on laparoscopic techniques and 
surgical equipment have made LLR of lesions 
located in the PS segments safe and feasible (117). 
LLR for HCC in the PS segments is technically 
demanding, and the key to the success of this 
procedure lies in surgical field exposure, bleeding 
control and safe margin determination. The studies 
to answer this question are scarce.  
The most recent study is from Xiang (112) with 
more than fifty patients with the diagnosis of HCC in 
PS segments; and where a comparative study versus 
resections on AL segments is performed. They 
concluded that operation time is longer in PS 
resections (217.5 ± 63.7 vs 176.8 ± 48.4 min, 
P=0.001), because they required the full 
mobilization of the liver and more time to expose 
the lesion.  
The number and duration of Pringle’s cycles is 
greater, and thus, enzyme peak is higher. As Xiao 
states (79) the resection of HCC located in PS 
segments is one of the most complex procedures. 
Xiao (79) showed significant advantages in short-
term outcomes for laparoscopic approach, shorter 
hospital stay (p=0.000) and  less blood loss 
(p=0.001). The overall complication rate was 
significantly lower in the laparoscopic group 
(p=0.021).  
Liver resection in patients with an HCC located 
in the PS segments might benefit from laparoscopic 
approach as it may be associated with lower blood 
loss, fewer postoperative complications and shorter 
hospital stay.  
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Current studies on this subject are no meta-
analysis nor randomized studies, and subsequently, 
conclusions obtained from the few number of 
comparative studies and case series are limited. 
As for other indications, intermittent clamping, 
selectively applied in patients with HCC, might help to 
decrease blood loss without detrimental effects on liver 
function. Evidence level: 4. Form of recommendation: 
Strong. 
The conclusions regarding this clinical question 
are based on expert opinions due to their 
experience and their observation in the clinical 
practice. Growing evidence supports that excessive 
blood loss and the need for blood transfusions are 
predictors of poor outcome in liver resections for 
both cirrhotic and non-cirrhotic patients.  
Dua (118) performed a comparative study 
about the use of intermittent clamping (IC) for 
parenchymal transection in laparoscopic liver 
resections. This manuscript concluded that there 
were no postoperative differences in the peak of 
AST and ALT (p=0.15 and p=0.14) and neither in 
serum bilirubin or INR (p=0.69 and p=0.62) 
between IC and no IC groups.   
This study has a high selection bias because 
patients in which IC was performed had higher rates 
of major resections and longer operative times. In 
the last Consensus Conference held in Morioka in 
2014 (51) the conclusions about essentials in 
bleeding control were centrally based on CO2 
pneumoperitoneum.   
Authors concluded that, in case of severe 
bleeding, increasing the pneumoperitoneum 
pressure and decreasing the airway pressure by a 
brief pause in the artificial ventilation are 
manoeuvres that can be used to decrease back-
bleeding.  
When used together with low central venous 
pressure and high CO2 pneumoperitoneum 
pressure, IC is especially effective in preventing 
blood loss. To address ischemia-reperfusion injury, 
which is a major concern in this technique, IC and 
ischemic preconditioning have been proposed as 
modifications of the original (119). 
The conclusions arising from expert’s opinion 
were that IC can be used if necessary. Blood loss can 
be reduced by careful application of ultrasonic 
dissectors. Careful administration of intravenous 
fluid and tight maintenance of low central venous 
pressure also contribute to minimal oozing during 
liver transection. In laparoscopic hepatectomy, 
raising of intra-abdominal pressure also leads to a 
relative reduction in venous pressure during liver 
transection. Randomized trials and comparative 
studies are encouraged in order to scientifically 
prove the benefits of IC in patients undergoing 
laparoscopic liver resections. 
In experienced hands, laparoscopic major 
resections for HCC are an appropriate option, like for 
open surgery, in highly selected patients. Evidence level: 
2++. Form of recommendation: Strong. 
Few manuscripts compare major LLR versus 
OLR. Zhang (81) compared 20 left hemi-
hepatectomies and concluded that LLR offers less 
blood loss (p<0.05), less hospital stay (p<0.05) and 
less postoperative morbidity rate with a mean 
operative time similar in both groups (143 min vs 
137 min). The oncologic outcomes were similar in 
both groups.  
Komatsu (80) performed a non-randomized 
comparative study including 76 patients (38:38) in 
an intention-to-treat basis and demonstrated the 
technical feasibility and superior short-term 
outcomes with equal oncological results with a 
minimally invasive approach. The overall 
complication rates were significantly higher in the 
open group than in the laparoscopic group (65% vs 
32%, respectively; p=0.011).  
Moreover, the laparoscopic approach showed a 
trend toward shorter, although not statistically 
significant, length of postoperative hospital stay 
(p=0.079). Cho (83) analysed the results of 24 major 
LLR vs 19 OLR, obtaining similar results. The mean 
operative time was longer in the laparoscopic 
group. There was no difference in the mean 
resection margin and the rate of postoperative 
complications. The duration of hospital stay in LLR 
group was shorter but not statistically different. 
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5.4.5. Statements and recommendations 
to CQ2 (Appendix 6) 
In patients with cirrhosis, the risk of postoperative 
ascites and decompensation might be lower than 
expected with open resections. Evidence level: 1+. Form 
of recommendation: Strong 
To the question of what is the role of LLR in 
cirrhotic patients, no differences in operative time, 
blood loss, intraoperative complications, hospital 
stay and morbidity were found in LLR for cirrhotics 
compared with noncirrhotics (114).  
The laparoscopic approach appears to reduce 
the incidence of postoperative ascites, liver failure 
(81), and morbidity assessed in terms of 
“comprehensive complication index”, with no 
difference in overall or disease-free survival rates at 
2 years (72). The evidence for both LLR in patients 
with significant portal hypertension, ascites, and 
Child-Pugh B cirrhosis is limited to single studies, 
(120) (121), and therefore, the guidelines 
recommend caution with these patient cohorts. 
Numerous studies have reported the potential 
benefits of laparoscopic liver resection in cirrhotic 
patients. There are two main groups of studies. The 
first ones compared the laparoscopic approach in 
cirrhotic livers versus non-cirrhotic patients (114) 
(122). The second group compared laparoscopic 
versus open approach in cirrhotic liver patients (68) 
(71) (63) (69) (70) (64) (65) (67).  
Chen (68) performed the most recent meta-
analysis, excluding patients with severe cirrhosis. 
The rest of the studies excluded patients with Child-
Pugh Score of C, except Truant (66) who also 
excluded Child B patients and those with portal vein 
thrombosis.  
Shehta (114) performed a well-designed 
retrospective case-control study analysing 232 
patients, 141 of which had biopsy-proven cirrhosis. 
There were no statistically significant differences 
between both groups regarding operation time, 
blood loss, transfusion requirements, intraoperative 
complications, hospital stay and postoperative 
complications. Postoperative ascites was not 
specifically analyzed.  
Similarly, although Belli (67) reported a lower 
complication rate, liver-related ones as ascites or 
failure were not analyzed. Yamashita (71) compared 
63 laparoscopic vs 99 open procedures in cirrhotic 
patients. Morbidity rates in the laparoscopic group 
(10%) were significantly lower than in the open 
group (26%) p=0.0459. The rate of ascites in the 
laparoscopic group (0%) was significantly lower 
than in the open group (7%) p=0.0077.  
The same happened with hospital stay, which 
was shorter in the laparoscopic group (p=0.0008). 
Memeo recently reported their series (69), in which 
complications in the laparoscopic group (20%) was 
much lower than for open patients (45%). No 
differences were detected in the type of 
postoperative complications, except for 
postoperative ascites, which was higher in the open 
group (18 vs 2% p=0.01), as was the development 
of postoperative liver failure (5 vs 1), although this 
was not statistically different (p=0.09).  
Kanazawa (64) also showed a higher incidence 
of intractable ascites in the open group (p<0.0001). 
With a high level of evidence, a meta-analysis 
performed by Morise (72) reported that a minimally 
invasive approach was associated with a reduced 
incidence of postoperative ascites (OR 0.26; 95% CI, 
0.14-0.49; p<0.0001) and liver failure (OR 0.24; 
95% CI, 0.10-0.56;p=0.001).  
It should be remarked that in most of the 
studies, wedge and minor resections were 
performed in laparoscopic groups, whilst complex 
procedures were performed in the open approach. 
Despite these biases, it seems that, even in cirrhotic 
patients, the laparoscopic approach decreases the 
incidence of intractable ascites and liver failure, and 
thus, consequently reduces the length of the 
postoperative hospital stay. 
The extension of indications into patients with 
significant portal hypertension (i.e. hepatic venous 
gradient ≥ 10mmHg) or ascites requires further 
evaluation. Evidence level: 3. Form of recommendation: 
Recommendation for research. 
Morise (123) concluded that, for cirrhotic 
patients with liver tumors, pure laparoscopic liver 
surgery might minimize the destruction of the 
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collateral blood and lymphatic flow compared with 
laparotomy. Pure laparoscopic hepatectomy results 
in minimal postoperative ascites production, which 
leads to a lower risk of electrolyte imbalance and 
hypoproteinemia. Accordingly, a lower rate of 
complications might potentially lead to a reduced 
incidence of postoperative serious liver failure.  
Kanazawa (47) also showed that the 
laparoscopic liver resections could be considered a 
safe and feasible procedure even in cirrhotic 
patients. Cheung (65) performed a high-quality 
case-control study matching 1:1 over 600 patients 
with cirrhotic liver (evaluated by Child score and 
ICG retention).  
This study concluded that laparoscopic 
approach for HCC stage I and II might achieve safety 
and long-term survival rates equivalent to those 
achieved by open approach. Randomized or 
comparative studies in patients with severe 
cirrhosis and portal hypertension are necessary in 
order to obtain conclusions regarding this clinical 
question. 
The majority of the studies did not include 
patients with portal hypertension or Child-Pugh C. 
The rate of ascites before surgery was not reported 
in most of the manuscripts. To date, no studies have 
been performed to find out the possibility of 
expanding the surgical criteria into patients with 
portal hypertension or ascites.  
Therefore, the indications for surgery in 
patients with significant portal hypertension or 
ascites are now equivalent both for the laparoscopic 
and open procedures. The studies show that a 
minimally invasive approach for HCC generally 
yields better short-term outcomes without 
compromising the long-term outcomes (72).  
The role of laparoscopic minor resection for single 
peripheral or subcapsular HCC in selected Child B 
patients needs further evaluation. Evidence level: 2-. 
Form of recommendation: Recommendation for 
research. 
Three manuscripts compared open or 
laparoscopic approaches vs radiofrequency ablation 
in subcapsular HCC (111) (124) (125). In general 
terms, the laparoscopic approach for minor 
resections in HCC shows several benefits over the 
open approach (hospital stay, blood loss rate, 
postoperative pain, need for transfusion, 
complications rate,…).  
According to the Morioka Consensus, overall 
postoperative complications and length of stay were 
generally better than for open procedures. No 
outcomes are worse for the laparoscopic approach 
(51). Truant (66) performed a case-control study in 
36 patients with chronic liver disease and 
peripheral HCC (laparoscopic group) vs 53 patients 
who underwent open hepatectomy. Severe 
complications were more frequent in the open 
group (p=0.09); meaning that hospitalizations were 
shorter in the laparoscopic group (p=0.003).  
The patients included in this study were 
patients with Child-A cirrhosis. Patients with Child-
Pugh grade B or C were excluded. Studies that 
include patients with Child-Pugh B stage are very 
scarce.  
Several studies compared laparoscopic versus 
open approach in patients with cirrhosis in which a 
few patients with Child-Pugh B were included, but 
the percentage is still very small. No comparative 
studies regarding this clinical question have been 
published to date. Future randomized or 
comparative studies focusing on patients with Child 
B stage are needed to answer this question.  
5.5. Updated Meta-analysis 
All the abovementioned literature search was the 
basis of the European Guidelines on Laparoscopic 
Liver Surgery that were published by all the 
researchers and experts that contributed to their 
development (52). With all these data, an updated 
systematic review and meta-analyses was 
performed by our team. As reported before, all 
manuscripts were deeply screened and patients 
were grouped into 5 blocks: Solitary tumors, Child-
Pugh A, Minor resections, Major resections and 
combined resections.   
From the initial 361 manuscripts, 28 were 
included in the meta-analysis. Five of these were 
specific to patients with CPA cirrhosis (321 cases), 
eleven focused on solitary tumors (1003 cases) 
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while sixteen focused on minor (1286 cases) and 
three in major (164 cases) resections respectively. 
All baseline results are depicted in table 15. 
Each of the subgroups underwent secondary meta-
analyses. All the series allocated to each subanalysis 
were independently assessed for bias in each 
variable. All the results (funnel plots) were 
graphically depicted. In this chart, the magnitude of 
the effect measured against a precision 
measurement is represented, which is usually the 
sample size, but which can also be the inverse of the 
variance or the standard error.  
Heterogeneity, reporting bias, and chance 
might all lead to asymmetry or other shapes in 
funnel plots. Bellow, the funnel plots for each of the 
subgroups analyzed are depicted. The heterogeneity 
analysis is performed on each of the variables 
represented by I2 value and its statistical 
significance.  
5.5.1. Solitary tumors 
A total of 11 studies were identified, including 562 
open resection and 441 LLRS for solitary HCC 
(Table 15). This group includes patients in whom 
imaging tests describe a single HCC compatible 
lesion.  
The type of resection performed does not 
influence, therefore there might be cases in which a 
major or minor liver resection is carried out. There 
could be cases in both groups, being the prognosis 
and clinical environment different. 
  




Figure 12.  Solitary tumors. Hospital stay. Heterogeneity p≤0.001; I2 = 78%; SMD -0.786 [95% CI -1.089 to -
0.483]; p<0.001 
 




Figure 13.  Solitary tumors. Mean resection margin. Heterogeneity p= 0.88; I2 = 0%; SMD 0.218 [95% CI 0.064–
0.371]; p = 0.005 
 
  





Figure 15.  Solitary tumors. Blood loss. Heterogeneity p≤0.001; I2 = 78%; [SMD] -0.476 [95% CI -0.828 to -0.124]; 
p<0.008 
 




Figure 16.  Solitary tumors. Transfusions. Heterogeneity p= 0.75; I2 = 0%; OR 1.703 [95% CI 1.067–2.717];  
p <0.026 
 
Regarding short-term outcomes, it can be seen 
that the laparoscopic approach provides several 
benefits in terms of complications rate and others.  
Operative times were equal between the groups 
but all other short-term outcomes, including 
complication rates (heterogeneity p-value = 0.095; 
I-squared = 38%; OR 2.42 [95% CI 1.695–3.456]; 
p<0.001), blood loss (heterogeneity p-value ≤0.001; 
I-squared = 78%; standardised mean difference 
[SMD] -0.476 [95% CI -0.828 to -0.124]; p<0.008), 
transfusions (heterogeneity p-value = 0.75; I-
squared = 0%; OR 1.703 [95% CI 1.067–2.717]; p 
<0.026), hospital stay (heterogeneity p-value 
≤0.001; I- squared = 78%; SMD -0.786 [95% CI -
1.089 to -0.483]; p<0.001), and resection margins 
(heterogeneity p-value = 0.88; I-squared = 0%; SMD 
0.218 [95% CI 0.064–0.371]; p = 0.005), favored a 
laparoscopic approach (Figures 11 to 16).  
PHLF and Mortality were not significantly 
different between the groups (Figure 17 and 18) 
and there were no significant differences in 1-, 3-, 





Figure 17.  Solitary tumors. Posthepatectomy liver failure. Heterogeneity p= 0.133; I2 = 40%; OR 0.038 [95% CI -
0.016–0.093]; p =0.170 
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Figure 19.  Solitary tumors. 1-y overall Survival. Heterogeneity p= 0.298; I2 = 17%; OR 1.246 [95% CI 0.591–




Figure 20.  Solitary tumors. 3-y overall Survival. Heterogeneity p= 0.405; I2 = 0%; OR 1.013 [95% CI 0.671–
1.527]; p =0.953 
 




Figure 21.  Solitary tumors. 5-y overall Survival. Heterogeneity p= 0.624; I2 = 0%; OR 1.082 [95% CI 0.706–




Figure 22.  Solitary tumors. 1-year disease-free Survival. Heterogeneity p= 0.868; I2 = 0%; OR 1.401 [95% CI 




Figure 23. Solitary tumors. 3-y disease-free Survival. Heterogeneity p= 0.703; I2 = 0%; OR 1.042 [95% CI 0.736–
1.475]; p =0.816 
 




Figure 24.  Solitary tumors. 5-y disease-free Survival. Heterogeneity p= 0.617; I2 = 0%; OR 1.202 [95% CI 0.801–
1.805]; p =0.375 
 
5.5.2. Child-Pugh A Resections 
Five studies including 172 open procedures and 149 
laparoscopic procedures were analyzed (Table 15).  
Both complication rates (heterogeneity p-value 
<0.001; I-squared = 81%; OR 0.256 [95% CI 0.066–
0.446]; p = 0.008) and hospital stay (heterogeneity 
p-value ≤ 0.001; I-squared = 87%; SMD -1.037 [95% 
CI -1.718 to -0.357]; p = 0.003) favored a 
laparoscopic approach. The rest of variables 
evaluated do not show significant differences with 
respect to the open approach group (Figures 25-30). 
Perioperative mortality was equivalent in both the 
open and laparoscopic approach (Figure 31). Long-
term outcomes were insufficiently reported, and 
hence only three manuscripts were analyzed. These 
demonstrated no difference in 5 years OS and 
disease-free survival (DFS) rates between the two 





Figure 25.  Child-Pugh A resections. Operative time. Heterogeneity p = 0.052; I2 = 57%; [SMD] -0.169 [95% CI -
0.187 to 0.524]; p=0.353 
 




Figure 26.  Child-Pugh A resections. Hospital Stay. Heterogeneity p≤ 0.001; I2= 87%; SMD -1.037 [95% CI -1.718 




Figure 27. Child-Pugh A resections. Mean resection margin. Heterogeneity p=0.425; I2= 0%; SMD 0.088 [95% CI -




Figure 28. Child-Pugh A resections. Complications. Heterogeneity p<0.001; I2= 81%; OR 0.256 [95% CI 0.066–
0.446]; p = 0.008 
 
  





Figure 29. Child-Pugh A resections. Blood loss. Heterogeneity p<0.001; I2 = 94%; SMD -0.817 [95% CI -1.825 to 




Figure 30.  Child-Pugh A resections. Transfusions. Heterogeneity p=0.270; I2 = 0%; OR 0.028 [95% CI -0.020 to 
0.076]; p = 0.255 
 
  
Figure 31.  Child-Pugh A resections. Mortality. Heterogeneity p=0.336; I2 = 11%; OR 0.052 [95% CI -0.007 to 
0.112]; p = 0.086 
 
  





Figure 32.  Child-Pugh A resections. 5-y overall Survival. Heterogeneity p=0.703; I2 = 0%; OR 0.091 [95% CI -




Figure 33.  Child-Pugh A resections. 5-y disease-free Survival. Heterogeneity p=0.703; I2 = 0%; OR 0.092 [95% CI -
0.030 to 0.213]; p = 0.139 
 
Perioperative mortality was equivalent in both 
the open and laparoscopic approach (Figure 31). 
Long-term outcomes were insufficiently reported, 
and hence only three manuscripts were analyzed. 
These demonstrated no difference in 5 years OS and 
disease-free survival (DFS) rates between the two 
groups (Figures 32,33) 
5.5.3. Minor-Only Liver Resections 
Sixteen manuscripts were identified that included 
628 open procedures and 658 laparoscopic 
procedures (Table 15).  
The short-term outcomes for complication 
rates (heterogeneity p-value <0.001; I-squared = 
75%; OR 0.175 [95% CI 0.093–0.257]; p <0.001), 
blood loss (heterogeneity p-value ≤0.001; I-squared 
= 85%; SMD -0.685 [95% CI -1.012 to -0.357]; p 
<0.001), transfusión rate (heterogeneity p-value = 
0.13; I-squared = 20%; OR 0.027 [95% CI 0.001–
0.053]; p <0.001), and hospital stay (heterogeneity 
p-value ≤0.001; I-squared = 75%; SMD -0.837 [95% 
CI -1.083 to -0.590]; p<0.001) all favored a 
laparoscopic approach, with no difference in 
operative time and resection margin (Figures 34 to 
39). 
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Figure 34. Minor-only liver resections. Operative time. Heterogeneity p<0.001; I2 = 81%; SMD -0.043 [95% CI -
0.244 to 0.330]; p = 0.770 
 
  
Figure 35.  Minor-only liver resections. Hospital Stay. Heterogeneity p≤0.001; I2 = 75%; SMD -0.837 [95% CI -
1.083 to -0.590]; p<0.001 
 
  
Figure 36.  Minor-only liver resections. Mean resection margin. Heterogeneity p=0.379; I2 = 7%; SMD -0.087 [95% 
CI -0.057 to 0.230]; p=0.236 
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Figure 37.  Minor-only liver resections. Complications. Heterogeneity p<0.001; I2= 75%; OR 0.175 [95% CI 0.093–
0.257]; p <0.001 
 
  
Figure 38.  Minor-only liver resections. Blood loss. Heterogeneity p≤0.001; I2 = 85%; SMD -0.685 [95% CI -1.012 




Figure 39.  Minor-only liver resections. Transfusions. Heterogeneity p= 0.13; I2 = 20%; OR 0.027 [95% CI 0.001–
0.053]; p <0.001 
 
Mortality and PHLF were not different between 
the groups (Figure 40 to 41), similar to the 
behaviour in solitary resections. Long-term 
outcomes (Figures 42 to 47) were similar between 
both approaches, except for the 1-year DFS  
(heterogeneity p-value = 0.019; I- squared = 66%; 




Tesis Doctoral  Irene Gómez Luque 
74 
  
Figure 40.  Minor-only liver resections. Posthepatectomy liver failure. Heterogeneity p= 0.480; I2 = 0%; OR 0.031 




Figure 41.  Minor-only liver resections. Mortality. Heterogeneity p= 0.528; I2 = 0%; OR 0.006 [95% CI -0.010–




Figure 42.  Minor-only liver resections. 1-y overall Survival. Heterogeneity p= 0.07; I2 = 54%; OR 0.050 [95% CI -
0.014–0.114]; p =0.129 
 




Figure 43.  Minor-only liver resections. 3-y overall Survival. Heterogeneity p= 0.193; I2 = 19%; OR 0.046 [95% CI -




Figure 44.  Minor-only liver resections. 5-y overall Survival. Heterogeneity p= 0.109; I2 = 39%; OR 0.047 [95% CI -




Figure 45. Minor-only liver resections. 1-y disease-free Survival. Heterogeneity p= 0.019; I2 = 66%; OR 0.133 
[95% CI 0.001–0.265]; p =0.048 
 




Figure 46.  Minor-only liver resections. 3-y disease-free Survival. Heterogeneity p= 0.212; I2 = 26%; OR -0.013 




Figure 47.  Minor-only liver resections. 5-y disease-free Survival. Heterogeneity p= 0.545; I2 = 0%; OR 0.008 [95% 
CI -0.057–0.072]; p =0.816 
5.5.4. Major-Only Liver Resections 
Only limited data were available for major liver 
resections and no long-term data could be retrieved 
(Table 15). 
Regarding short-term outcomes, the 
complication rate was lower when using a 
laparoscopic approach (heterogeneity p-value = 
0.232; I-squared = 31%; OR 0.277 [95% CI 0.149–
0.406]; p <0.001). However, operative time was 
shorter for OLR (heterogeneity p-value = 0.015; I-
squared = 76%; SMD 0.835 [95% CI 0.155–1.516]; p 
= 0.016). There was a trend towards a shorter 
hospital stay in the laparoscopic group, but this did 




Figure 48.  Major-only liver resections. Operative time. Heterogeneity p= 0.015; I2 = 76%; SMD 0.835 [95% CI 
0.155–1.516]; p = 0.016 





Figure 49.  Major-only liver resections. Hospital Stay. Heterogeneity p<0.001; I2 = 94%; SMD -1.066 [95% CI -




Figure 50.  Major-only liver resections. Complications. Heterogeneity p= 0.232; I2 = 31%; OR 0.277 [95% CI 0.149–
0.406]; p <0.001 
 
In the other items (margin resection, 
transfusions rate and blood loss) the analysis could 
not be performed because only two papers (80) 
(81) had data available, therefore the sample was 
not sufficient enough. In the major-only resections 
group, mortality and PHLF were not calculated due 
to insufficient data. The same problem occurs with 
long-term results where data could not be obtained. 
5.5.5. Combined Resections 
The three manuscripts that contained combined 
studies did not have any long-term data available 
(Table 15).  
Regarding short-term outcomes, the rate of 
complications (heterogeneity p value = 0.469; I-
squared = 0%; OR 0.076 [95% CI 0.036–0.115]; p 
<0.001) and hospital stay (heterogeneity p-value 
≤0.001; I-squared = 92%; SMD -0.788 [95% CI -
1.339 to -0.237]; p =0.005) favored a laparoscopic 
approach, but the remaining short-term outcomes 
(operative time and blood loss) were not different 
to the open approach (Figures 51 to 54).  
In the other items (margin resection and 
transfusions rate) the analysis could not be 
performed because only two papers had data 
available, therefore insufficient information existed. 
Regarding post-hepatectomy liver failure and 
mortality rate the results are not available due to 
insufficient data. As with long-term outcomes, the 
data available for calculation was also insufficient. 
 
 




Figure 51.  Combined resections. Operative time. Heterogeneity p= 0.030; I2 = 72%; SMD 0.127 [95% CI -0.157 to 




Figure 52.  Combined resections. Hospital stay. Heterogeneity p≤0.001; I2 = 92%; SMD -0.788 [95% CI -1.339 to -




Figure 53.  Combined resections. Complications. Heterogeneity p= 0.469; I2 = 0%; OR 0.076 [95% CI 0.036–0.115]; 
p < 0.001 
 




Figure 54.  Combined resections. Blood loss. Heterogeneity p<0.001; I2 = 96%; SMD 0.055 [95% CI -0.676 to 
0.787]; p = 0.883 
 
Then, summay tables where short-term results 
are represented by Forests Plot were created. The 
sense of statistical significance might be observed 
through the red, green or yellow colour, in favour of 
open, laparoscopic approach or without significance 
differences respectively.  
A single significant statistically difference is 
found in favour of the open approach. This is the 
case of major liver resections in which the operative 
time is shorter than in the laparoscopic approach 
group. However, a lower complication rate is 
observed under laparoscopic approach in the 5 
subgroups analyzed (Figures 55 to 58) 
Data from short-outcomes and long-outcomes 
are shown in Table 16, considering if they were 
statiscally significant towards open of laparoscopic 
approach. 
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Figure 55. Meta-analysis of short-term outcomes (I) 
 
  




Figure 56. Meta-analysis of short-term outcomes (II) 
 
  




Figure 57. Meta-analysis of long-term outcomes (I) 
 
  




Figure 58. Meta-analysis of long-term outcomes (II) 
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Table 16.  Summary of short and long outcomes in each subgroup analyzed. If results were statistically significant 
towards open approach they are shown in red, and green for laparoscopic approach. If no significant 
differences were found, results are shown in yellow. 
Solitary Tumors Favors Open Approach Equivalent Favors Lap Approach 
Operative time    
Hospital stay    
Mean resection margin    
Complications    
Blood loss    
Transfusion    
Posthepatectomy liver failure    
Mortality    
1-y Overall survival    
3-y Overall survival    
5-y Overall survival    
1-y Disease free survival    
3-y Disease free survival    
5-y Disease free survival    
Child-Pugh A resections    
Operative time    
Hospital stay    
Mean resection margin    
Complications    
Blood loss    
Transfusion    
Mortality    
5-y Overall survival    
5-y Disease free survival    
Minor-only resections    
Operative time    
Hospital stay    
Mean resection margin    
Complications    
Blood loss    
Transfusions    
Posthepatectomy liver failure    
Mortality    
1-y Overall Survival    
3-y Overall Survival    
5-y Overall Survival    
1-y disease-free Survival    
3-y disease-free Survival    
5-y disease-free Survival    
Major-only liver resections    
Operative time    
Hospital stay    
Complications    
Combined resections    
Operative time    
Hospital stay    
Complications    
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Minimally invasive approaches have completely 
transformed the conception of surgery over the past 
2 decades. In many cases, the laparoscopic approach 
is considered as the standard of practice (126) 
(127) (128) (129) (130) (131) (132) (133) (134). 
Patients diagnosed of liver tumors who are 
considerd for surgery are complex as most of them 
may have undergone extensive chemotherapy (in 
metastasic liver disease) or may have any kind of 
underlying liver disease (hepatitis, fibrosis or 
cirrhosis). Certainly, case-by-case evaluations are 
required, and it should be emphasized that open 
and laparoscopic techniques should not be opposed 
but considered as complementary. They can even be 
associated with the same patient by hybrid 
procedures.  
A recent extensive worldwide review and the 
results from its meta-analysis suggest that 
laparoscopic liver surgery might be considered a 
safe alternative to the open traditional approach 
that should be offered to a growing proportion of 
selected patients (48).  
This was the largest meta-analysis to date (48), 
and it suggests that a significant proportion of LLRs 
are performed for the management of HCC, as 3072 
out of 6190 LLRs for malignancies were performed 
for HCC. Up to this date, different comparative 
studies and case series have been published with a 
higher or lower level of evidence. There are few 
publications focused on LLR for HCC.  
HCC resection is normally performed on 
patients with cirrhotic livers, with a complication 
index greater than in resections on healthier livers. 
All this leads to a difficult extrapolation of the 
results published in the current literature for this 
type of resection. For this reason, a study with a 
high methodological level was necessary in order to 
focus on HCC resections and study if the benefits of 
the laparoscopic approach on liver resections could 
also be obtained in cirrhotic livers.  
6.1. Literature Discussion 
In 2017, Southampton hosted the EGMLLS, with the 
specific aim of presenting and validating the first set 
of evidence-based guidelines for laparoscopic liver 
surgeons (135). In this setting, the aim of our study 
was to perform a high-quality systematic review 
and meta-analysis examining the short- and long-
term outcomes of LLR for HCC.  
Previous meta-analyses have already reported 
the results of open resection versus LLR for HCC 
(136) (137) (72) (138) (63) (68) (113).  
Twaij (63) performed a systematic review and 
meta-analysis based on 4 studies with an acceptable 
level of evidence. The aim was to review the 
currently available data comparing LR vs OR for 
HCC in patients with known cirrhosis. The risk of 
bias was assessed using NOS with acceptable quality 
(7 and 8 out of 9).  
All studies included were single centre 
retrospective studies. The limitations of this 
manuscript were: a small number of studies with no 
randomized trials, tumor size was not reported and 
neither patients demographics data. Twaij suggests 
that a laparoscopic approach, compared to open 
surgery, might result in improved short-term 
outcomes considering wider resection margins, 
reduced intraoperative blood loss and need for 
transfusions, as well as reduced morbidity rates and 
shorter lengths of stay.  
A year later, Leong published a systematic 
review (including 17 comparative studies) and a 
comparative study in their hospital (113) with 
better level of evidence. Their analysis of the 17 
studies showed that the rates of postoperative 
complications were significantly lower in patients 
who underwent LLR. The studies included were 
specific to HCC patients with underlying CLD or 
cirrhosis, showing that LLR resulted in fewer 
postoperative complications compared to OLR.  
Leong found, as in our study, a significant 
increase in disease-free survival rates in the LLR 
group; this could be attributed to the higher 
incidence of microscopic vascular invasion found on 
histology in the OLR group, which is a significant 
underlying risk factor for tumor recurrence.  
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This systematic review had some limitations, 
which warrant discussion and should be considered 
when interpreting the results. Selection of patients 
in both the LLR and OLR groups followed certain 
criteria based on the pre-operative clinicopathologic 
characteristics of each case, as well as according to 
the experience and expertise of the surgeons 
(selection bias). Leong concluded that as a curative 
treatment for HCC, LLR provides better short-term 
outcomes than OLR in terms of intraoperative blood 
loss, blood transfusions, and length of hospital stay, 
while both LLR and OLR provide similar long-term 
oncologic outcomes.  
The last meta-analysis reported was published 
by Chen (68) and was based on 7 retrospective 
studies. NOS was used to assess the risk of bias for 
quality assessment of non-randomized studies. The 
overall quality of this study was good (NOS score 7 
out of 9) with a high-quality evidence level.  
Chen (68) found wider tumor margin, similar 
operating time, less blood loss, less transfusion rate, 
lower postoperative morbility, similar 
postoperative mortality, similar curative resection 
and shorter hospital stay in the laparoscopic 
approach vs the open approach. Regarding long-
term results, the overall survival rate at 1 year was 
similar, but at 5 years in LH it seemed to be 
significantly higher than in OH (RR=1.28, 95% CI 
1.01 to 1.62, p=0.04, i2 =62%). Similar disease-free 
survival rates at 1-, 3- and 5-years were found.  
The limitations of this study are similar to the 
ones in previous studies. All studies are 
retrospective, non-randomized, which could 
increase the selection bias. The sample size is small, 
so it decreases the reliability of the final results. The 
patients in OH had huge HCC, higher degree of 
cirrhosis and difficult locations, leading to an 
increased risk of blood loss (selection bias).  
Cipriani et al. (138) published a recent 
interesting manuscript comparing results in 
cirrhotic vs non-cirrhotic liver, showing the 
advantages of the laparoscopic approach in liver 
resections and assessing the impact of the 
laparoscopic approach in the specific setting of 
chronic liver disease with impaired liver function.  
This study shows a similar complication rate in 
the cirrhotic and non-cirrhotic liver, also in the 
development of ascites or liver failure. Comparing 
the obtained complication rate (10-30%), a 
reduction in the complication rate of the 
laparoscopic approach versus open in cirrhotic 
livers could be observed.  
The study also shows a subanalysis between 
Child A and Child B with similar mortality and 
morbidity rates. The findings are of major 
importance, as it is still presumed that the specific 
advantages of LLR might remain restricted to 
patients with compensated cirrhosis. It is suggested 
that laparoscopy may offer a protective effect with 
regards to postoperative liver failure and ascites, 
even in Child B patients (138). They propose that 
the lower fluid requirement, the preservation of 
collateral circulation and the minimum hepatic 
mobilization would explain the lower rate of 
decompensation in patients undergoing 
laparoscopic approach. 
The previous meta-analyses have already 
reported the results of open resection versus LLR 
for HCC; however, most of them focused only on 
short-term outcomes. Only the studies by Zhou et al. 
(136) and Fancellu et al. (137) analysed long-term 
OS and DFS (both in 2011), including few reports in 
which different types of resection were mixed.  
The study of Zhou (136) shows one of the most 
complete analysis of long-term outcomes with 
survival rates and morbidity at 3-5 years (3-6 
studies). No significant differences were found 
between the groups regarding pathologic resection 
margins, overall survival and disease-free survival 
rates. Nine out of ten studies showed no 
recurrences related to laparoscopy, recurrences 
such as peritoneal dissemination and port-site 
recurrences, were not observed in the laparoscopic 
group.  
In our study, short- and long-term outcomes for 
each category identified have been matched with 
the intention of increasing the evidence of the 
currently available results. A subgroup meta-
analyses specifically examining patients with Child-
Pugh A cirrhosis, solitary tumors, and those 
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undergoing minor and major liver resections have 
been performed in the study.  
This detail of performing subgroup analysis is 
based on the ability to obtain conclusions for each 
type of liver and patient resection. Therefore, those 
patients with HCC in which the laparoscopic 
approach would be indicated could be selected.  
Additional literature searches were performed 
for “portal hypertension” (using platelet count 
and/or esophageal varices), multicentric HCC, 
Barcelona Liver Clinic (BCLC)-A or –B, or severe 
cirrhosis, but not enough comparative series were 
available.  
In the near future, with the advance and 
extension of laparoscopic surgery, a greater number 
of resections will be carried out on cirrhotic livers. 
Therefore, future studies might be carried out with 
a greater number of resections that could lead to 
more specific and detailed conclusions for each type 
of LLR or patients profiles.  
6.2. Methodological Discussion 
In 1992 the “Evidence-Based Medicine Working 
Group” introduced the concept of Evidence-Based 
Medicine (MBE) for the first time (139). Since that 
time, medical practice has undergone dramatic 
changes where clinical decisions are based on the 
best existing evidence judged from its 
methodological quality and not only on the 
experience of the attending physician (140).  
There are multiple biases that must be taken 
into account when performing meta-analyses. 
Among these, researchers only consider publication 
bias, while other types of biases are ignored or not 
taken into account. Publication bias is basically 
related to the publication itself and not to the data 
obtained in a scientific research study. So this bias 
represents a risk to the validity of meta-analyses 
due to selective publication based on its findings 
(141).  
There are many ways to assess publication bias. 
The publication bias is derived from the fact that 
many scientific works, mostly with “negative” 
results (those that do not find significant differences 
or with results against the hypothesis of study or 
the usual established) never get published, take 
longer to do so or are less cited in other 
publications. This fact may have an impact on the 
results of a bibliographic search and can lead to 
biased results in a meta-analysis. Other factors that 
may contribute to this type of bias are the duplicate 
publication of studies or the disregard of works 
published in a language other than English (142).  
In our case, the graphic method of Light and 
Pillemer (funnel plot) where a graph is calculated 
using the effect sizes and sample sizes of each study 
was used. From this graph, the possibility of 
publication bias can be examined. In our study, 
although there are a limited number of studies in 
certain subcategories, it can be visually observed 
how a high publication bias can not be detected.  
The represented point cloud does not deform 
the funnel plot and does not lose its symmetry since 
small studies are not arranged towards the right 
side with respect to the central estimator. However, 
this graphic technique has some limitations such as 
some subjectivity and difficulty in its interpretation, 
mostly where there are few studies, which is the 
normal circumstance.  
A secondary test for the measurement of 
heterogeinity was considered in our statistical 
method. The I² statistic describes the percentage of 
variation across studies that is due to heterogeneity 
rather than chance (143) (144). I² is an intuitive and 
simple expression of the inconsistency of studies’ 
results.  
A confidence interval for I² is constructed using 
either i) the iterative non-central chi-squared 
distribution method of Hedges and Piggott (145) or 
ii) the test-based method of Higgins and Thompson 
(143). The non-central chi-square method is 
currently the method of choice. It is computed if the 
'exact option is selected. 
Choosing between fixed and random effects 
models 
If there is very little variation between studies 
then I² will be low and a fixed effects model might 
be appropriate. With fixed effects all of the studies 
that you are trying to examine as a whole are 
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considered to have been conducted under similar 
conditions with similar subjects – in other words, 
the only difference between studies is their power 
to detect the outcome of interest. An alternative 
approach, 'random effects', allows the study 
outcomes to vary in a normal distribution between 
studies. Many investigators consider the random 
effects approach to be a more natural choice than 
fixed effects, for example in medical decision 
making contexts (146)(88)(147).  
More data are required for random effects 
models to achieve the same statistical power as 
fixed effects models, and there is no 'exact' way to 
handle studies with small numbers when assuming 
random effects. This should not be a problem with 
most meta-analyses, however do not use random 
effects models with sparse datasets without expert 
statistical guidance.  
Random effects is not a cure for difficulty in 
generalising the results of a meta-analysis to real-
world situations. Generalisability might be explored 
through additional analyses that incorporate 
specific predictive uncertainties on top of the 
intrinsic uncertainties of the studies under review 
(147). 
It should be noted that the I2 score was high in 
many of the comparisons and thus lower confidence 
in the estimates might be considered a limitation to 
our manuscript. 
In order to minimize this limitation, our meta-
analysis included several steps that tried to 
minimize biases. As per the EGMLLS methodology, 
we initially performed an extensive literature 
review with strong quality discrimination.  
For this purpose, we used two well-validated 
quality assessment tools to obtain the best quality of 
evidence. Firstly, the SIGN methodology and the 
NOS manuscripts that were rated as low quality in 
the SIGN and/or received less than six stars in the 
NOS were discarded.  
Secondly, we performed subgroup meta-
analyses, as aforementioned, specifically examining 
patients with Child-Pugh A cirrhosis, solitary 
tumors, and those undergoing minor and major 
liver resections.  
Finally, all meta-analyses performed to date 
used the methodology of Hozo et al. (148), however, 
we have chosen to use the methodology of Wan et 
al., which has recently been demonstrated to 
achieve more precise calculations of mean and SD, 
and which in turn allows for more accurate 
conclusions. In meta-analyses, researchers often 
pool the results of the sample mean and standard 
deviation from a set of similar clinical trials (149).  
The included studies can represent their data in 
a different way such as minimum-maximum or first-
third quartile. Hence, in order to combine results, 
the mean and standard deviation of the study 
samples must be estimated.  
Wan et al. developed different scenarios with 
different distributions applying different 
approximation methods for the estimation of the 
sample mean and standard deviation and proposed 
some new estimation methods to improve the 
existing literature.  
Wan et al. point out that the widely accepted 
estimator for the standard deviation proposed by 
Hozo et al. has some serious limitations and is 
always less satisfactory in practice because the 
estimator does not fully incorporate the sample size.  
Therefore, the use of this novel method to 
estimate the mean and standard deviation in our 
analysis gives greater consistency and accuracy to 
our results, avoiding biases and errors that could 
appear when using other methods in the published 
meta-analyses before ours. 
6.3. Discussion of results 
6.3.1. Controversies in the use of 
minimally invasive techniques in 
the treatment of hepatocellular 
carcinoma 
The three most important changes in the evolution 
of laparoscopic surgery were the Consensus 
Conferences held in Louisville, Morioka and 
Southampton in 2008, 2014 and 2017 respectively. 
It is interesting to show the evolution of the 
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establishment of the laparoscopic approach for the 
resection of hepatocellular carcinoma in cirrhotic 
livers.  
Resection remains the first-line treatment for 
HCC in compensated cirrhosis in many centres. It 
was also recognized that anatomic resection was 
associated with less recurrence and better survival 
rates than wedge or tumorectomy resections (1). 
Therefore, the exponential trend that this approach 
has presented in recent years is obvious.  
Today, laparoscopic liver surgery is a reality 
that keeps under a continuous progress. Therefore, 
an update on the worldwide situation was 
necessary to asses the current status of minimally 
invasive liver surgery (48). The largest meta-
analysis to date suggested that a significant 
proportion of LLRs are performed for the 
management of HCC, as 3072 out of 6190 LLRs for 
malignancies were performed for HCC (48). 
The data from the Louisville Consensus 
presented suggested that laparoscopic resection on 
small HCC is associated with reduced morbidity in 
cirrhotic patients as compared with open resection, 
especially with reduced occurrence of postoperative 
ascites.  
The conclusions were that laparoscopic 
resections of small hepatocellular cancers in a 
cirrhotic liver are feasible and safe in experienced 
centres, and follow-up data from a French group 
suggested that the long-term oncologic outcome has 
not been compromised by the laparoscopic 
approach compared with open resection.   
The Second International Consensus 
Conference on LLR was held in Morioka with the 
dual goal of defining the current role of LLR and 
developing recommendations and guidelines. The 
conclusions of Morioka regarding HCC were that 
anatomical resection for HCC is the standard of care 
procedure, but the laparoscopic versions of this 
technique need to be standardized to increase 
propagation.  
The last consensus of Laparoscopic liver 
surgery was held in Southampton in 2017.In this 
meeting the clinical questions raised about HCC 
were more concrete than in previous consensus. A 
specific section for HCC liver resections surgery was 
raised in order to answer certain questions 
observed in the clinical practice. 
The Southampton Guidelines were based on the 
aforementioned methodology and thus are based on 
published evidence and expert opinions (52). The 
conclusions focused on topic 3 in reference to HCC, 
were of great interest since for the first time they 
answered questions raised in case of cirrhotic 
patients with HCC resections.  
In the previous Consensus, the conclusions 
drawn were ambiguous and did not present specific 
cases for cirrhotic livers or in what sense patients 
with chronic liver disease who underwent HCC 
resection surgery could benefit from the 
laparoscopic approach. 
This guideline strongly suggested that LLR for 
HCC is associated with reduced blood loss, 
transfusion rate, postoperative ascites, liver failure 
and hospital stay with comparable operative time, 
disease-free margin and recurrence rates (52).  
In the case of cirrhotic patients no differences 
in operative time, blood loss, intraoperative 
complications, hospital stay, and morbidity were 
found in LLR.  
The laparoscopic approach appears to reduce 
the incidence of postoperative ascites, liver failure, 
and morbidity assessed, with no difference in 
overall or disease-free survival rates at 2 years (52).  
These conclusions are a great step from the 
point of view of laparoscopic surgery. Previously, 
the question of whether the laparoscopic approach 
was dangerous in the cirrhotic liver was constant in 
most centres due to the complexity of these patients 
and the increased risk of bleeding.  
Additionally, due to the complex vasculature, 
clotting abnormalities and development of ascites, 
laparoscopic resection in cirrhotic livers has taken 
longer to receive endorsement by the wider surgical 
community (63). Although higher-quality data is 
desirable, the currently available data suggest that 
laparoscopic resection of HCC in cirrhotic patients is 
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safe and potentially provides better outcomes for 
patients when compared to the open approach (84). 
In this setting, the aim of our study was to 
perform a high-quality meta-analysis examining the 
short- and long-term outcomes after LLR for HCC. 
The results of our meta-analysis demonstrated that 
for most short-term outcomes, a laparoscopic 
approach provides better results than an open 
approach. In accordance with the rest of the recent 
meta-analyses, we can conclude that cirrhotic 
patients who underwent liver resections for HCC 
benefited from the laparoscopic approach (63) (82) 
(113).  
Our study presents a deeper step, where a 
specific profile has been performed for each type of 
resection. Therefore, the five most common 
scenarios in the clinical practice can be found: 
Minor-resection, Major-resection, Solitary tumor, 
Child-Pugh A and combined resection.  
As the results have been analysed in each one of 
the feasible scenarios, the statistical value and 
clinical significance of this study are higher.  
The meta-analysis showed that the 
laparoscopic approach did better than the open 
approach, especially within the subgroup analyses 
for solitary tumors and minor resections. Similarly, 
the complication rate was more favourable for a 
laparoscopic approach in all analyses.  
The results suggest that a laparoscopic 
approach is similar, if not better than, the open 
approach for the management of HCC in patients 
with Child-Pugh A cirrhosis, solitary tumors, and 
those undergoing minor resections in terms of 
short-term outcomes.  
In modern surgical society, laparoscopic and 
minimally invasive surgeries have become the gold 
standard for many surgical procedures. Similar to 
other areas of surgery, this review indicates that a 
laparoscopic approach to hepatic resection in 
cirrhotic patients should be considered as the 
standard for care.  
6.3.2. Objective and potential benefits of 
laparoscopic liver surgery in 
hepatocellular carcinoma 
During and after liver resection, blood loss and 
transfusions are important factors that impact not 
only early postoperative outcomes but also long-
term results with an increased risk of cancer 
recurrence and decreased patient survival rates 
(150). However, there is a lack of evidence on the 
value of LLR for hepatocellular carcinoma (HCC) 
and severe cirrhosis (138).  
The aim of the last studies is to assess the 
surgical and oncological outcomes of LLR in 
cirrhotic HCC patients. Liver resections have been 
shown to be a valuable option for patients with HCC 
(1). However, the risk of complications as ascitic 
decompensation, liver failure, bleeding or need for 
transfusion can be important in patients with severe 
cirrhosis.  
Multiple studies have shown the possibility and 
validation of the laparoscopic approach in HCC liver 
resections (63) (151). LLR has been shown to be 
feasible, safe, and oncologically efficient. However, it 
has developed slowly in patients with HCC who 
often suffer from a chronic liver disease which 
represents an additional challenge for the surgeon.  
The experience with large HCCs is even more 
limited (152). Comparable oncological results have 
been presented showing several benefits from the 
point of view of hospital discharge and 
complications such as ascites and liver failure (55) 
(62) (67) (110). 
Several studies published in the last decade 
have been of great interest within the 
multidisciplinary teams, as they suggest that the 
laparoscopy approach might provide a better 
tolerance of liver resections in patients with HCC 
(63) (64). Such results should be considered with 
caution so far because they had been obtained from 
retrospective studies with mixed samples.  
As time has passed, comparative studies with a 
larger sample volume in each group and with 
propensity analysis have been published making a 
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stronger validation of this approach in patients with 
liver cirrhosis (58) (61) (62).  
Our study shows favorable results for the 
laparoscopic approach in solitary tumors and minor 
resections. These results suggest that a laparoscopic 
approach is similar, if not better than, the open 
approach for the management of HCC in patients 
with Child-Pugh A cirrhosis, solitary tumors, and 
those undergoing minor resections in term of short-
term outcomes.  
It should be remarked that limited information 
was available for specific postoperative variables 
such as mortality (not clearly defined as 
perioperative, or 30- or 90-days) and PHLF. 
Henceforth, perioperative mortality was considered 
as a whole in our analysis.  
Similarly, PHLF could not be individually 
screened by the ISGLS groups and was thus 
analyzed as a single category. It should be 
encouraged that all research teams perform 
statistics for their manuscripts using currently 
validated classifications rather than institutional or 
self-raised criteria.  
In addition, limited information was available 
for long-term outcomes of the surgical management 
of HCC. Only data for 3- and 5-year survival rates 
provided sufficient detail for analysis. A trend 
towards improved survival was identified for the 
laparoscopic approach, however, the data did not 
reach enough statistical significance.  
DFS followed a similar pattern, with the 
noteworthy exception of an improved rate at 1 year 
for laparoscopic minor resections. Although 
statistically significant, this difference should be 
considered with caution and no strong conclusions 
should be drawn from this finding as only five 
studies with a slight dispersion were included in the 
analysis.  
Therefore, the stated objective that the 
laparoscopic approach can be applied to minimize 
postoperative complications, transfusion rate, blood 
loss and others in patients with HCC liver cirrhosis 
is confirmed. Our review of the literature and meta-
analyses shows a growing adoption of laparoscopic 
liver resection for HCC patients.  
Minor resections are now performed by many 
teams worldwide. Reports of major and complex 
resections are increasing in the last literature 
published but remain concentrated in a limited 
number of expert centres.  
For the future, randomized trials are needed 
and strongly encouraged. Limitations to performing 
meaningful randomized controlled trials (RCTs) in 
LLR include variability of procedures (minor, major 
or atypical resections) and quality underlying liver 
(fibrosis, cirrhosis, steatosis or normal).  
The performance of these studies with correctly 
stratified and prospective groups will lead to 
conclusions with greater and more firm statistical 
evidence with a high diffusion and global 
acceptance.  
Therefore, the laparoscopic approach for HCC 
liver resections will be disseminated more 
extensively over a higher number of patients. 
Training to laparoscopic liver surgery, including the 
creation of fellowship programs in high-volume 
units, should be encouraged to improve the safety 
and quality of patient care (48). 
Our results provide a new approach that should 
be raised in patients diagnosed with potentially 
resectable HCC. The laparoscopic approach should 
be considered in HCC liver resection as the first 
option. Its results confirm the benefits of LLR and 
promote its expansion to HCC patients with limited 
liver function.  
Current literature is committed to a multimodal 
approach (138), laparoscopic resection in liver 
cirrhosis should be considered as a curative option 
independent of open surgery, due to the benefits it 



















1. Our exhaustive literature review, and assessment of current evidence by SIGN methodology has been the 
basis for the development of the European Guidelines Meeting on Laparoscopic Liver Surgery and for the 
eachievement of consistent, reliable and evidence-based statements in the application of minimally 
invasive approaches for the treatment of hepatocellular carcinoma.  
2. According to the results of our updated meta-analysis, a minimally invasive approach might be more 
beneficial compared to an open approach as it may offer a lower rate of complications, blood loss, 
transfusion rate and postoperative hospital stay for patients with Child-Pugh A cirrhosis, solitary tumors 
and those undergoing minor resections. 
3. Considering severe morbidity including liver-specific posthepatectomy liver failure and 90-days 
mortality, laparoscopic approach was not different compared to open approach.  
4. Laparoscopic approach does not have an impact on short-, mid- and long-term outcomes considering 
overall survival. A trend towards better disease-free survival when laparoscopic approach is used was 
observed but no robust conclusions may be obtained.  Its impact on re-do hepatectomies or on feasibility 
of rescue or salvage transplantation procedures remains unresolved.  
5. Considering the optimal results obtained from laparoscopic approach, its use for the treatment of 
hepatocellular carcinoma should be considered as first option and standard of practice in selected 
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Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Sposito C, Battiston C, Facciorusso A, Mazzola M, Muscarà C, Scotti M, 
et al.  
 
Propensity score analysis of outcomes following laparoscopic or 
open liver resection for hepatocellular 
carcinoma 





Control Group Notes Study quality 
Patients Cases 
 Case-control  Retrospective 
 Single centre 
 Comparative 
 Non-randomized 




 Patients who underwent only minor liver 
resections 
 Initially the two groups were different 
statistically for some patient and tumor 
characteristics. To overcome this 
unavoidable selection bias, 1:1 propensity 
score matching was applied. 
 ++ High quality  
 + Acceptable  
 - Low quality 
To compare in a retrospective cohort of patients who underwent liver resection for HCC short- and long-term outcomes of patients undergoing a LLR vs OLR and to 
analyze the factors related to the risk of developing postoperative complications (Dindo-Clavien classification). 
Limitations: After Propensity Score matching the “d” values between groups showed no variable qualifying as unbalanced, with the exception of bilobar tumour 
distribution, which was more frequent in the LLR than in the OLR (7 versus 1; p=0.151, d=0.76). Relatively small sample size and the absence of randomization limit the 
strength of the results. Limitation of 1:1 matching because many control subjects (OLR) not matched to treated subjects (LLR) are excluded from the analysis, which can lead 
to loss information. 
Conclusions: Laparoscopic minor liver resections for HCC improved short-term outcomes (lower complication rate and shorter hospital stay in LLR) with similar survival 
results. The only independent predictor of relevant postoperative complications was the use of laparoscopy (OR=0,12; 95% CI [0.03-0.55] p=0.006). After PSM no difference 
was found between the OLR and LLR groups with respect to long-term outcomes (overall survival and disease-free survival). 
 
  




Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Vitali GC, Laurent A, Terraz S, Majno P, Buchs NC, Rubbia-Brandt L, et 
al.  
 
Minimally invasive surgery versus percutaneous radio 
frequency ablation for the treatment of single small (≤3 cm) 
hepatocellular carcinoma: a case-control study. 





Control Group Notes Study quality 
Patients Cases 
 Case-control  Retrospective 
 Single centre 
 Comparative 
 Non-randomized 
105 43 45 HCC 
underwent MIS 
 Patients in RFA group showed worse liver 
synthetic function with lower albumin and 
higher bilirubin serum levels, and higher ASA 
scores. 
 Only patients with CP class A or B biopsy-
proven cirrhosis were included and to 
homogenize the population, patients with a 
single, 1-3 cm HCC were selected. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this case control study was to compare RFA with MIS for the management of patients with single ≤3 cm HCCs. 
Limitations: Patients underwent RFA demostrated worse liver synthetic function with lower albumin and higher bilirubin levels and also tended to have more 
comorbidities as ASA score 3. This is a retrospective study and non-randomized.  
Conclusions: The rate of complications were similar in both groups. The median hospital stay was 6 (1–16) days in the MIS group versus 1 day (range 1–12 days) in the 
RFA group (p=0.001). After a median follow-up of 26 (2–129) months, a local tumor progression was detected in 11.7 % (7/60) of patients in the RFA group, while no MIS 
patient had a local recurrence (p = 0.056). Overall survival was significantly higher in the MIS group (p=0.042). 
 
  




Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Komatsu S, Brustia R, Goumard C, Perdigao F, Soubrane O, Scatton O.  
 
Laparoscopic versus open major hepatectomy for hepatocellular 
carcinoma: a matched pair analysis. 





Control Group Notes Study quality 
Patients Cases 
 Case-control  Retrospective 
 Single centre 
 Comparative 
 Non-randomized 
76 38  
(10 left,  
28 right) 
38 
(10 left, 28 right) 
Matching 1:1 
 Intention-to-treat analysis. 
 Very small sample. 
 High rate of conversion 
 Significantly larger maximal 
tumour size in the open group 
 ++ High quality  
 + Acceptable  
 - Low quality 
This study analyzed the short- and long-term outcomes of Laparoscopic Major hepatectomy for HCC compared with open hepatectomy.  
Limitations: The study has a very small sample. Selection bias, there is a significantly larger maximal tumour size in the open group. This is an intention-to-treat analysis; 
for this reason, all 12 converted cases in the laparoscopic group were analysed as laparoscopic cases. They tried to do a subset analysis, but we think that the sample is so 
small to get strong conclusion.   
Conclusions: the present study demonstrates the technical feasibility as well as superior short-term and comparable oncological outcomes of LMH for HCC compared with 
the open procedure. The overall complication rates were significantly higher in the open group (23 of 38 (65%)) than in laparoscopic group (12 of 38(31.6%)) p=0.011. The 
laparoscopic group showed a trend towrd shorter, although not statiscally significant, lengths of postoperative hospital stay (p=0.079). In long-term disease free and overall 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Tokuji Ito, Shogo Tanaka, Shuji Iwai, Shigekazu Takemura, Atsushi Hagihara, 
Sawako Uchida-Kobayashi, Hiroji Shinkawa,Takayoshi Nishioka, Norifumi 
Kawada and Shoji Kubo.   
 
Outcomes of laparoscopic hepatic resection versus percutaneous 
radiofrequency ablation for hepatocellular carcinoma located at the 
liver surface: A case-control study with propensity score matching.  





Control Group Notes Study quality 
Patients Cases 











(27 after PSM) 
Matching 1:1 
 To compare the short-term 
outcome of patients with surface 
HCC who underwent LH with 
those who underwent P-RFA. 
 Matched at a ratio 1:1 according to 
propensity scores. 
 ++ High quality  
 + Acceptable  
 - Low quality 
Case control Study with Propensity Score Matching (1:1-27:27) Patients with surface HCC treated by laparoscopic resection vs percutaneous RFA.  
Limitations: In this study all tumours were located at the liver surface and were small size (in both groups). The total number of patients was relatively small in both 
groups.  
Conclusions: In the Laparoscopic group the duration of hospitalization was longer than in the radiofrequency ablation (12.6 vs 7.6 days, p <0.01). The incidence of local 
recurrence was lower in the LH group (0%) than in the p-RFA group (8 patients (30%), p=0.004) even after PSM. LH is an effective treatment for surface HCC with regard to 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Zhang Y, Huang J, Chen X-M, Sun D-L.  
 
A Comparison of Laparoscopic Versus Open Left Hemihepatectomy for 
Hepatocellular Carcinoma 
2016 Surgical Laparoscopy Endoscopy & 
Percutaneous Techniques 





Control Group Notes Study quality 
Patients Cases 






25 (open)  To compare the short-term 
outcome of patients underwent 
left hemihepatectomy for HCC. 
Two groups. Open resection vs 
laparoscopic 
 ++ High quality  
 + Acceptable  
 - Low quality 
Retrospective Case control study in patients with HCC underwent left hemihepatectomy, open Vs laparoscopic resection. The objectives were to evaluate and compare the 
safety and preioperative and short-term outcomes of laparoscopic Vs open.  
Limitations: All results are expressed as median and range values. Very small sample. A short follow up (1 years). 
Conclusions: Laparoscopic resection requires a great deal of experience by HPB surgeons, this approach is deemed safe for malignant liver lesions with oncological results 
comparable to that of open surgery. It offers better short-term results including a shorter hospital stay (7±1 vs 12±2 d; p<0.05), less postoperative pain, and lower 












Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Lai ECH, Tang CN.  
 
Long-term Survival Analysis of Robotic Versus Conventional 
Laparoscopic Hepatectomy for Hepatocellular Carcinoma: A 
Comparative Study. 
2016 Surgical Laparoscopy Endoscopy & 
Percutaneous Techniques 





Control Group Notes Study quality 
Patients Cases 




 Historical Cohort 
413 100 (robotic) 35 (laparoscopic)  To compare the long-term 
oncological outcomes of robotis 
and conventional laparoscopic 
hepatectomy for HCC 
 ++ High quality  
 + Acceptable  
 - Low quality 
Prospective Case control study in patients with HCC underwent laparoscopic Vs robotic resection..  
Limitations: In the robotic group there is a significant higher proportion of major hepatectomies and tumours located at or across posterosuperior segments than 
conventional laparoscopic group. The groups of patients are maden in difference time of the study (since 1998 to 2015), laparoscopic group at the beginning.  
Conclusions: There was no difference in overall morbidity rate and operative mortality rate between both groups. Both groups had no mortality. There was no difference 
between the 2 groups in R0 resection rate, long-term overall survival and disease-free survival after mean follow up of 61.6 months. This study is the largest study comparing 
robotic vs laparoscopic partial hepatectomy. Robotics surgery may have an impact on therapeutic strategy of HCC. 
 
  




Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
LAI C, Jin R-A, Liang X, Cai XJ.  
 
Comparison of laparoscopic hepatectomy, percutaneous 
radiofrequency ablation and open hepatectomy in the treatment of 
small hepatocellular carcinoma 
2016 Journal of Zhejiang University-
SCIENCE B (Biomedicine & 
Biotechnology) 





Control Group Notes Study quality 
Patients Cases 








matched by age, 
sex, CPC, HCV, HBV, 
cirrhosis status and 
preoperative 
laboratory results. 
 Null hypothesis: LH, OH and p-RFA 
provided similar prognostic 
outcomes and survival rates for 
patients with small HCC (Milan 
criteria). 
 ++ High quality  
 + Acceptable  
 - Low quality 
Prospective Cohort study where compare 3 groups (resection by open or laparoscopic surgery and p-RFA).  
Limitations: The patients in the p-RFA groups were older and the tumour size was smaller than in the other groups. Bias may exist in the treatment selection based on the 
patient’s age, their intension-ti-treat wishes and the tumour status. 
Conclusions: For small HCC patients radical resections including OH and LH offer better survival results than p-RFA. Laparoscopic surgery shared similar curative effects 
with OH in terms of both disease-free survival and 3-year overall survival. Minimally invasive surgery should be recommended in younger patients with small HCC, while 
elderly patients may choose either liver resection or RFA. 
 
  




Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Chang SK, Tay CW, Shen L, Iyer SG, Kow AW, Madhavan K.  
 
Long-Term Oncological Safety of Minimally Invasive Hepatectomy in 
Patients with Hepatocellular Carcinoma: A Case- Control Study. Ann 
Acad Med Singap 





Control Group Notes Study quality 
Patients Cases 




60 30 (LR) 30 (OR)  Matching for extent of tumour 
resection, age nad cirrhosis status. 
 ++ High quality  
 + Acceptable  
 - Low quality 
This Case control retrospective study comparing the short and long-term oncological safety of HCC patients who underwent Minimally invasive hepatectomy and open 
hepatectomy. 
Limitations: Retrospective. Non-randomized study. 
Conclusions: The mean blood loss during surgery was significantly lower in LR (p=0.04). Hospitalization is significantly shorter in LR (p=0.04). The survival (p=0.18) and 
disease-free survival rate (p=0.41) were similar in both groups. Laparoscopic resection is a safe and feasible curative treatment option for HCC with similar oncological 
outcomes compared to open resection. 
 
  




Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
What is the role of LLR in cirrhotic patients? 
 
Shehta A, Han H-S, Yoon Y-S, Cho JY, Choi Y.  
 
Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic 
patients: 10-year single-center experience. 





Control Group Notes Study quality 
Patients Cases 
 Case-control  Retrospective 
 Single centre 
 Non randomized 
 Comparative 
389 141 liver 
cirrhotic (LC) 
91 Non-LC  Patients were divided into two 
groups according to the status of 
their liver parenchyma, with and 
without liver cirrhosis (LC). LC 
group with histologically 
confirmed F4 cirrhosis. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to evaluate our experience of LLR for HCC and to compare perioperative and long-term outcomes between patients with and without liver 
cirrhosis.  
Limitations: Minor resection were more performed in LC group and showed a smaller median tumor size and smaller resection margin. Retrospective and non 
randomized study. 
Conclusions: More minor resection were done in LC group (p=0.011). There were no statistically significant differences between the two groups regarding operation time, 
blood loss, transfusión requiriments and intraoperative complications. The non-LC group had a significantly larger resection margin than did the LC group [LC, 0.8 cm (0.01–
6.5); non-LC, 1.3 cm (0.1–6.8); p =  0.019]. There were no statistically significant differences between groups in terms of recurrence pattern and overall survival. In conclusion, 
the current study demonstrated that LLR for HCC is feasible in patients with cirrhosis. LLR in cirrhotic patients showed comparable results to non-cirrhotic patients in terms of 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Cheung TT, Poon RTP, Dai WC, Chok KSH, Chan SC, Lo CM.  
 
Pure Laparoscopic Versus Open Left Lateral Sectionectomy for 
Hepatocellular Carcinoma: A Single Center Experience. 





Control Group Notes Study quality 
Patients Cases 













 To analyse the survival outcome of 
laparoscopic left lateral 
sectionectomy compared to open 
approach in patients with HCCs. 
 ++ High quality  
 + Acceptable  
 - Low quality 
This study was the first report on laparoscopic left lateral sectionectomy with HCCs and liver cirrhosis. 
Limitations. It is a good study with an adecaute statistical methodology. Maybe a limitation could be the small number of patients (they use median and range-no gaussian 
distribution) and the retrospective character. 
Conclusion: The laparoscopic group had a median blood loss of 100 ml while the open group ha d a median of 300 ml (p<0.001). Less blood loss is  observed in 
laparoscopic group even in the presence of liver cirrhosis.  
They do a subgroup analysis in patients with cirrhosis (F4) in which the amount of bleeding is significantly lower in the laparoscopy group being tumor characteristics 
and  resection margins similar (p>0.05). 
There are no significant differences in terms of survival and disease-free survival in both groups at 1 year, 3 years and 5 years.. Laparoscopic left lateral sectionectomy is a 
safe procedure due to the advancement of technology and accumulating experience. Its simplicity, repeatability, and association with less blood loss makes it a good option for 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Zhang J, Zhou Z-G, Huang Z-X, Yang K-L, Chen J-C, Chen J-B, et al.  
 
Prospective, singlecenter cohort study analyzing the efficacy of 
complete laparoscopic resection on recurrent hepatocellular 
carcinoma. 





Control Group Notes Study quality 
Patients Cases 
 Case-control  Cohorts 
 Prospective 
 Non randomized 
 Single-centre 
64 31 (LR) 33 (OR)  Inclusion criteria: Recurrent HCC, 
recurrent in left or right lobe 
without noteworthy surgical 
contraindications, no major vessel 
or bile duct tumor invasion or 
metastasis, Grade A or B liver 
function or grade C. 
 Exclusion criteria: major vessel or 
bile duct tumor invasion, recurrent 
HCC located in right liver 
parenchyma and near secondary 
vessels and bile ducts, extrahepatic 
metastasis, grade C liver function, 
noteworthy surgical 
contraindication. 
 ++ High quality  
 + Acceptable  
 - Low quality 
This study examined the treatment of recurrent HCC in patients who received a prior hepatectomy. 
Limitations. Small number of patients. No randomized study. With a sample size so small subgroup analysis does not have a good statistical power. 
Conclusion: Significant differences were observed between the LR (shorter) and OR (p=0.031), intraabdominal blood loss (p=0.012), postoperative time until the patient 
could walk (p=0.004), anal exsufflation time (p=0.041), VAS scores (p<0.001), postoperative hepatic function (p<0.05) and length of hospital stay (p=0.014) were better in lap 
group than open group. Subgroup analysis in the lap group compared patients with ipsilateral recurrence with contralateral recurrence. The last one tended to have less 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
What is the role of LLR in cirrhotic patients? 
 
Takahara T, Wakabayashi G, Nitta H, Hasegawa Y, Katagiri H, Takeda D, et al. 
 
Laparoscopic liver resection for hepatocellular carcinoma with 
cirrhosis in a single institution. 





Control Group Notes Study quality 
Patients Cases 
 Case-control  Retrospective 
 Single centre 
 Comparative 
 Non-randomized 
118 (LLR) 60 (NLC-LLR) 58 (LC-LLR)  Inclusion criteria for LLR were a 
tumor size of less than 10 cm and 
the absence of severe adhesions, 
invasión to major vessels, or a 
need for vessel reconstruction. 
 One of the major obstacles ofLLR 
in cirrhotic patients is the risk of 
massive bleeding, because these 
patients have a bleeding tendency 
related to primary hemostasis 
dysfunction 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this retrospective study was to compare the feasibility and safety of LLR for HCC between non-liver cirrosis and liver cirrosis patients at a single high volumen 
laparoscopy center.  
Limitations: Wedge resections were mainly performed in the LC-LLR group. Non-randomized study and retrospective and small number of patients. 
Conclusions: The tumor size in the LC-LLR was significantly smaller than NLC (p<0.001). There were similar surgical margin, incidence of blood loss and transfusión 
requerements. No significant difference in the complication rate. There was a significantly lower incidence of postoperative ascites in the LC-LLR than in the NLC group. LLR 
for selected HCC patients with cirrosis is a feasible and promising procedure that is associated with less blood loss and fewer postoperative complications, especially the 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Leong WQ, Ganpathi IS, Kow AWC, Madhavan K, Chang SKY.  
 
Comparative study and systematic review of laparoscopic liver 
resection for hepatocellular carcinoma. 





Control Group Notes Study quality 
Patients Cases 
 Systematic 
review and  
 Comparative 
study in their 
hospital 
 Case-control 
 Retrospective  
 Non-randomized 







110 open resection   ++ High quality  
 + Acceptable  
 - Low quality 
This study is a systematic review and comparative study of patients who underwent open vs laparoscopic liver resection for HCC. Comparative study use 152 patients (42 
laparoscopic and 110 open surgery). A total of 17 studies published between 2001 and 2014 were identified as eligible for analysis using Forest plots. 
Limitations. In the comparative study with 152 patients there are several selection bias. In lap groups the tumour size is bigger than in the open group. The ASA score is 
higher in the open group and has more patients with microscopic vascular invasión.For this reason is possible that the disease free survival rate was higher in the open group. 
In the systematic review one important limitation is that all comparative studies including are non-randomized controlled studies (retrospective or retrospective 
matched). 
Conclusion: The systematic review and comparative study show that as a curative treatment for HCC, LLR provides better short-term outcomes than OLR in terms of 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Li W, Zhou X, Huang Z, Zhang H, Zhang L, Shang C, et al. 
 
Laparoscopic surgery minimizes the release of circulating tumor cells 
compared to open surgery for hepatocellular carcinoma. 











 Single centre 
 Randomized 
26 12 (LR) 14 (OR)  Inclusion criteria: Compensated 
cirrhosis or noncirrhotic liver, 
platelet count of 100x109/l or 
higher, and a tumor location that 
was not in contect with the portal 
pedicle or hepatic veins. 
 Exclusion criteria: distant 
metastases, ASA>3 and age>80 
years, patients who underwent 
intraoperative blood transfusion. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to determine whether tumor manipulation enhances cáncer cell reléase from the primary tumor in HCC patients and which surgical approach 
(OR vs LR) is superior with respect to preventing tumor cells from scattering in the blood. 
Limitations: There are some limitations, despite the high sensitivity of this method in detecting CCSCs, the overall detection accuracy did not reach 100 %.They cannot 
completely exclude the impact of variations in clinical situations, such as individual patient differences. In the study did not investigate which clinical implications have the 
results obtained in patients, as recurrence or survival. 
Conclusions: The two groups presented a homogeneous distribution in the characteristics and potential confounders. The IL-6, IL-8 and TNF levels were similar between 
groups before the operation. The mean increases in the POD serum levels of IL-6 and IL-8 in the LR group were significantly less than those in the OR group. Only the IL-6 
levels in the LR showed a significantly diminished increase 24 h after surgery compared to OR.  
No signinficant difference was found in the level of CCSCs between the two groups before surgery manipulation. There was a trend toward an increased level of CCSCs in 
the two groups after tumor resection, and a comparison of the median levels revealed a significantly lower increase (P =  0.041) following laparoscopic surgery compared to 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Xiao L, Xiang L-J, Li J-W, Chen J, Fan Y-D, Zheng S-G.  
 
Laparoscopic versus open liver resection for hepatocellular carcinoma 
in posterosuperior segments 









 Case control 
 Retrospective 
 Non-randomized 
 Single centre 
127 41 (LR) 86 (OR)  Inclusion criteria: Diagnosis of 
HCC, solitary lesion (8 cm or less), 
located posterosuperior segment, 
no satellite lesions or intrahepatic 
metastases and no blood vessel or 
bile duct invasion, Child-Pugh A or 
B, ICG≤15%, no tumor rupture or 
bleeding and no severe adhesions 
in the surgical field. 
 ++ High quality  
 + Acceptable  
 - Low quality 
This study was designed to compare the short-term efficacy and survival of patients with HCC, particularly when combined with cirrhosis, who underwent LLR and OLR 
of the posterosuperior segments. 
Limitations: The optimal distance of the surgical margin for malignant tumors has not been determinated, althougn studies have suggested that if negative margins are 
ensured, this distance does not have a significant effect on tumor recurrence. Retrospective study and non-randomized. 
Conclusions: Intraoperative blood loss was significantly lower and postoperative hospital stay significantly shorter in the LLR than in the OLR group. The overall 
complication rates were significantly lower in the LR than in OR (p=0.021). Overall survival rate and disease-free survival rate were similar in both groups.  
LR for selected patients with HCC in the posterosuperior segments may offer the same oncologic outcomes as conventional procedures, while being associated with such 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Takahara T, Wakabayashi G, Beppu T, Aihara A, Hasegawa K, Gotohda N, et al.  
 
Longterm and perioperative outcomes of laparoscopic versus open 
liver resection for hepatocellular carcinoma with propensity score 
matching: a multi-institutional Japanese study. 
2015 Journal of Hepato-Biliary-Pancreatic 
Sciences 





Control Group Notes Study quality 
Patients Cases 
 Case-control   Case control 
 Retrospective 
 Multicentre 
 One to one 
propensity case-
matched analysed 




 The PSM were generated with sex, 
age, underlying liver disease, 
tumor size, number, AFP, ICGR 15 
min, extent of liver damage 
(CLCSGJ), Child-Pugh Score, 
difficult tumor location and distant 
metastasis. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to compare the long term outcomes and perioperative outcomes of LR with those of OR for HCC between well-Matched patient groups. 
Limitations: This study after PSM included a small number of patients. Non-randomized and retrospective. 
Conclusions: In LR the median blood loss was significantly less than in the OR (p<0.001), and the median postoperative hospital stay for LR was significantly shorter 
(p<0.001). The operation time was significantly longer in LR (p=0.025). Postoperative complication rate in LR were significantly lower (p=0.003). There were no significant 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Han H-S, Shehta A, Ahn S, Yoon Y-S, Cho JY, Choi Y.  
 
Laparoscopic versus open liver resection for hepatocellular carcinoma: 
Case-matched study with propensity score matching. 





Control Group Notes Study quality 
Patients Cases 
 Case-control   Case-control  
 Matching 1:1 
 PSM 
 Retrospective 
 Single centre 
389 232 (LR) 
(88 after PSM) 
157 
(88 after PSM) 
 The PSM model was generated 
using baseline variables (Sex, 
age…), CP score, preoperative 
laboratory results, liver state, 
cause of liver cirrhosis, tumor 
charasteristics, ascites and extend 
of liver resection. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study is to compare perioperative and long term outcomes of laparoscopic versus open liver resection for HCC between two matched groups. 
Limitations: In spite of PSM, there is still possibility that OR is more performed for major and complex cases. 
Conclusion: LR showed longer operative time than OR (p=0.07), less use of Pringle manoeuver (p=0.034) and duration (p=0.026), shorter hospital stay (p≤0.001), larger 
resection margin (p=0.011). There was no difference in the rates of intraoperative complications. Also, the LR group showd statistically significant lower postoperative 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Cho JY, Han H-S, Yoon Y-S, Choi Y, Lee W.  
 
Outcomes of laparoscopic right posterior sectionectomy in patients 
with hepatocellular carcinoma in the era of laparoscopic surgery. 





Control Group Notes Study quality 
Patients Cases 
 Case-control   Case-control 
 Retrospective 
 Non-randomized 
408 24 19  Case control study 
 Very small sample 
 Not strong results 
 ++ High quality  
 + Acceptable  
 - Low quality 
When determining the extent of liver resection for the treatment of HCC, it is important to achieve a balance between operative curability and preservation of remaining 
hepatic function. RPS should be considered when it is necessary to preserve the liver’s functional reserve. This is a case control study to evaluate the safety of laparoscopic 
Right Posterior sectionectomy (RPS) in terms of its operative and oncologic outcomes. From 408 patients they analyzed the clinical data of 24 patients who underwent 
laparoscopic RPS for HCC and compared outcomes with patients who underwent open RPS (n=19). 
Limitations: The complex case were not considered for a laparoscopic approach (tumors larger than 5 cm, adjacent to the main portal pedicle or IVC, a central lesions…). 
The study has a small number of patients. 
Conclusions: When compare the two groups the mean operation time was longer in laparoscopy group, there was no difference in the mean resection margin and rate of 
postoperative complications. The duration of Hospital stay in the LG was shorter but no statistical difference.With a median follow up of 56 months there was no statistical 
difference in 5 year overall patient survival rate and disease-free survival rate. Therefore, RPS have been regarded as major liver resectio, complexity and wide resection, and 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Martin RCG, Mbah NA, St Hill R, Kooby D, Weber S, Scoggins CR, et al.  
 
Laparoscopic versus open hepatic resection for hepatocellular 
carcinoma: improvement in outcomes and similar cost. 





Control Group Notes Study quality 
Patients Cases 





354 100 LR 
(65 pure lap 
and 35 hand-
assisted) 
254  Financial analysis was restricted to 
the post-laparoscopic era 
 Cost was modelled with 
multivariable linear regression, 
with adjustments for the year of 
operation and centre in which the 
operation was performed. 
 Analyses depends of the surgical 
era (2004) 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to compare outcomes of LR vs OR exclusively for HCC regards to morbidity and cost (First study to evaluate cost) 
Limitations: There was a signifcant difference in tumor size with larger tumors in the open group (p=0.006). The open group had higher percentage of major 
hepatectomy. Another limitation of this study is the relatively short median follow-up of 26 months. Non- randomized.  
Conclusions: Blood loss was significatly less in LR (p<0.001). The incidence of any complication and 90-day mortality were similar between the two groups, with a similar 
reoperation rate. Laparoscopic procedures remained independently associated with shorter length of stay in the multivariable model (OR 0.23, 95 % CI 0.06–0.87; p =  0.031). 
With regards to cost analysis, a comparison of operating room charges for the laparoscopic approach compared to an open technique demonstrated no statistically significant 










Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Xiang L, Xiao L, Li J, Chen J, Fan Y, Zheng S.  
 
Safety and feasibility of laparoscopic hepatectomy for hepatocellular 
carcinoma in the posterosuperior liver segments. 





Control Group Notes Study quality 
Patients Cases 
 Case control 
study 
 Retrospective 
 Case control 
 Nonrandomized 
 Single centre 
 Comparative 
126 56 patients 
posterosuperio
r segments (I, 




segments (II, III, 
IVb, V and VI) 
 Inclusion criteria: preoperative 
diagnosis of HCC, good general 
condition and normal function of 
vital organs tolerant to 
hepatectomy, ≤8 cmdiameter 
solitary lesión, CH score A or B, 
hepatic reserve capacity (ICGR-
15), no tumor ruptura, no 
preoperative treatment. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The purpose of this study was to investigate the safety and feasibility of LH for the treatment of HCC in posterosuperior liver segments (I, IVa, VII and VIII), especially in 
association with cirrhosis. 
Limitations: The operation time was longer in PS group probably because this segments required full mobilization of the liver and more time to expose the lesión than in 
AL group. The high levels of enzymes in the 1 and 3 day is because the longer Pringle maneuver in these patients, without any clinical significanceSmall number of patients. 
Retrospective. Non randomized. 
Conclusions: There were statistically significant differences between the two groups of patients in the operation time (217.5 ±  63.7 vs 176.8 ±  48.4 min, P =  0.000), 
blood loss (295.5 ±  186.8 vs 220.4 ±  164.2 ml, P =  0.001), conversion rate from laparoscopy to laparotomy (17.9 vs 7.1 %, P =  0.031), and transfusion rate (16.1 vs 4.3 %, P =  
0.025). The tumor size (P =  0.894) and resection margin of the pathological specimen (P =  0.102) showed no statistically significant differences between the PS and AL group. 
The postoperative complication rate showed no statiscally significant difference between the PS al AL group (p=0.873). There were not statistically significant differences in 
terms of survival and disease-free survival rate. These results suggest that the use of LH to treat cirrosis associated HCC was safe, feasible and achieved the same oncological 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Lee JJ, Conneely JB, Smoot RL, Gallinger S, Greig PD, Moulton C-A, et al.  
 
Laparoscopic versus open liver resection for hepatocellular carcinoma 
at a North-American Centre: a 2- to-1 matched pair analysis 





Control Group Notes Study quality 
Patients Cases 




129 43 LLR 86 (OLR)  To compare the outcomes of HCC 
patients with LLR vs OLR on a 2-
to-1 matched-case basis. 
 Matching according to age, size 
and number tumor (risk factor of 
survival) 
 ++ High quality  
 + Acceptable  
 - Low quality 
LLR for HCC in comparison to OLR in peri-operative and long term oncológical outcomes are described from a single North American Institution. 43 cases Vs 86 control 
matched for age, maximal tumour size and number. 
Subgroup analysis of the cirrhotic patients shows that there was no statistical difference between the LLR and OLR groups in terms of overall survival and recurrence-free 
survival. 
Limitations: Small simple size. Tehre is a discrepancy in length of follow up between groups (LLR has a shorter follow up thna OLR).  
Conclusions: LLR offers significant benefits in term of peri-operative outcomes compared with OLR and suggest that LLR should be considered as a first-line modality. 
Overall survival appears equivalent after LLR and OLR, however there appears to be a non-significant trend suggesting a potentially higher intra-hepatic recurrence rate after 
LLR in this series, probably there may be a predilection towards non-anatomic resections in LLR  in this group.and because there are more patients with HCV (two factors 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Beppu T, Hayashi H, Okabe H, Imai K, Nitta H, Masuda T, et al.  
 
Hybrid-including endoscopic versus open hepatic resection for patients 
with hepatocellular carcinoma meeting the Milan criteria: a propensity 
case-matched analysis. 





Control Group Notes Study quality 
Patients Cases 
 Case control  Case control 
 Matching 1:1 




 Single centre 
269 89 EH  
(52 after PSM) 
180 OH  
(52 after PSM) 
 One to one propensity case-
matched analysis was used. 
 Patients who meeting the Milan 
criteria with sufficient liver 
function. 
 ++ High quality  
 + Acceptable  
 - Low quality 
Patients with HCC who meet the Milan criteria are suitable candidates for EH. This study was undertaken to determine the surgical outcome and long-term prognosis of 
EH in comparison to those of conventional OH for HCC patients who met the Milan criteria. 
Limitations: In the OH groups there were patients with complicated tumor location. The study included relatively small number of patients. Non-randomized. 
Retrospective. 
Conclusions: The median operative time (p=0.049) and the median blood loss (p<0.001) were significantly less with EH than with OH. The morbidity rates were siilar 
between the two groups. Median postoperative hospital stay was significantly shorter for EH patients than for OH patients (p=0.002). There were no significant differences in 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Luo L, Zou H, Yao Y, Huang X.  
 
Laparoscopic versus open hepatectomy for hepatocellular carcinoma: 
short- and long-term outcomes comparison. 
2015 International journal of clinical and 
experimental medicine 





Control Group Notes Study quality 
Patients Cases 




 Single centre 
106 53 53  Matching 1:1 
 Outcomes short and long-term. 
 Median follow up 35 months. 
 ++ High quality  
 + Acceptable  
 - Low quality 
Case control study (1:1) matching according for age, gender, liver function, underlying liver disease, type of surgery, and American Society of Anesthesiologists (ASA) 
class. 
Limitations: The patients who required conversión to an open procedure were excluded. Type of surgery. Only easy cases, LLS and subsectionectomy (No added cases of 
major hepatectomy or posterior segments). The patients were not assigned randomly into the two goups. The mean follow-up time was not very long (median 35 months). 
Conclusions: The lap group presented longer operative time, lower blood loss, less pain, lower nedd of analgesic and less hospital recovery time (ss), no differences in the 
complications were found. Both groups did not have significant differences in overall survival trend and disease-free survival.. However, further randomized studies are 









Guideline topic: HCC-comparative  
CQ  What is the role of LLR in cirrhotic patients? 
 
Chen J, Bai T, Zhang Y, Xie Z-B, Wang X-B, Wu F-X, et al.  
 
The safety and efficacy of laparoscopic and open hepatectomy in 
hepatocellular carcinoma patients with liver cirrhosis: a systematic 
review 
2015 International journal of clinical and 
experimental medicine 
















828 281 LH 547 OH  NOS was used to assess the risk of 
bias for quality assessment of non-
randomized studies.  
 The overall quality was good. (NOS 
score 7 out of 9) 
 ++ High quality  
 + Acceptable  
 - Low quality 
Systematic review and analysis (Meta-analysis intention-to-treat) the safety and the efficiency of LH in HCC patients with liver cirrhosis. Included 7 retrospective trials 
with 828 patients. They analyzed the heterogeneitu by calculating i2 and the homogeneity between trials was assessed using X2 test. 
Results: In LH: tumor margin was wider (p=0.002), Similar operating time (p=0.2), less blood loss (p=0.03), less blood transfusión (p=0.004), decreased postoperative 
moribility (p<0.0001), similar postoperative mortality (p=0.48), similar curative resection (p=0.26), shorter hospital stay (p=0.0002).The overall survival at 1 year was similar, 
but at 5 year in LH seemed to be significaty higher than OH (RR=1.28, 95% CI 1.01 to 1.62, p=0.04, i2 =62%).Similar disease free survival at 1-,3- and 5-years. 
Limitations: There is a problema because all the studies included were retrospective, non-randomized; which would increase the selection bias. The simple size is small 
which decrease the reliability of the final results. The patients in OH had huge HCC, higher degree of cirrhosis, improper location that had high risk of blood loss.(selection 
bias). 
Conclusions: LH may provide better intraoperative and short-term outcomes than OH in HCC patients with liver cirrhosis. However no significant survival benefit was 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Ahn KS, Kang KJ, Kim YH, Kim T-S, Lim TJ.  
 
A propensity score-matched case-control comparative study of 
laparoscopic and open liver resection for hepatocellular carcinoma. 
2014 Journal of laparoendoscopic & 
advanced surgical techniques 





Control Group Notes Study quality 
Patients Cases 
 Case control  Case control 
 Retrospective 
 Nonrandomized 
 Propensity score 
matching 1:1 
292 (202) 52 (after PSM= 
51 LR) 
150 (after PSM=51 
OR) 
 LR was applied to patients with CP 
class A, without invasion or close 
to the main portal pedicle or major 
hepatic veins.  
 Conversion cases were excluded. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The purpose of this study was to compare the perioperative and long-term oncologic outcomes of LLR and OLR for single HCC in groups of well-matched patients using 
PSM. 
Limitations: A well-designed prospective study will be needed to affirm the validaty of LR for HCC. Non-randomized. Retrospective. 
Conclusions: The postoperative hospital stay period was significantly shorter in the LR (p=0.004). The overall survival and disease-free survival rates were similar 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
What is the role of LLR in cirrhotic patients? 
 
Yamashita Y-I, Ikeda T, Kurihara T, Yoshida Y, Takeishi K, Itoh S, et al.  
 
Long-term favorable surgical results of laparoscopic hepatic resection 
for hepatocellular carcinoma in patients with cirrhosis: a single-center 
experience over a 10-year period. 





Control Group Notes Study quality 
Patients Cases 
 Case control 
study 
 Case control study 
 Retrospective 
 Single centre 
 Non-randomized 
162 63 (LR) 99 (OR)  Patients with cirrhosis underwent 
surgery for primary HCC within 
the Milan Criteria. 
 ++ High quality  
 + Acceptable  
 - Low quality 
They review the long-term surgical results of LR for HCC in patients with cirrhosis over the 10 year period at a single institution compared with OR group. 
Limitations: the definition of cirrhotic liver is not clear how and when set it. They did not analyze the type of liver resection on each group to study the homogeneity. LR 
group tends to be applied for limited resection to peripheral ventral small HCC in which hepatic resections are relatively easy to perform.  
Conclusions: The morbidity rate in LR was lower (p=0.045), the positive rate of ascites in LR was lower (p=0.007), the duration of hospital stay in LR was shorter 
(p=0.0008) than in the OR group. There were no significant difference in DFS (p=0.519) or overall survival (p=0.679) between the two groups. LR for HCC in patients with 








Guideline topic: HCC-comparative  
CQ  What is the role of LLR in cirrhotic patients? 
 
Twaij A, Pucher PH, Sodergren MH, Gall T, Darzi A, Jiao LR.  
 
Laparoscopic vs open approach to resection of hepatocellular 
carcinoma in patients with known cirrhosis: systematic review and 
meta-analysis. 











 Systematic review 
(4 studies) 
420 150 (LR) 270 (OR)  The aim was to review the 
currently available data comparing 
LR vs OR for HCC in patients with 
known cirrhosis. 
 The risk of bias was assessed using 
NOS with a good quality (7 and 8 
out of 9). 
 ++ High quality  
 + Acceptable  
 - Low quality 
All studies included were single centre retrospective cohort studies (case matched).  
Limitations: Small number of studies (4) with a lack of randomized trials. In the studies there was no reported in tumour size or patients demographics. Relatively small 
size of the studies included. For this reason this review had several selection bias. 
Conclusions: laparoscopic approach, compared to open surgery, may result in improved short-term outcomes in the form of wider resection margins, reduced 
intraoperative blood loss and need for transfusions, as well as reduced morbility rates and shorter lengths of stay in cirrhotic liver. No statistically significant difference was 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
What is the role of LLR in cirrhotic patients? 
 
Memeo R, de'Angelis N, Compagnon P, Salloum C, Cherqui D, Laurent A, et al.  
 
Laparoscopic vs. Open Liver Resection for Hepatocellular Carcinoma of 
Cirrhotic Liver: A Case–Control Study. 





Control Group Notes Study quality 
Patients Cases 
 Case control 
study 
 Case control study 
 Matching 1:1 
 Retrospective 
 Single centre 
 Nonrandomized 
176 113 (45 LR) 63 (45 OR)  Matching by cause of cirrhosis, CP 
score, tyoe surgical resection, 
tumor number, size and AFP. 
 All patients had confirmed F4 
cirrhosis. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to compare morbidity, mortality and long-term patient survival between LR and OR for HCC in patients with histologically proven cirrhosis. 
Limitations: Despite the fact that LR and OR groups were matched, the study is not randomized and thus some selection bias may exist related to the tumor accessibility 
that may play a role in the R0 outcome. 
Conclusions: LR group displayed a shorter operative time (p=0.02), shorter hospital stay (p<0.0001) and lower morbidity rate at 90-day (p=0.01). A higher rate of R0 
resection was observed in the LR group than in OR (p=0.03). the presence of postoperative ascites was more frequently observed in OR (p=0.01). There was no difference in 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Kim H, Suh K-S, Lee K-W, Yi N-J, Hong G, Suh S-W, et al.  
 
Long-term outcome of laparoscopic versus open liver resection for 
hepatocellular carcinoma: a case-controlled study with propensity 
score matching. 





Control Group Notes Study quality 
Patients Cases 
 Case control 
study 
 Case control 
 Retrospective 
 Propensity score 
matching (1:1) 
 Single centre 
 Nonrandomized 
1566 (205) 43 (29 after 
PSM) 
162 (29 after PSM)  PSM were generated with sex, age, 
ASA, BMI, underlying liver disease, 
preoperative laboratory, CP score, 
history of preoperative procedure 
for HCC, size and number tumor, 
location, range of resection. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to compare the preoperative and long-term oncologic outcomes of LR vs OR for HCC between well-matched patient groups. 
Limitations: Only minor resection. The total number of patients was relatively small in both groups. Retrospective, non-randomized and observational study. The 
surgeons perhaps tended to select LR only in relatively simple and superficial lesión and easy case. 
Conclusions: The hospital stay is significantly shorter than OR group and postoperative ascites occurred much less in the LR group. There were no differences of 
pathologic results including resection margin, and overall complications and major complications more than grade II of Clavien-Dindo grade. Recurrence tended to be earlier in 
the LR group but not a significant difference (p=0.120). There was no differences in overall survival time and overall disease-free survival time between the LR and OR groups. 
The present study showed that the outcome of LR for HCC was technically feasible and safe in selected patients. LR showed similar perioperative and long-term oncologic 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Kim S-J, Jung H-K, Lee DS, Yun SS, Kim HJ.  
 
The comparison of oncologic and clinical outcomes of laparoscopic liver 
resection for hepatocellular carcinoma. 
2014 Annals of surgical treatment and 
research 





Control Group Notes Study quality 
Patients Cases 










76 (open group)  Control were selected by PSM 
method and matched for sex, age, 
INR, albumin, AFP, AST, ALT, Blna, 
ICG, hepatitis, tumor location and 
size and type of resection. 
 ++ High quality  
 + Acceptable  
 - Low quality 
This case-control study evaluate the operative outcome and oncologic outcome of laparoscopic liver resection for HCC and compare with open liver resction. Matching by 
PSM method.They did a subgroup analysis based on the type of treatment of first recurrence (distributions of treatment after recurrence were similar between two groups 
(p=0.360). 
Limitations: No difference in hospital stay because they did a CT control at 7 day of postoperative time. All patients must  be at least 7 days admitted to hospital.  
Conclusion: Laparoscopic liver resection for HCC is feasible and safe in a large number of patients, and not inferior to open liver resection in regard to perative outcome. 









Guideline topic: HCC-comparative  
CQ  What is the role of LLR in cirrhotic patients? 
 
Siniscalchi A, Ercolani G, Tarozzi G, Gamberini L, Cipolat L, Pinna AD, et al.  
 
Laparoscopic versus Open Liver Resection: Differences in 
Intraoperative and Early Postoperative Outcome among Cirrhotic 
Patients with Hepatocellular Carcinoma-A Retrospective Observational 
Study. 
2014 HPB surgery: a world journal of 
hepatic, pancreatic and biliary 
surgery. 





Control Group Notes Study quality 
Patients Cases 
 Case control  Case-control 
 Retrospective  
 Non-randomized 
 Comparative 
194 23 (LR) 
(33 patients; 5 
excluded for 
lack of data, 5 
for conversion) 
133 (OR) 
(166 patients; 28 
were excluded for 
major 
hepatectomy) 
 Matching for type of resection, 
median number of nodules, and 
median diameter of largest lesions. 
Preoperative liver and renal 
function tests. 
 They study the MELD score and 
renal function (before and after 
surgery). 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to identify the differences in terms of perioperative complications and early outcome in cirrhotic patients undergoing minor hepatic resection 
for HCC with open or laparoscopic technique. In statistical analysisthey used a two linear model for repeated measures using the group membership as a factor between the 
subjects. The open group was worse Cr (p<0.001) and worse MELD. 
Limitations: The control patients had larger (>5 cm), central, bilateral or connected with liver hilum, major hepatic veins or the IVC tumor. For this reason, the patients in 
control group were more complex. Patients in both groups underwent minor liver resection. There was not major liver resection in this study.There is an important difference 
in simple size between the two groups and its retrospective nature. Significant difference in the average age of the two groups (lower in the LR). 
Conclusion: The patients in LR presented lower incidence of AKI (0% vs 6.8%) and postoperative liver faliure. Reduced necessity for transfusión of blood products. Lower 
values of MELD score after LR. Lower postoperative ascites (ns). 
Mortality, morbility and postoperative hospital stay were lower.  The advantages of laparoscopic liver resection compared to traditional technique are several, especially 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
What is the role of LLR in cirrhotic patients? 
 
Kanazawa A, Tsukamoto T, Shimizu S, Kodai S, Yamazoe S, Yamamoto S, et al.  
 
Impact of laparoscopic liver resection for hepatocellular carcinoma 
with F4-liver cirrhosis. 





Control Group Notes Study quality 
Patients Cases 




 Single centre 
 Non-randomized. 
245 (56) 28 (LR) 28 (OR)   Patients who underwent partial 
hepatectomy for HCC (3 cm or 
smaller in a dimater) in the surface 
area of the liver and had complete 
liver cirrhosis diagnosed 
histologically. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The purpose of this study was to compare the feasibility and safety of LR for HCC in cirrhotic patients with those of open liver resection in the same period. 
Limitations: The inclusion criteria are very strict. Therefore this study is focused on patients with a precise characteristics. Reproducibility of it is difficult, and its 
application in the population is complicated. ONly for patients with liver cirrhosis and specific tumor characteristics. This is a retrospective study and with a small numbers of 
patients. 
Conclusions: The intraoperative blood loss was lower lower in the LR than OR (p=0.0003). The incidence of the postoperative complications was significantly higher in 
the OR than in LR (p<0.001). The duration of the postoperative hospital stay was significantly shorter in the laparoscopy group than in OR (p<0.001). IN conclusión, even in 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
What is the role of LLR in cirrhotic patients? 
 
Cheung TT, Poon RTP, Yuen WK, Chok KSH, Jenkins CR, Chan SC, et al.  
 
Long-term survival analysis of pure laparoscopic versus open 
hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a 
single-center experience. 





Control Group Notes Study quality 
Patients Cases 
 Case control   Case control 
 Retrospective 
 Non-randomized 
 Matching 1:1 
 Single centre. 
600 32 (LR) 64 (OR)   Matching in terms of cancer stage, 
tumor size, location of tumor and 
magnitude of resection. 
 The magnitude of surgery in both 
groups was comparable. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to analyze the survival outcome of laparoscopic liver resection versus open liver resection in patients with HCC 
Limitations: Retrospective non-randomized study. Small number of patients. Inclusion criteria very strict therefore, the number of patients each group is small. The 
diagnosis of cirrhosis was after surgery. 
Conclusions: The median hospital stay was shorter in LR (p<0.0001). The LR group showed low median blood loss (p=0.001). There were no differences in overall 
survival and disease-free survival rate at 1-, 3- and 5-years in both groups (this study is the first report to comment on the long-term survival of patients with HCC in reference 
to the stage of disease). Laparoscopic liver resection for HCC is associated with less blood loss, shorter hospital stay and fewer postoperative complications in selected patients 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Kobayashi S, Nagano H, Marubashi S, Kawamoto K, Wada H, Eguchi H, et al.  
 
Hepatectomy based on the tumor hemodynamics for hepatocellular 
carcinoma: a comparison among the hybrid and pure laparoscopic 
procedures and open surgery  














 Non randomized 




27 (OR)   Solitary HCC tumors measuring 
less than 3 cm located in segment 
2, 3, 4, 5, or 6, with no macroscopic 
evidence of vessel invasion, in 
patients who had not received any 
preoperative treatments. 
 ++ High quality  
 + Acceptable  
 - Low quality 
This study was designed to evaluate the surgical parameters and treatment outcomes of tumor hemodynamics-based pure laparoscopic (PURE) and laparoscopy-assisted 
(HYBRID) hepatectomy for small HCC compared with those of open hepatectomy. 
Limitations: In the survival analyses they excluded patients with HCC more than 3 cm in diameter. Nonrandomized. Retrospective. 
Conclusions: Pure and Hybrid were not inferior to OPEN, PURE was associated with a lower resected liver weight, lesser blood loss and smaller skin incisión than HYBRID 
and OPEN. The duration of hospitalization was shorter for PURE and HYBRID than for OPEN. The operation time for HYBRID was longer than for PURE and OPEN. There were 
no statistically significant differences in the overall survival or disease free survival between LAP and OPEN. From these evaluations of 50 consecutive cases, we concluded that 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Ai J-H, Li J-W, Chen J, Bie P, Wang S-G, Zheng S-G.  
 
Feasibility and safety of laparoscopic liver resection for hepatocellular 
carcinoma with a tumor size of 5-10 cm. 





Control Group Notes Study quality 
Patients Cases 
 Case control 
study 
 Retrospective 




275 97 LR 178 (OR)   The 178 patients in the OR were 
considered potential candidates 
for LR but underwent OR as a 
control group, with permission 
from the patients and theis 
dependents. The preoperative HCC 
characteristics were similar 
between LR and OR. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to explore the safety and feasibility of laparoscopic liver resection for the treatment of HCC with a tumor size of 5-10 cm. There were no 
significant differences in mean operative time (p=0.469), mean stimated intraoperative blood loss (p=0.913), or blood transfusión rate (p=0.480) between lap and open group. 
There was a lower rate of postoperative complications in LR than OR. Postoperative hospital stay was shorter in the LR group (p=0.028). Median overall follow-up time was 25 
months in the LR and 20 months in OR. There were no significant differences in the 1-year and 3-years overall survival and disease-free survival. 
Limitations: Small sample. Retrospective study. Short follow up to study oncological outcome as recurrence. Only the time period were matched between the two groups.  
The most complex cases, as patients with previous surgery were excluded fron LR group. 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Hu B-S, Chen K, Tan HM, Ding X-M, Tan JW.  
 
Comparison of laparoscopic vs open liver lobectomy (segmentectomy) 
for hepatocellular carcinoma. 





Control Group Notes Study quality 
Patients Cases 
 Cohort study  Cohort study 
 Retrospective 
 Non-randomized 
 Single centre 
60 30 LR 30 (OR)   The patients in the OR group were 
retrospectively selected by the 
same criteria than LR group. 
 No differences in any of the 
preoperative backgroung variables 
between the two groups (including 
tumor size). 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to investigate the effects of laparoscopic hepatectomy for the treatment of HCC. 
Limitations: Very small sample. They only did one control per case. The recurrence and survival rate are low (although there were no significant differences) and do not 
show that % of patients completed follow up at 5 years. 
Conclusions: Outcomes postoperative, patients in the LR group started walking and eating significantly earlier, recovered was more rapidly and shorter hospitalization. 
No difference statistical significance in complication rate.There were no differences in the survival rate or disease-free survival rate. Laparoscopic liver resection is a safe and 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
What is the role of LLR in cirrhotic patients? 
 
Truant S, Bouras AF, Hebbar M, Boleslawski E, Fromont G, Dharancy S, et al.  
 
Laparoscopic resection vs. open liver resection for peripheral 
hepatocellular carcinoma in patients with chronic liver disease: a case-
matched study. 





Control Group Notes Study quality 
Patients Cases 






122 36 LR 53 (OR)   The two groups were similar in 
term of tumor number and size 
and number of resected segments. 
 Intention-to-treat basis 
 ++ High quality  
 + Acceptable  
 - Low quality 
This study dertermined the impact of laparoscopic resection on postoperative and long-term outcomes in a large series of cirrhotic patients with HCC compared with 
open resection. This is one of the largest case-matched studies of LR vs OR. 
Limitations: Small number of patients. Tumor location according to liver segment was not considered in the matching criteria. Do not explain the inclusión cirteria for 
open group. 
Conclusions: The two groups were similar in terms of mean operating time, vascular clamping, blood transfusions with similar blood loss. 4 died in OR (0% vs 7.5% 
p=0.3). Similar overall morbility rate in both groups (25% vs35.8%; p=0.3). There was a non significant (p=0.09) trend toward a higher rate of severe complications in the OR 
than in LR group. The mean duration of hospitalization was significantly shorter in LR (p=0.003). Overall 5 year survival tended to be higher in the LR (p=0.073) and five year 
disease-free survival was similar in two groups (p=0.8). The laparoscopic approach was particularly beneficial in cases of portal hypertension complicated by postoperative 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Lee KF, Chong CN, Wong J, Cheung YS, Wong J, Lai P.  
 
Long-term results of laparoscopic hepatectomy versus open 
hepatectomy for hepatocellular carcinoma: a case-matched analysis 





Control Group Notes Study quality 
Patients Cases 
 Case control 
study 
 Case- control 
 Retrospective 
 Non-randomized 
 Single centre 
233 33 LR 50 (OR)   Matching to magnitude of 
operation, size tumor, site of 
tumor, and the absence of 
concominant local ablation or 
major procedure.  
 Intention-to-treat basis 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was evaluate the long-term results of LH compared with a cohort of case-matched open hepatectomy. 
Limitations: There were more patients in LR group underwent left lateral sectionectomy (improve the resection margin). There were more cirrhotic patients in the LH 
group. They did a subgroup analysis in order to get the difference between LLS and cirrhotic patients but the findings may not be strong because the sample is very small. 
Conclusions:Compared with OH, LH for HCC has similar long-term outcomes, but it has short-term advantages of less operative complications and shorter hospital stay. 
The resection margin was significantly wider in LR than OR (p=0.016). There was no mortality in both groups and less complications in LR group. No difference in blood loss 
and blood transfusión rate. The operative time was significantly longer in LH but hospital stay was shorter than in OR group. There was no significant difference between the 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Kim HH, Park EK, Seoung JS, Hur YH, Koh YS, Kim JC, et al.  
 
Liver resection for hepatocellular carcinoma: case-matched analysis of 
laparoscopic versus open resection 





Control Group Notes Study quality 
Patients Cases 





 Single centre 
102 26 LR 29 OR (from 73 
patients) 
 Matched in terms of demographic 
data, tumor size, degree of liver 
cirrhosis, ASA score, type of 
resection and tumor location 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to analyze the outcomes of laparoscopic liver resection compared with open liver resection for HCC using a case-matched analysis. No difference 
was found between the two groups for the type of resection (p=0.467). 
Limitations: Small number of cases. Study non-randomized. There are several bias as selection bias related to the choice of approach based merely on tumor 
characteristics.  
Conclusions: This study confirmed the feasibility, safety, and benefits of laparoscopic liver resection for selected patients, including HCCs located in segments 7 and 8 and 
major hepatectomies. Laparoscopic liver resection for HCC lead good surgical results with a shorter postoperative hospital stay, shorter operating time, less intraoperative 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Nguyen KT, Marsh JW, Tsung A, Steel JJL, Gamblin TC, Geller DA.  
 
Comparative benefits of laparoscopic vs open hepatic resection: a 
critical appraisal. 





Control Group Notes Study quality 
Patients Cases 
 Case control 
matched 
 Literature review 
of 2473 patients 
(31 publications). 
 Case control study 
at single tertiary 
centre. 




17 for HCC (10 
hand-assited 
and 7 pure 
laparoscopic) 
20 OR for HCC  There were no significant 
differences in sex, age, percentage 
of patients with cirrhosis, type of 
resection, concurrent resection, or 
concurrent procedure for HCC 
group. 
 ++ High quality  
 + Acceptable  
 - Low quality 
Limitations: Is a retrospective analysis. There is some variation as to the selection criteria among surgeons (selection bias). Small number of patients with HCC. 
Conclusions: The LR for HCC had a significantly smaller BMI compared with OR. There were no statistical differences between the tumor size and percentage of negative 
margins between LR or OR. OR was associated with significantly closer negative margins than the LR (p=0.04). There were no statistically significant differences in operative 
time, blood loss, or transfusión rate. The complication rates were nor significantly different. The length os stay was significantly shorter for patients who underwent LR 
(p=0.002). Disease free survival was significantly better for the LR compared with OR and no difference in terms of overall survival. For patients with HCC, the operating room 
costs for the laparoscopic liver resection were not significantly higher than the operating room costs for open liver resection cases ($1.14 vs $1.03; P=.68). In addition, the total 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Ker CG, Chen JS, Kuo KK, Chuang SC, Wang SJ, Chang WC, et al.  
 
Liver Surgery for Hepatocellular Carcinoma: Laparoscopic versus Open 
Approach 












 Single centre 
324 116 LR 208 OR   No difference in both groups 
related to overall survival and 
disease-free survival rate. 
 ++ High quality  
 + Acceptable  
 - Low quality 
This study tried to compare the benefit of laparoscopic versus open operative procedures doing a case-control retrospective single centre study. 
Limitations: There were important bias in this study. The tumor size was bigger in OG, the patients in OR underwent more complex resection (>2 segments) with 
statistically significance difference.  
Conclusions: Postoperative complications were more frequent in OR group (p=0.001). The developed of transient ascites was more frequent in OR group (p=0.002).Mean 
Hospital stay was shorter in LR group (p=0.001). After a man follow-up of 94 months there were no significant differences in relation to overall survival rate and disease-free 
survival rate at 1-, 3-, 5- year. Laparoscopic hepatectomy is beneficial for patient life quality as a minimally invasive procedure, is more feasible and with a low morbility and 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Alemi F, Kwon E, Freise C, Kang S-M, Hirose R, Stewart L, et al.  
 
Hepatic surgery at a VA tertiary medical center: lessons learned. 












 Single centre 
126 patients 28 LR (with 
RFA 46; only 
lap 33) 
25 OR   Review the spectrum of liver 
disease treated by surgery 
 Focus the analysis in patients with 
chronic hepatitis C virus-related 
HCC and liver cirrhosis. 
 Cohorts retrospective study 
 ++ High quality  
 + Acceptable  
 - Low quality 
This study hypothesize that appropriate fellowship training combined with a supportive hospital environment can translate into low operative morbility and mortality 
rates even at low-volume medical centers.  
Limitations: Retrospective character of the study. Small sample size. Patients selected to undergo the laparoscopic resections were treated more often by either wedge 
resection or segmental resection compared with patients treated by the open technique. Selection bias.  
Conclusions: Significantly lower intraoperative blood loss and need for transfusión in lap group. No significant difference in hospital stay between the two groups. 
Comparable complication rates, although the lap group have less severe wound complication and leakage of ascites. Appropriate training in HPB surgery can translate into 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Yoon Y-S, Han H-S, Cho JY, Ahn KS.  
 
Total laparoscopic liver resection for hepatocellular carcinoma located 
in all segments of the liver 
2010 Surgical Endoscopy 
 





Control Group Notes Study quality 
Patients Cases 




 Single centre 




AL 44  LLR was applied as a totally 
laparoscopic procedure regardless 
of tumor location unless the tumor 
was larger than 5 cm, had invaded 
or was close to the main portal 
pedicle or major hepatic veins, or 
was located in the suprahepatic 
junction adjacent to the major 
hepatic veins. 
 ++ High quality  
 + Acceptable  
 - Low quality 
This study evaluated clinical and oncologic outcomes after LLR for HCC located in all segments, including lesions located in the posterosuperior (PS) segments. 
Limitations: Anatomical resection was perfomred more frequently in group PS than in group AL. Small number of patients. And nonrandomized study 
Conclusions: There was a male predominance in group PS (p =  0.021), and there were more patients with thrombocytopenia less than 100 9  103 /mm3  in group AL (p =  
0.001). Otherwise, there were no differences between the two groups in clinicopathologic characteristics. Nonanatomical liver resection was a more common operative 
procedure in group AL, whereas anatomical liver resection including right posterior sectionectomy and right hemihepatectomy was a more common operative procedure in 
group PS (p\ 0.001). COnversion rate was 7.2%. Operative time was longer in PS group (p=0.001), blood loss tended to be greater in PS group (p=0.068). The mean 
postoperative hospital stay was 9.7 days, longer for PS group (p=0-039). There were no statistically significant difference in survival and disease free survival rate in both 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Tranchart H, Di Giuro G, Lainas P, Roudie J, Agostini H, Franco D, et al.  
 
Laparoscopic resection for hepatocellular carcinoma: a matched-pair 
comparative study. 










 Case control 
(pair-matched) 
156 42 LR (27%) 42 OR  Matched for sex, age, ASA, Severity 
of liver disease, tumor siza, and 
type of resection. 
 Intention-to-treat basis. 
 The two groups did not differ 
significantly in terms of tumor 
characteristics, namely, tumor size, 
surgical margin, the presence of 
vascular invasion, a well-formed 
capsule and satellite nodules. 
 ++ High quality  
 + Acceptable  
 - Low quality 
This study describes the results of a pair matched comparative study between OR and LR for HCC. 
Limitations: The patients underwent laparoscopic approach presented smaller tumor, located in the inferior or anterior segments of the liver and distant from the portal 
pedicle or hepatic veins. Small number of patients and retrospective study. Only selected one control per each case. 
Conclusions: LR of HCC for Significantly less bleeding was observed in LR (p<0.0001). Postoperative ascites was less frequent after LR (p=0.03). Severity of complications 
was similar in the two groups. The main hospital stay after surgery was shorter for the patients who underwent LR (p<0.0001).  No difference in survival and disease-free 
survival rate in both groups at 1,3 and 5 year of follow-up. 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Aldrighetti L, Guzzetti E, Pulitanò C, Cipriani F, Catena M, Paganelli M, et al.  
 
Casematched analysis of totally laparoscopic versus open liver 
resection for HCC: short and middle term results. 











 Single centre 
 Prospectively 
collected database 
56 16 LR  16 OR  Matched in terms of type of 
resection, tumor size and severity 
of cirrhosis. 
 The cases and controls are not 
from the same period of time. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to evaluate surgical results and mid-term survival of minor hepatic resection performed for HCC. 
Limitations: The controls and cases patients are not from the same period of time (the OR were older than LR). All patients in LR underwent minor resection. Short 
follow-up of patients. 
Conclusions: Mean operative time was shorter in LR (p=0.044). Less intraoperative blood loss (p=0.008). Postoperative complications in both groups are not statistically 
difference. Mean hospital stay was shorter in LR (p=0.039). Both groups showed similar outcomes in terms of overall and disease-free survival. Laparoscopic approach does 








Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Zhen ZJ, Lau WY, Wang FJ, Lai ECH.  
 
Laparoscopic liver resection for hepatocellular carcinoma in the left 
liver: Pringle maneuver versus tourniquet method. 
2010 World Journal of Surgery 
 





Control Group Notes Study quality 
Patients Cases 
 Case-control  Retrospective 
 Nonrandomized 
 Comparative 
 Single centre 




 Selected patients with normal or 
mildly cirrhotic liver, tumor size B 
8 cm, and tumor located at 
Couinaud segments II, III, or IV for 
laparoscopic resection. 
 Both group were matched in the 
demographic data, tumor size, 
severity of cirrhosis and surgical 
procedures. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The objective of this nonrandomized comparative study was to compare the efficacy of the tourniquet method with the Pringle maneuver in laparoscopic liver resection 
for HCC in the left liver. 
Limitations: Very small sample. This study because of its small sample can not draw conclusions that easily extrapolated to the target population. Technique very 
dependent on the surgeon performed it would be desirable way of multicentric study. Non randomized. 
Conclusions: There were no differences in the operation time, operative blood loss, and perioperative blood transfusión between the two groups. The postoperative 
hospital stay for group B was significantly shorter than group A. Group A had significantly higher ALT levels on the first postoperative day  compared with group B. The liver 
function in group B recovered significantly faster than group A (P\ 0.01). The torniquet method gave a wider safety margin for patients with chronic liver disease with a 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Endo Y, Ohta M, Sasaki A, Kai S, Eguchi H, Iwaki K, et al.  
 
A comparative study of the long-term outcomes after laparoscopy-
assisted and open left lateral hepatectomy for hepatocellular 
carcinoma. 













 Matched (1:1) 





11 OR (open 
conventional) 
 Patients themselves chose which 
procedures they preferred. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aims for this study were to assess our results of laparoscopy-assisted left lateral hepatectomy for HCC and to compared them with those of open conventional 
procedures. 
Limited: Only patients with tumor less than 5 cm. One inclusión criteria was no earlier history of operation in the upper abdomen. Each group comes from different 
period of time. The patients who underwent LAR were older than OR (p<0.01).  
Conclusions: There were no significant differences in the mean operation time, blood loss, resected liver weight and resected margin between two groups. There were no 
significant differences in morbidities between the groups. Postoperative hospital stay were statistically better in laparoscopy-assisted group than those in open group. There 
were no significant differences in the survival and disease-free survival rate between the 2 groups. Laparoscopy-assisted hepatectomy may be a useful alternative for the 









Guideline topic: HCC-comparative  
CQ  What is the role of LLR in cirrhotic patients? 
 
Belli G, Limongelli P, Fantini C, D'Agostino A, Cioffi L, Belli A, et al. 
 
Laparoscopic and open treatment of hepatocellular carcinoma in 
patients with cirrhosis 











 Single centre 
 Non-randomized 
179 54 LR 125 OR   Surgical experience in LR were 
assessed by comparison of two 
time periods: before and after 
November 2004. 
 Did a subgroup analysis of patients 
stratified respect tumor 
characteristics to show the 
influence on cancer outcomes 
 ++ High quality  
 + Acceptable  
 - Low quality 
Retrospective analysis of 179 liver resections performed for HCC in cirrhotic liver. 
Limitations: Patients who underwent by laparoscopic approach were smaller size tumor and liver resection was less extensive than in the open resection. Those patients 
with complicated cirrhosis or whose ASA grade exceded III were excluded from resection. The more complex tumor (big, next to vessels, postero-superior segments were 
excluded from laparoscopic group). Only three major hepatectomy were performed in LR (p<0.001) 
Conclusions: Pringle manoeuvre was used in one patient in the LR group and 26 in OR group (p<0.001). Patients underwent LR had a higher proportion wide resection 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Sarpel U, Hefti MM, Wisnievsky JP, Roayaie S, Schwartz ME, Labow DM.  
 
Outcome for patients treated with laparoscopic versus open resection 
of hepatocellular carcinoma: casematched analysis. 












 Single centre 
76 20 LR 56 OR   Matching by cirrhosis and tumor 
size 
 Multivariate models were adjusted 
for age, sex, presence of cirrhosis 
and tumor size. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this project was to perform a case-matched analysis of patients undergoing laparoscopic versus open liver surgery for HCC, with specific regard to margin 
status and survival. 
Limitations: Small number of patients. The study was done in a huge period time. For this reason in several results, for example the duration of the surgery, the learning 
curve could influence. 
Conclusions: Multivariate analyses showed that patients undergoing LR have similar rates of intraoperative transfusión, and positive margins compared with open group. 
The adjusted odds of length of stay ≥6 days was significantly lower in patients treated with LR (OR=0.07, 95% CI=0.02-0.27). Also showed that liver cirrhosis significantly 
increased the risk for transfusión (OR=8.01, 95% CI=1.29-49.61). Neither margin status, nor recurrence, nor survival was significantly different between the two cohorts. 
Laparoscopic resection for malignancy is safe, with a similar operative time as open hepatectomy. If tumor location is amenable, laparoscopic resection for HCC is a reasonable 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Lai ECH, Tang CN, Ha JPY, Li MKW.  
 
Laparoscopic liver resection for hepatocellular carcinoma: ten-year 
experience in a single center. 













 Single centre 
58 25 LR 33 OR   Matching in terms of demographic 
data, tumor size, severity cirrhosis 
and surgical procedure. 
 Inclusion criteria: Normal livers or 
CP A, tumor size of 5 cm or less, 
tumor location at the 
anteroinferolateral segments. 
Solitary exophytic tumors larger 
than 5 cm that were accessible by 
LR. 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this Comparative study was to study the feasibility, safety and mid term results of laparoscopic liver resection of HCC.  
Limitations: In this series most of the procedures (84%) used the hand-assisted laparoscopic approach. Non-randomized. Small number of patients with HCC. 
Conclusions: No differences in operation time, postoperative complication rate, and hospital mortality rate were found between the 2 groups. The postoperative hospital 
stay for LR was significantly shorter than for OR (p=0.008). No differences between procedures with regard to overall (p=0.23) and disease-free survival rate (p=0.14) at 3-
year. Laparoscopic hepatectomy for HCC is feasible and safe in selected patients. Midterm survival is also 
favorable. The laparoscopic approach has the benefit of a shorter hospital stay. However, the procedure should be 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Cai XJ, Yang J, Yu H, Liang X, Wang YF, Zhu ZY, et al.  
 
Clinical study of laparoscopic versus open hepatectomy for malignant 
liver tumors. 









 Pair matched  
 Retrospective 
 Single centre 
 Nonrandomized 
62 31 LR (24 HCC 
specimen) 
31 OR (26 HCC 
specimen) 
 The groups were matched for age, 
sex, the size and location of the 
tumor and the presence or absence 
of cirrhosis. 
 Subgroups analyses in term of 
period of time 
 ++ High quality  
 + Acceptable  
 - Low quality 
The aim of this study was to evaluate the intraoperative hazards, recovery and survival outcomes of theses procedures for liver cancer.  
Limitations: Retrospective study, non-randomized. The patients of this study have tumors of different etiology: HCC, Metastasis, cholangiocarcinoma and for this reason 
the curves of survival and recurrence should not be construed in the same way. 
Conclusions: The length of hospital stay was 7.5(5-15) days, which was significantly shorter than those in OR (p<0.01). By log-rank test, the two survival curves (overall 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Chen H-Y, Juan C-C, Ker C-G.  
 
Laparoscopic liver surgery for patients with hepatocellular carcinoma. 
2005 Annals of Surgical Oncology 
 





Control Group Notes Study quality 
Patients Cases 
 Case control 
 Comparative 
 Retrospective 
 Case control 
 Single centre 
 Non randomized 
116 LR 97 VR less than 
2 segments 
(Group I) 
19 VR more than 
two segments 
(group II) 
 The criteria for liver resection 
were HCC, with pathological 
diagnosis before operation, 
whichwas found to be resectable 
after imaging and clinicalstudies. 
The indications for a laparoscopic 
procedure were tumor located in 
the peripheral part of left liver or 
the anterior sector of right liver, 
and the size less than 5 cm in 
diameter 
 ++ High quality  
 + Acceptable  
 - Low quality 
This is a retrospective study of patients with HCC treated by liver resection with a totally laparoscopic approach. 
Limitations: This is a poor study with a Little clinic transcendence. The numbers of patients is very small. It is no clear if the approach of the patients is pure laparoscopic 
in all of them or if they used hand-assisted. Non randomized.  
Conclusions: Conversion rate was 5.2%. The average length hospital stay was 6 days. Blood transfusion was necessary in five patients (5.2% ) in group I and three 
patients (15.8% ) in group II (p  = 0.122). After a mean follow up duration of 94 months, the 1-year, 3-year, and 5-year survival rates were 85.4% , 66.4% , and 59.4%  in group 
I, and 94.7% , 74.2% , and 61.7%  for group II, respectively. There was no significant difference in survival rates between the two groups (p  = 0.1237).Laparoscopic liver 
resection is feasible in HCC of the tumor is singular, smaller than 5 cm and located in the left lateral segments or anterior or inferior sector of the right liver. laparoscopic 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Kamiyama T, Kurauchi N, Nakagawa T, Nakanishi K, Kamachi H, Matsushita 
M, et al.  
 
Laparoscopic hepatectomy with the hook blade of ultrasonic 
coagulating shears and bipolar cautery with a saline irrigation system. 
2005 J Hepatobiliary Pancreat Surg 
 





Control Group Notes Study quality 
Patients Cases 
 Case control  Retrospective 
 Single centre 
 Nonrandomized 
18 8 LR 10 LLS open  The characteristics of patients who 
had the laparoscopic left lateral 
segmentectomy were not 
significantly different from those 
of the patients who had had a left 
lateral segmentectomy with 
laparotomy 
 ++ High quality  
 + Acceptable  
 - Low quality 
They report their experience with seven anatomical and 1 nonanatomical laparoscopic hepatectomies, performed with a hook blade of ultrasonic coagulating shears, and 
bipolar cautery with a saline irrigation system, with minilaparotomy. 
Limitations: In all patients they performed cholecystectomy to prevent cholecystitis (after probably TACE in the future) –this do the operative time longer than other 
studies- Small number of patients. Non randomized. Nowadays this is a old study because the gold estándar treatment for the LLS in the pure laparoscopic approach (case 
control, randomized and metaanalyses). 
Conclusions: The overall mean postoperative hospital stay was 9.88 (median 8 days). The time of surgery  and the hospital stay were significantly shorter than in open 
group. The mean amount of blood loss was less in LR group. In this study they dissected the liver parenchyma with the hook blade of ultrasonic coagulating shears and 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Kaneko H, Takagi S, Otsuka Y, Tsuchiya M, Tamura A, Katagiri T, et al. 
 
Laparoscopic liver resection of hepatocellular carcinoma. 





Control Group Notes Study quality 
Patients Cases 
 Case control 
study 
 Case-control 
 Matching 1:1 
 Retrospective 
 Single centre 
 Non-randomized 
144 30 HCC LR 28 OR  The groups have the same 
inclusion criterias 
 Subgroups analyses in term of 
period of time (shorter operative 
time in recent time) 
 ++ High quality  
 + Acceptable  
 - Low quality 
To evaluate less invasive surgery, they used the Estimation of Physiologic Ability and Surgical Stress (E-PASS) scoring system, which predicts postoperative morbidity and 
mortality by quantifying the patient’s reserve and surgical stress. 
Limitations: All HCCs were localized in the left lobe or lower segment (except 1 case). Retrospective and nonrandomized study. 
Conclusions: The patients started walking and eating significantly earlier in LR group group and shorter hospitalizations. According to the E-PASS score there was no 
difference in preoperative risk. Bur a significant difference was seen in the surgical stress and comprehensive risk scores between the OR and LR groups. Survival rate and 
disease-free survival rate were no significant differences between both group at 5 years. The laparoscopic approach in selected patients with HCC should be considered the 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Laurent A, Cherqui D, Lesurtel M, Brunetti F, Tayar C, Fagniez PL.  
 
Laparoscopic liver resection for subcapsular hepatocellular carcinoma 
complicating chronic liver disease. 





Control Group Notes Study quality 
Patients Cases 
 Case control 
study 
 Case control 
 Retrospective 
 Single centre 
 Non-randomized 
27 13 LR 14 OR  Inclusion criteria: Tumors were 5 
cm or smaller, subcapsular, and 
located in anterolateral segments 
(II-VI) 
 Matching with identical liver 
disease, tumor size, location and 
type of hepatectomy 
 ++ High quality  
 + Acceptable  
 - Low quality 
A case-comparison study. The aim of study is show laparoscopic liver resection for subcapsullar HCC in patients with chronic liver disease is associated with lower 
morbility than open resections. 
Limitations: Only psubcapsular tumor, small size and no major hepatectomy included. This study is limited by the relatively small number of patients. Retrospective 
nature. The results in relation to surgery time is due to learning curve effect. 
Conclusions: Operative duration (p=0.006) and cumulative clamping time (p=0.006) were significntly longer in LR group. There were no differences in mortality (p=0.2), 
morbility (ns) and hospital stay (0.83) in both groups. Overall 3-year survival was significantly higher in LR group (89% vs 55% p=0.04). Recurrence-free survival was similar 
in both groups. 









Guideline topic: HCC-comparative  
CQ  Are LLR indicated for the management of HCC? 
 
Shimada M, Hashizume M, Maehara S, Tsujita E, Rikimaru T, Yamashita Y, et 
al.  
 
Laparoscopic hepatectomy for hepatocellular carcinoma. 





Control Group Notes Study quality 
Patients Cases 
 Case control 
study 
 Case control 
 Retrospective 
 Single centre 
 Non-randomized 
285 17 LR 38 OR  Inclusion criteria: First 
hepatectomy, Tumors were 5 cm 
or smaller, Solitary tumor, and 
located in anterolateral segments 
(II-VI) or LLS. 
 Matching with inclusion criteria 
and the time period. 
 ++ High quality  
 + Acceptable  
 - Low quality 
This case-control study presented their long experiences with laparoscopic hepatectomy for HCC. Also discussed the importance of this procedure from the viewpoints of 
both short- and long-term outcomes. 
Limitations: The % of cases and controls extracted from the population is small. So the statistical power of this study is low. It does not explain exactly why perform 
splenectomy in some patients (18%). The operative time was longer maybe for this reason. Only included patients with tumor localized in left lateral segments or anterior (the 
more complex resection were excluded). 
Conclusions: The postoperative hospital stay of LR was significantly shorter than OR (<0.001). Operative time tended to be longer and blood loss tended to be smaller in 
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Considered Judgement Form  
Part B – Evidence to recommendations 
Proforma 
CQ *: Are LLR indicated for the management of HCC?  
a. Short term outcomes 
b. Oncologic and Long term outcomes 
B.1 Balancing benefits and harms (see SIGN 50, section 6.2.2, 6.2.3) 
Comment here on the potential clinical impact of the intervention/action – eg. magnitude of effect; balance of risk and benefit. 
B.1.a What benefit will the proposed intervention/action have? 
Describe the benefits. Highlight specific outcomes if appropriate. 
Potential benefits from the laparoscopic approach of HCC patients may come from: 
 Improved outcomes for HCC patients with reduced complications 
 Short hospital stay, less blood loss, less transfusion rate, fewer complications rate. 
 Better esthetical impact due to reduced surgical incision.  
 Against those who previously thought, due to laparoscopic approach a better visualization for liver transection and 
better control of bleeding is achieved.  
B.1.b What harm might the proposed intervention/action do? 
Describe the benefits. Highlight specific outcomes if appropriate. 
There are no specific harms derived from the laparoscopic approach in HCC patients.  
B.2 Impact on patients (see SIGN 50, section 6.2.4, 6.2.5) 
Is the intervention/action acceptable to patients and carers compared to comparison?  
Consider benefits vs harms, quality of life, other patient preferences (refer to patient issues search if appropriate). 
Are there any common comorbidities that could have an impact on the efficacy of the intervention? 
The laparoscopic approach offers benefits over patients who are offered. In comparative studies, the patients in the open 
group often come from prior periods in which laparoscopic approach was not performed in all centres. This is the selection 
bias which exist in these studies. Because patients in the open group use to be patients with bigger tumour size, closer to main 
vessels or with previous surgery that are expected to could not be performed by laparoscopic approach. 
B.3 Feasibility (see SIGN 50, section 6.2.6) 
Is the intervention/action implementable in the European context? Consider existing cost effectiveness, financial, human and 
other resource implications. 
The intervention is totally feasible in the European context. Cost effectiveness may not be significative, considering the 
reduced postoperative complications and hospital stay.  
B.4 Recommendation (see SIGN 50, section 6.3) 
B.4.a What recommendation(s) does the guideline development group agree are appropriate based on this evidence? 
Strong recommendation: Laparoscopic approach in HCC patients is not inferior in terms of operative mortality, margin 
negativity, overall survival and disease free survival. (major and minor resection) 
Strong recommendation: Laparoscopic approach is superior than open approach in term of hospital stay, transfusion rate, 
operative time, blood loss and postoperative complications. 
Conditional recommendation: Regarding complex resection as posterosuperior segment and major resection or lesion very 
close to hepatic pedicle should be considered with caution, there are insufficient data about that and need more studies. 
Recommendation for research:  Further research should be undertaken in the form of prospective randomized control trials to 
substantiate our findings even further. 
B.4.b “Strong” recommendation should be made where there is confidence that, for the vast majority of people, the 
intervention/action will do more good than harm (or more harm than good). The recommendation should be clearly 
directive and include ‘should/ should not’ in the wording. 
“Conditional” recommendations should be made where the intervention/action will do more good than harm (or more harm 
than good) for most patients, but may include caveats eg on the quality or size of the evidence base, or patient preferences. 
Conditional recommendations should include ‘should be considered/ should not be considered’ in the wording. 
STRONG/CONDITIONAL 
Strong recommendations for the use of laparoscopic approach for HCC patients in minor and major resections by specialized 
team is justified due to the number of comparative series and existing evidence.  
There is insufficient evidence for complex resections as lesions in posterosuperior segments or very close to the hepatic 
pedicle, this decisions depends in strong way of the team experience. That is why conditional evidence is the current status.  
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5. Recommendations for research 
List any aspects of the question that have not been answered and should therefore be highlighted as an area in need of further 
research. 
The main problem of selection bias should be considered for research: 
 To perform multicentre and randomized studies where will be possible to avoid the heterogeneity of the sample on 
each group. At the moment it has been tried to avoid instead of matching method and propensity score matching 
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Considered Judgement Form  
Part B – Evidence to recommendations 
Proforma 
CQ *: What is the role of LLR in cirrhotic patients? 
a. Short term outcomes 
b. Oncologic outcomes 
c. Special advantages / difficulties for cirrhotic patients 
d. Technical aspects for liver resections in cirrhotics 
B.1 Balancing benefits and harms (see SIGN 50, section 6.2.2, 6.2.3) 
Comment here on the potential clinical impact of the intervention/action – eg. magnitude of effect; balance of risk and benefit. 
B.1.a What benefit will the proposed intervention/action have?  
Describe the benefits. Highlight specific outcomes if appropriate. 
Potential benefits from the minimally invasive approach of cirrhotic HCC patients may come from: 
 Improved outcomes for HCC cirrhotic patients with reduced complications 
 Improved short term outcomes (less transfusion rate, less risk of bleeding, short hospital stay, low risk of liver 
failure) 
 Better esthetical impact due to reduced surgical incision.  
 Better control of bleeding due to improved laparoscopic visualization thanks to the image magnification during 
resection.  
B.1.b What harm might the proposed intervention/action do? 
Describe the benefits. Highlight specific outcomes if appropriate. 
There are no specific harms derived from the laparoscopic approach.  
B.2 Impact on patients (see SIGN 50, section 6.2.4, 6.2.5) 
Is the intervention/action acceptable to patients and carers compared to comparison?  
Consider benefits vs harms, quality of life, other patient preferences (refer to patient issues search if appropriate). 
Are there any common comorbidities that could have an impact on the efficacy of the intervention? 
The laparoscopic approach offers benefits over patients who are offered. Laparoscopic resection of HCC in patients with 
cirrhosis is safe and may provide improved outcomes when compared to the open technique.  
B.3 Feasibility (see SIGN 50, section 6.2.6) 
Is the intervention/action implementable in the European context? Consider existing cost effectiveness, financial, human and 
other resource implications. 
The intervention is totally feasible in the European context. Cost effectiveness may not be significative, considering the 
reduced postoperative complications and hospital stay.  
B.4 Recommendation (see SIGN 50, section 6.3) 
B.4.a What recommendation(s) does the guideline development group agree are appropriate based on this evidence? 
Strong recommendation: laparoscopic resection for Cirrhotic HCC patients is safe. 
Strong recommendation: laparoscopic resection for cirrhotic HCC patient provide a better short outcomes as short hospital 
stay, less blood loss, less transfusion rate and low risk of complications (pleural effusion, ascites, pain…) 
Strong recommendation: There are no differences in relation to oncological outcomes and long term between the two 
approaches. 
Strong recommendation: Cirrhotic HCC patients underwent laparoscopic approach could be benefit from this approach in case 
of need transplant for recurrence. This approach reduces transfusion rate, operation time and cold isquemia time on the 
transplant. 
Conditional recommendation: The laparoscopic approach could improve the rate of recurrence due to better margins of 
resection and lower rate of transfusion. 
Conditional recommendation: Laparoscopic approach could be beneficial and safe in patients with Child-Pugh grade C. 
Recommendation for research: Multicentre studies randomized should be done in the future to obtain firmer conclusions. It 
would be required studies comparing specific cirrhotic patients according to the Child-Pugh grade. And also on patients with 
portal vein thrombosis, if in this case the laparoscopic approach could be beneficial. 
B.4.b “Strong” recommendation should be made where there is confidence that, for the vast majority of people, the 
intervention/action will do more good than harm (or more harm than good). The recommendation should be clearly 
directive and include ‘should/ should not’ in the wording. 
“                                           w                     / ction will do more good than harm (or more harm than 
good) for most patients, but may include caveats eg on the quality or size of the evidence base, or patient preferences. Conditional 
                               ‘                    /                         ’        w        
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STRONG/CONDITIONAL 
Strong recommendations for the use of laparoscopic approach for hepatic resection in cirrhotic 
patients should be considered as standard care. 
There is insufficient evidence for complex resection in cirrhotic liver and Child-C liver function. That is why conditional evidence is 
the current status.  
5. Recommendations for research 
List any aspects of the question that have not been answered and should therefore be highlighted as an area in need of further 
research. 
To date, there are a small number of studies comparing laparoscopic hepatic resection for HCC specifically in patients with 
cirrhosis. All studies are non-randomized cohorts from single centres; an element of surgeon and selection bias is possible. 
And the patients in open groups use to be more complex cases, with a localised tumour in posterosuperior segments with a 
bigger size and needing a major resection. These concerns could affect the potential generalizability of results. 
These areas of interest should be considered for research: 
 A multicentre case series of laparoscopic resection in cirrhotic HCC patients 
 A randomized study with a bigger sample size to avoid selection bias existing in this moment. 
 
